Gene Symbol | Gene ID | Gene Info |
---|---|---|
Irf2
|
ENSMUSG00000031627.7 | interferon regulatory factor 2 |
Irf1
|
ENSMUSG00000018899.10 | interferon regulatory factor 1 |
Irf8
|
ENSMUSG00000041515.3 | interferon regulatory factor 8 |
Irf9
|
ENSMUSG00000002325.8 | interferon regulatory factor 9 |
Irf7
|
ENSMUSG00000025498.8 | interferon regulatory factor 7 |
CRE | Gene | Distance | Association probability | Pearson corr. coef. | P-value | Plot |
---|---|---|---|---|---|---|
chr11_53771704_53771855 | Irf1 | 1270 | 0.253147 | 0.56 | 2.8e-06 | Click! |
chr11_53772445_53772970 | Irf1 | 446 | 0.445100 | 0.55 | 6.1e-06 | Click! |
chr11_53768408_53768559 | Irf1 | 1531 | 0.238896 | -0.26 | 4.4e-02 | Click! |
chr11_53769695_53771180 | Irf1 | 40 | 0.951842 | 0.08 | 5.4e-01 | Click! |
chr8_46742571_46742960 | Irf2 | 2499 | 0.213945 | 0.45 | 2.7e-04 | Click! |
chr8_46740059_46740401 | Irf2 | 36 | 0.930177 | 0.39 | 1.9e-03 | Click! |
chr8_46750581_46750732 | Irf2 | 10390 | 0.141713 | 0.23 | 7.2e-02 | Click! |
chr8_46743841_46743992 | Irf2 | 3650 | 0.178498 | -0.12 | 3.5e-01 | Click! |
chr8_46740451_46741590 | Irf2 | 754 | 0.524148 | 0.06 | 6.3e-01 | Click! |
chr7_141265283_141266780 | Irf7 | 12 | 0.937271 | 0.90 | 4.3e-23 | Click! |
chr7_141268805_141269528 | Irf7 | 2685 | 0.107635 | 0.62 | 1.1e-07 | Click! |
chr7_141264658_141264809 | Irf7 | 398 | 0.655888 | 0.33 | 9.0e-03 | Click! |
chr8_120737339_120737490 | Irf8 | 1029 | 0.455481 | 0.76 | 1.5e-12 | Click! |
chr8_120738932_120739951 | Irf8 | 802 | 0.561676 | 0.74 | 9.5e-12 | Click! |
chr8_120737841_120738467 | Irf8 | 485 | 0.750695 | 0.74 | 1.3e-11 | Click! |
chr8_120737059_120737225 | Irf8 | 757 | 0.580268 | 0.74 | 2.1e-11 | Click! |
chr8_120737517_120737814 | Irf8 | 974 | 0.477845 | 0.68 | 1.6e-09 | Click! |
chr14_55604116_55604924 | Irf9 | 57 | 0.898878 | 0.84 | 2.2e-17 | Click! |
chr14_55603475_55604083 | Irf9 | 206 | 0.778323 | 0.72 | 6.4e-11 | Click! |
chr14_55603292_55603443 | Irf9 | 204 | 0.778240 | 0.56 | 4.2e-06 | Click! |
chr14_55605101_55605252 | Irf9 | 597 | 0.395828 | 0.54 | 7.0e-06 | Click! |
chr14_55605603_55606168 | Irf9 | 65 | 0.896327 | 0.47 | 1.6e-04 | Click! |
Move your cursor over a bar to see sample name and corresponding Z-value.
Cis Regulatory Element (CRE) | Target Score | Top associated gene | Gene Info | Distance of CRE to TSS | CRE/Gene association probability |
---|---|---|---|---|---|
chr19_8518372_8518525 | 79.06 |
Gm8189 |
predicted gene 8189 |
23350 |
0.14 |
chr3_142619966_142621017 | 68.03 |
Gbp2 |
guanylate binding protein 2 |
111 |
0.95 |
chr12_99406813_99407850 | 55.65 |
Foxn3 |
forkhead box N3 |
5274 |
0.18 |
chr16_23609555_23610281 | 55.00 |
Rtp4 |
receptor transporter protein 4 |
1 |
0.98 |
chr15_74967661_74968375 | 54.30 |
Ly6e |
lymphocyte antigen 6 complex, locus E |
11463 |
0.08 |
chr5_119830922_119832010 | 53.95 |
Gm43050 |
predicted gene 43050 |
325 |
0.82 |
chr10_79417219_79417524 | 47.30 |
Gm47015 |
predicted gene, 47015 |
534 |
0.77 |
chr7_141265283_141266780 | 45.00 |
Irf7 |
interferon regulatory factor 7 |
12 |
0.94 |
chr1_105971547_105972390 | 44.59 |
Gm18801 |
predicted gene, 18801 |
15658 |
0.14 |
chr11_86581322_86581839 | 44.53 |
Mir21a |
microRNA 21a |
2578 |
0.21 |
chr5_92353176_92354033 | 44.39 |
Cxcl10 |
chemokine (C-X-C motif) ligand 10 |
4715 |
0.11 |
chr3_27316895_27317871 | 43.82 |
Tnfsf10 |
tumor necrosis factor (ligand) superfamily, member 10 |
322 |
0.89 |
chr2_39325776_39326109 | 43.66 |
Vmn2r-ps2 |
vomeronasal 2, receptor, pseudogene 2 |
51836 |
0.11 |
chr19_34640515_34641380 | 42.80 |
Ifit1 |
interferon-induced protein with tetratricopeptide repeats 1 |
76 |
0.67 |
chr7_78913499_78914279 | 40.77 |
Isg20 |
interferon-stimulated protein |
92 |
0.95 |
chr16_84621188_84621719 | 39.89 |
Gm2477 |
predicted gene 2477 |
20247 |
0.15 |
chr1_136685464_136685771 | 39.39 |
Gm19705 |
predicted gene, 19705 |
1988 |
0.24 |
chr10_4611597_4612860 | 38.85 |
Esr1 |
estrogen receptor 1 (alpha) |
207 |
0.95 |
chr8_25099338_25100715 | 37.88 |
5830408C22Rik |
RIKEN cDNA 5830408C22 gene |
1190 |
0.33 |
chr11_78984345_78985263 | 37.83 |
Lgals9 |
lectin, galactose binding, soluble 9 |
27 |
0.98 |
chr11_87756102_87757558 | 37.42 |
Mir142 |
microRNA 142 |
34 |
0.59 |
chrX_52783996_52784386 | 37.30 |
Gm7851 |
predicted gene 7851 |
1175 |
0.3 |
chr8_121082801_121085531 | 36.71 |
Foxf1 |
forkhead box F1 |
220 |
0.71 |
chr4_88550254_88550926 | 36.56 |
Ifna15 |
interferon alpha 15 |
7655 |
0.1 |
chr4_156200257_156201200 | 36.36 |
Isg15 |
ISG15 ubiquitin-like modifier |
68 |
0.93 |
chr18_41860653_41861741 | 36.19 |
Gm50410 |
predicted gene, 50410 |
13637 |
0.22 |
chr13_113013114_113013713 | 36.07 |
Mcidas |
multiciliate differentiation and DNA synthesis associated cell cycle protein |
19568 |
0.08 |
chr10_14085530_14086610 | 35.71 |
Gm28289 |
predicted gene 28289 |
68376 |
0.1 |
chr1_156037391_156037734 | 35.64 |
Tor1aip1 |
torsin A interacting protein 1 |
1082 |
0.37 |
chr11_100931288_100932301 | 35.19 |
Stat3 |
signal transducer and activator of transcription 3 |
7586 |
0.15 |
chr2_60939895_60940920 | 35.14 |
Rbms1 |
RNA binding motif, single stranded interacting protein 1 |
22785 |
0.21 |
chr1_134801821_134802618 | 34.63 |
Gm37949 |
predicted gene, 37949 |
234 |
0.87 |
chr6_31125380_31126701 | 34.24 |
5330406M23Rik |
RIKEN cDNA 5330406M23 gene |
15120 |
0.11 |
chr17_44136051_44136319 | 34.18 |
Clic5 |
chloride intracellular channel 5 |
1417 |
0.48 |
chr2_105125289_105128976 | 33.66 |
Wt1 |
Wilms tumor 1 homolog |
78 |
0.91 |
chr5_99339481_99340596 | 33.59 |
Gm35394 |
predicted gene, 35394 |
65943 |
0.12 |
chr2_18821363_18822378 | 33.30 |
Carlr |
cardiac and apoptosis-related long non-coding RNA |
20052 |
0.17 |
chr3_60408400_60409132 | 33.12 |
Mbnl1 |
muscleblind like splicing factor 1 |
64064 |
0.12 |
chr9_72448745_72450029 | 32.71 |
Gm27231 |
predicted gene 27231 |
7608 |
0.08 |
chr6_57580700_57581747 | 32.30 |
Herc6 |
hect domain and RLD 6 |
215 |
0.92 |
chr4_11146992_11147797 | 32.15 |
Gm11830 |
predicted gene 11830 |
2684 |
0.17 |
chr11_72301272_72302549 | 32.09 |
Xaf1 |
XIAP associated factor 1 |
245 |
0.87 |
chr4_59546414_59547011 | 32.00 |
Ptbp3 |
polypyrimidine tract binding protein 3 |
2025 |
0.25 |
chr1_13293396_13293901 | 31.98 |
Gm38223 |
predicted gene, 38223 |
3142 |
0.16 |
chr7_49633274_49634660 | 31.96 |
Dbx1 |
developing brain homeobox 1 |
2882 |
0.33 |
chr2_11192452_11193359 | 31.76 |
Gm37520 |
predicted gene, 37520 |
407 |
0.78 |
chr11_119392783_119393622 | 31.75 |
Rnf213 |
ring finger protein 213 |
102 |
0.95 |
chr14_66279066_66281333 | 31.66 |
Ptk2b |
PTK2 protein tyrosine kinase 2 beta |
783 |
0.61 |
chr6_34862829_34863673 | 31.36 |
Tmem140 |
transmembrane protein 140 |
11 |
0.96 |
chr8_71788982_71789349 | 31.34 |
Gm35572 |
predicted gene, 35572 |
7843 |
0.12 |
chr7_75655719_75656017 | 30.88 |
Akap13 |
A kinase (PRKA) anchor protein 13 |
11683 |
0.18 |
chr2_44988425_44989191 | 30.45 |
Zeb2 |
zinc finger E-box binding homeobox 2 |
34107 |
0.17 |
chr4_98436713_98437393 | 30.26 |
Patj |
PATJ, crumbs cell polarity complex component |
110 |
0.97 |
chr1_37478065_37479166 | 30.07 |
4930594C11Rik |
RIKEN cDNA 4930594C11 gene |
9990 |
0.14 |
chr15_79891602_79892946 | 29.99 |
Apobec3 |
apolipoprotein B mRNA editing enzyme, catalytic polypeptide 3 |
129 |
0.93 |
chr17_33919393_33920922 | 29.98 |
Gm19412 |
predicted gene, 19412 |
132 |
0.67 |
chr7_102564580_102565487 | 29.94 |
Trim21 |
tripartite motif-containing 21 |
412 |
0.62 |
chr14_64501457_64502171 | 29.91 |
Gm47202 |
predicted gene, 47202 |
35724 |
0.15 |
chr18_11049995_11051717 | 29.89 |
Gata6os |
GATA binding protein 6, opposite strand |
631 |
0.64 |
chr4_132397551_132398511 | 29.50 |
Phactr4 |
phosphatase and actin regulator 4 |
168 |
0.89 |
chr14_79518977_79519658 | 29.42 |
Elf1 |
E74-like factor 1 |
3619 |
0.2 |
chr8_92772093_92772432 | 29.33 |
Mmp2 |
matrix metallopeptidase 2 |
55029 |
0.1 |
chr9_92207507_92207757 | 29.27 |
Plscr5 |
phospholipid scramblase family, member 5 |
14696 |
0.18 |
chr3_51553033_51553829 | 29.22 |
Setd7 |
SET domain containing (lysine methyltransferase) 7 |
2111 |
0.18 |
chr5_139793597_139793944 | 29.13 |
Mafk |
v-maf musculoaponeurotic fibrosarcoma oncogene family, protein K (avian) |
2236 |
0.2 |
chr19_29371530_29372436 | 29.04 |
Cd274 |
CD274 antigen |
4528 |
0.15 |
chr2_157131218_157131461 | 28.94 |
Samhd1 |
SAM domain and HD domain, 1 |
1282 |
0.39 |
chr3_102723836_102724451 | 28.83 |
Gm42682 |
predicted gene 42682 |
9891 |
0.12 |
chr15_41916865_41917296 | 28.75 |
Gm5469 |
predicted gene 5469 |
4996 |
0.22 |
chrX_168779063_168779495 | 28.32 |
Gm15233 |
predicted gene 15233 |
4023 |
0.27 |
chr1_66838249_66838716 | 28.26 |
Gm15793 |
predicted gene 15793 |
11120 |
0.08 |
chr1_88575722_88576248 | 27.85 |
Gm19589 |
predicted gene, 19589 |
24468 |
0.16 |
chr16_97534630_97535746 | 27.82 |
Mx2 |
MX dynamin-like GTPase 2 |
120 |
0.95 |
chr2_65471251_65471800 | 27.57 |
Scn3a |
sodium channel, voltage-gated, type III, alpha |
23706 |
0.18 |
chr4_71291873_71292024 | 27.53 |
Gm11229 |
predicted gene 11229 |
6006 |
0.31 |
chr5_120812597_120813108 | 27.47 |
Oas1b |
2'-5' oligoadenylate synthetase 1B |
214 |
0.61 |
chr2_65792466_65792642 | 27.42 |
BX284648.1 |
sodium channel, voltage-gated, type II, alpha (Scn2a) pseudogene |
30357 |
0.17 |
chr15_65744522_65744909 | 27.39 |
Efr3a |
EFR3 homolog A |
42319 |
0.15 |
chr4_135313499_135314239 | 27.39 |
Gm12982 |
predicted gene 12982 |
5899 |
0.12 |
chr12_36216606_36217252 | 27.29 |
Lrrc72 |
leucine rich repeat containing 72 |
1273 |
0.4 |
chr19_55643153_55643655 | 27.22 |
Tcf7l2 |
transcription factor 7 like 2, T cell specific, HMG box |
98416 |
0.08 |
chr18_35847749_35850271 | 27.09 |
Cxxc5 |
CXXC finger 5 |
5677 |
0.11 |
chr12_103434225_103434651 | 26.77 |
Ifi27 |
interferon, alpha-inducible protein 27 |
146 |
0.91 |
chr8_71205665_71206018 | 26.76 |
Aprt-ps |
adenine phosphoribosyl transferase, pseudogene |
18108 |
0.15 |
chr9_111055888_111057545 | 26.73 |
Ccrl2 |
chemokine (C-C motif) receptor-like 2 |
530 |
0.62 |
chr1_51291546_51292409 | 26.56 |
Cavin2 |
caveolae associated 2 |
2851 |
0.27 |
chr11_119394258_119394694 | 26.49 |
Rnf213 |
ring finger protein 213 |
1376 |
0.33 |
chr19_34583152_34583838 | 26.48 |
Ifit3 |
interferon-induced protein with tetratricopeptide repeats 3 |
36 |
0.96 |
chr3_24782863_24783977 | 26.42 |
Naaladl2 |
N-acetylated alpha-linked acidic dipeptidase-like 2 |
202 |
0.97 |
chr7_115040411_115040712 | 26.26 |
Gm34225 |
predicted gene, 34225 |
8624 |
0.24 |
chr10_42631631_42634217 | 26.20 |
Ostm1 |
osteopetrosis associated transmembrane protein 1 |
45992 |
0.12 |
chr18_5603232_5604403 | 26.09 |
Zeb1 |
zinc finger E-box binding homeobox 1 |
73 |
0.96 |
chr9_92265520_92266260 | 26.05 |
Plscr1 |
phospholipid scramblase 1 |
405 |
0.75 |
chr4_135727528_135728972 | 26.00 |
Il22ra1 |
interleukin 22 receptor, alpha 1 |
78 |
0.96 |
chr18_79257057_79258150 | 25.83 |
Gm2116 |
predicted gene 2116 |
47559 |
0.15 |
chr7_127014020_127014913 | 25.80 |
Mvp |
major vault protein |
84 |
0.88 |
chr11_49086704_49087417 | 25.77 |
Olfr56 |
olfactory receptor 56 |
8 |
0.49 |
chr5_123318053_123318557 | 25.70 |
Gm15857 |
predicted gene 15857 |
7981 |
0.1 |
chr11_89100652_89101580 | 25.50 |
Gm22534 |
predicted gene, 22534 |
13965 |
0.13 |
chr13_94382387_94382639 | 25.42 |
Ap3b1 |
adaptor-related protein complex 3, beta 1 subunit |
23553 |
0.16 |
chr15_75862074_75863063 | 25.32 |
Gsdmd |
gasdermin D |
189 |
0.88 |
chr9_114730432_114730583 | 25.22 |
Cmtm6 |
CKLF-like MARVEL transmembrane domain containing 6 |
609 |
0.7 |
chr3_116859587_116859815 | 25.19 |
Frrs1 |
ferric-chelate reductase 1 |
134 |
0.94 |
chr6_57582472_57582776 | 25.16 |
Herc6 |
hect domain and RLD 6 |
1616 |
0.33 |
chr4_154926952_154928851 | 25.13 |
Tnfrsf14 |
tumor necrosis factor receptor superfamily, member 14 (herpesvirus entry mediator) |
176 |
0.92 |
chr13_3636880_3637291 | 25.01 |
Asb13 |
ankyrin repeat and SOCS box-containing 13 |
2986 |
0.21 |
chr9_45417234_45417420 | 25.01 |
Gm48135 |
predicted gene, 48135 |
3237 |
0.16 |
chr6_51169545_51171295 | 25.00 |
Mir148a |
microRNA 148a |
99490 |
0.07 |
chr3_38202158_38202473 | 24.90 |
5430434I15Rik |
RIKEN cDNA 5430434I15 gene |
5804 |
0.21 |
chr10_12874878_12875307 | 24.84 |
Utrn |
utrophin |
5727 |
0.21 |
chr19_20389423_20390852 | 24.74 |
Anxa1 |
annexin A1 |
514 |
0.81 |
chr18_11051784_11053949 | 24.46 |
Gata6 |
GATA binding protein 6 |
178 |
0.66 |
chr19_29940390_29940617 | 24.44 |
Il33 |
interleukin 33 |
5287 |
0.21 |
chr11_109331606_109331875 | 24.36 |
1700096J18Rik |
RIKEN cDNA 1700096J18 gene |
15099 |
0.14 |
chr12_63552794_63553211 | 24.17 |
Gm48417 |
predicted gene, 48417 |
18861 |
0.25 |
chr11_58214604_58215588 | 24.16 |
Irgm2 |
immunity-related GTPase family M member 2 |
68 |
0.95 |
chr10_44380217_44380973 | 23.92 |
Mir1929 |
microRNA 1929 |
20919 |
0.18 |
chr3_14869711_14869953 | 23.81 |
Car3 |
carbonic anhydrase 3 |
654 |
0.71 |
chr13_41583704_41583962 | 23.74 |
Gm24819 |
predicted gene, 24819 |
5759 |
0.17 |
chr6_137931136_137931732 | 23.68 |
Gm24308 |
predicted gene, 24308 |
11463 |
0.27 |
chr17_36020346_36021134 | 23.65 |
H2-T24 |
histocompatibility 2, T region locus 24 |
180 |
0.83 |
chr3_126692835_126693702 | 23.60 |
Gm15551 |
predicted gene 15551 |
24224 |
0.12 |
chr12_34713492_34714861 | 23.55 |
Gm47357 |
predicted gene, 47357 |
85538 |
0.09 |
chr12_110498335_110499098 | 23.52 |
Gm19605 |
predicted gene, 19605 |
12508 |
0.16 |
chr7_104445679_104446146 | 23.43 |
Trim30a |
tripartite motif-containing 30A |
19281 |
0.09 |
chr12_61994411_61994562 | 23.43 |
Gm48358 |
predicted gene, 48358 |
2717 |
0.31 |
chr14_79515651_79516545 | 23.41 |
Elf1 |
E74-like factor 1 |
400 |
0.83 |
chr14_36863736_36864289 | 23.36 |
n-R5s46 |
nuclear encoded rRNA 5S 46 |
7968 |
0.22 |
chr17_34197631_34198714 | 23.35 |
Psmb8 |
proteasome (prosome, macropain) subunit, beta type 8 (large multifunctional peptidase 7) |
198 |
0.82 |
chr8_108599682_108599941 | 23.28 |
Zfhx3 |
zinc finger homeobox 3 |
12527 |
0.21 |
chr18_21821900_21822125 | 23.24 |
Klhl14 |
kelch-like 14 |
167294 |
0.04 |
chr2_158159832_158160227 | 23.24 |
Tgm2 |
transglutaminase 2, C polypeptide |
13593 |
0.14 |
chr1_78817332_78818790 | 23.19 |
Kcne4 |
potassium voltage-gated channel, Isk-related subfamily, gene 4 |
1134 |
0.48 |
chr3_96300488_96301435 | 23.10 |
Fcgr1 |
Fc receptor, IgG, high affinity I |
6992 |
0.06 |
chr1_181852456_181853806 | 23.07 |
Gm5533 |
predicted gene 5533 |
58 |
0.96 |
chr1_101902231_101902382 | 23.04 |
Gm28187 |
predicted gene 28187 |
7215 |
0.26 |
chr18_10532272_10533276 | 23.03 |
Gm24894 |
predicted gene, 24894 |
18632 |
0.16 |
chr19_36117589_36118325 | 22.97 |
Ankrd1 |
ankyrin repeat domain 1 (cardiac muscle) |
1953 |
0.34 |
chr4_83315229_83315966 | 22.96 |
Ttc39b |
tetratricopeptide repeat domain 39B |
8592 |
0.19 |
chr3_27839708_27840308 | 22.85 |
Gm26040 |
predicted gene, 26040 |
28105 |
0.2 |
chr1_85735264_85735792 | 22.82 |
A630001G21Rik |
RIKEN cDNA A630001G21 gene |
1026 |
0.4 |
chr2_79087179_79088090 | 22.81 |
Gm14469 |
predicted gene 14469 |
48900 |
0.14 |
chr11_88998963_89000826 | 22.71 |
Trim25 |
tripartite motif-containing 25 |
518 |
0.65 |
chr8_47851685_47852685 | 22.67 |
Cldn22 |
claudin 22 |
27703 |
0.12 |
chr6_51129516_51130052 | 22.62 |
Mir148a |
microRNA 148a |
140126 |
0.04 |
chr12_77059916_77060880 | 22.53 |
Gm35189 |
predicted gene, 35189 |
18197 |
0.2 |
chr5_101239366_101239752 | 22.53 |
Cycs-ps2 |
cytochrome c, pseudogene 2 |
66019 |
0.13 |
chr13_59820826_59821264 | 22.52 |
Tut7 |
terminal uridylyl transferase 7 |
1543 |
0.23 |
chr11_29647613_29648153 | 22.48 |
Gm12092 |
predicted gene 12092 |
2374 |
0.23 |
chr14_55193882_55194237 | 22.47 |
Gm46455 |
predicted gene, 46455 |
24350 |
0.1 |
chr14_76449046_76449258 | 22.39 |
Tsc22d1 |
TSC22 domain family, member 1 |
10219 |
0.25 |
chr16_36989294_36990265 | 22.39 |
Fbxo40 |
F-box protein 40 |
688 |
0.6 |
chr12_70136349_70136831 | 22.38 |
Abhd12b |
abhydrolase domain containing 12B |
17552 |
0.14 |
chr4_6452386_6452782 | 22.38 |
Nsmaf |
neutral sphingomyelinase (N-SMase) activation associated factor |
995 |
0.58 |
chr1_194879772_194880217 | 22.35 |
Mir3962 |
microRNA 3962 |
57993 |
0.08 |
chr6_101532530_101532930 | 22.26 |
Gm44171 |
predicted gene, 44171 |
6023 |
0.23 |
chr1_153751697_153752752 | 22.25 |
Rnasel |
ribonuclease L (2', 5'-oligoisoadenylate synthetase-dependent) |
256 |
0.82 |
chr17_36121600_36121886 | 22.24 |
Gm19684 |
predicted gene, 19684 |
65 |
0.72 |
chr1_37495785_37496430 | 22.24 |
Mgat4a |
mannoside acetylglucosaminyltransferase 4, isoenzyme A |
12 |
0.97 |
chr18_84292976_84293446 | 22.19 |
Gm37216 |
predicted gene, 37216 |
82935 |
0.08 |
chr5_90491353_90492067 | 22.16 |
Afp |
alpha fetoprotein |
472 |
0.75 |
chr2_30942616_30942842 | 22.15 |
Tor1b |
torsin family 1, member B |
10230 |
0.12 |
chr12_55465326_55465841 | 22.15 |
Nfkbia |
nuclear factor of kappa light polypeptide gene enhancer in B cells inhibitor, alpha |
26227 |
0.14 |
chr12_114378743_114379451 | 22.14 |
Ighv1-1 |
immunoglobulin heavy variable V1-1 |
27102 |
0.1 |
chr7_49525132_49526263 | 22.12 |
Nav2 |
neuron navigator 2 |
22495 |
0.22 |
chr6_143750987_143751675 | 22.09 |
1700060C16Rik |
RIKEN cDNA 1700060C16 gene |
100043 |
0.08 |
chr4_115057577_115059724 | 22.08 |
Tal1 |
T cell acute lymphocytic leukemia 1 |
839 |
0.56 |
chr12_40018053_40018384 | 21.88 |
Arl4a |
ADP-ribosylation factor-like 4A |
3734 |
0.23 |
chr5_150599337_150599741 | 21.87 |
Gm43598 |
predicted gene 43598 |
1 |
0.95 |
chr4_66414553_66415137 | 21.86 |
Astn2 |
astrotactin 2 |
10234 |
0.28 |
chr7_16844794_16846016 | 21.81 |
Prkd2 |
protein kinase D2 |
172 |
0.9 |
chr19_3905104_3905901 | 21.81 |
Tcirg1 |
T cell, immune regulator 1, ATPase, H+ transporting, lysosomal V0 protein A3 |
272 |
0.79 |
chr19_41345332_41345831 | 21.80 |
Pik3ap1 |
phosphoinositide-3-kinase adaptor protein 1 |
39515 |
0.17 |
chr6_15793443_15794046 | 21.79 |
Gm43924 |
predicted gene, 43924 |
17579 |
0.22 |
chr1_112456627_112457016 | 21.73 |
Gm22331 |
predicted gene, 22331 |
11090 |
0.28 |
chr9_95743075_95743310 | 21.72 |
Trpc1 |
transient receptor potential cation channel, subfamily C, member 1 |
7166 |
0.18 |
chr4_140770313_140770939 | 21.71 |
Padi4 |
peptidyl arginine deiminase, type IV |
3610 |
0.16 |
chr7_90060194_90061467 | 21.64 |
Gm44861 |
predicted gene 44861 |
18133 |
0.12 |
chr13_59820073_59820550 | 21.63 |
Tut7 |
terminal uridylyl transferase 7 |
2277 |
0.17 |
chr6_3620342_3620981 | 21.56 |
Vps50 |
VPS50 EARP/GARPII complex subunit |
26643 |
0.17 |
chr8_45409699_45410897 | 21.51 |
Tlr3 |
toll-like receptor 3 |
78 |
0.71 |
chr3_127123282_127124895 | 21.44 |
Ank2 |
ankyrin 2, brain |
774 |
0.59 |
chr5_114897030_114897905 | 21.43 |
Oasl2 |
2'-5' oligoadenylate synthetase-like 2 |
65 |
0.94 |
chr17_71204583_71205351 | 21.41 |
Lpin2 |
lipin 2 |
291 |
0.89 |
chr8_127439574_127440903 | 21.34 |
Pard3 |
par-3 family cell polarity regulator |
7508 |
0.31 |
chr4_154635108_154637998 | 21.33 |
Prdm16 |
PR domain containing 16 |
244 |
0.83 |
chr2_4389431_4390235 | 21.32 |
Frmd4a |
FERM domain containing 4A |
217 |
0.93 |
chr14_63247276_63249044 | 21.31 |
Gata4 |
GATA binding protein 4 |
2889 |
0.24 |
chr7_49462236_49462770 | 21.29 |
Gm38059 |
predicted gene, 38059 |
7209 |
0.23 |
chr11_20132956_20133378 | 21.28 |
Gm12030 |
predicted gene 12030 |
9401 |
0.16 |
chr5_72796212_72796844 | 21.15 |
Tec |
tec protein tyrosine kinase |
10508 |
0.15 |
chr8_71536912_71538170 | 21.09 |
Bst2 |
bone marrow stromal cell antigen 2 |
85 |
0.92 |
chr1_173879500_173880236 | 21.03 |
Mndal |
myeloid nuclear differentiation antigen like |
243 |
0.89 |
chr2_48332539_48333378 | 21.03 |
Gm13482 |
predicted gene 13482 |
34050 |
0.18 |
chr7_115845255_115845445 | 20.99 |
Sox6 |
SRY (sex determining region Y)-box 6 |
755 |
0.78 |
chr17_69396592_69397159 | 20.96 |
Gm49894 |
predicted gene, 49894 |
12667 |
0.14 |
chr4_97920128_97920941 | 20.96 |
Nfia |
nuclear factor I/A |
9501 |
0.3 |
chr4_56221989_56222579 | 20.88 |
2310081O03Rik |
RIKEN cDNA 2310081O03 gene |
2237 |
0.41 |
chr11_106381933_106382567 | 20.84 |
Icam2 |
intercellular adhesion molecule 2 |
531 |
0.7 |
chr9_5345433_5346237 | 20.76 |
Casp12 |
caspase 12 |
331 |
0.91 |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
18.9 | 56.7 | GO:1900169 | regulation of glucocorticoid mediated signaling pathway(GO:1900169) |
17.2 | 34.4 | GO:0060375 | regulation of mast cell differentiation(GO:0060375) |
14.4 | 43.1 | GO:0032911 | negative regulation of transforming growth factor beta1 production(GO:0032911) |
13.7 | 68.7 | GO:0003175 | tricuspid valve development(GO:0003175) |
13.3 | 40.0 | GO:0043321 | regulation of natural killer cell degranulation(GO:0043321) |
12.4 | 37.1 | GO:0034165 | positive regulation of toll-like receptor 9 signaling pathway(GO:0034165) |
11.5 | 34.6 | GO:0060523 | prostate epithelial cord elongation(GO:0060523) |
11.5 | 103.5 | GO:0070269 | pyroptosis(GO:0070269) |
11.5 | 34.5 | GO:0048769 | sarcomerogenesis(GO:0048769) |
11.2 | 33.5 | GO:2000195 | negative regulation of female gonad development(GO:2000195) |
10.6 | 53.2 | GO:1900227 | positive regulation of NLRP3 inflammasome complex assembly(GO:1900227) |
10.5 | 31.6 | GO:0060931 | sinoatrial node cell development(GO:0060931) |
10.5 | 73.2 | GO:0002756 | MyD88-independent toll-like receptor signaling pathway(GO:0002756) |
10.3 | 31.0 | GO:0048369 | lateral mesoderm morphogenesis(GO:0048369) lateral mesoderm formation(GO:0048370) lateral mesodermal cell differentiation(GO:0048371) |
9.9 | 29.6 | GO:0033031 | positive regulation of neutrophil apoptotic process(GO:0033031) |
9.7 | 19.5 | GO:1904179 | positive regulation of adipose tissue development(GO:1904179) |
8.3 | 24.9 | GO:0032819 | positive regulation of natural killer cell proliferation(GO:0032819) |
8.2 | 272.1 | GO:0035456 | response to interferon-beta(GO:0035456) |
8.0 | 32.0 | GO:0010529 | regulation of transposition(GO:0010528) negative regulation of transposition(GO:0010529) |
7.7 | 23.0 | GO:0016554 | cytidine to uridine editing(GO:0016554) |
7.3 | 22.0 | GO:2000111 | positive regulation of macrophage apoptotic process(GO:2000111) |
7.3 | 22.0 | GO:0034146 | toll-like receptor 5 signaling pathway(GO:0034146) |
7.3 | 36.3 | GO:0032020 | ISG15-protein conjugation(GO:0032020) |
7.2 | 14.4 | GO:0061031 | endodermal digestive tract morphogenesis(GO:0061031) |
7.2 | 7.2 | GO:0061325 | cell proliferation involved in outflow tract morphogenesis(GO:0061325) |
7.1 | 21.2 | GO:0042520 | positive regulation of tyrosine phosphorylation of Stat4 protein(GO:0042520) |
7.0 | 7.0 | GO:1905005 | regulation of epithelial to mesenchymal transition involved in endocardial cushion formation(GO:1905005) |
7.0 | 21.0 | GO:0051891 | positive regulation of cardioblast differentiation(GO:0051891) |
6.9 | 20.7 | GO:1904139 | microglial cell migration(GO:1904124) regulation of microglial cell migration(GO:1904139) |
6.9 | 27.5 | GO:0009414 | response to water deprivation(GO:0009414) |
6.7 | 6.7 | GO:0097296 | activation of cysteine-type endopeptidase activity involved in apoptotic signaling pathway(GO:0097296) |
6.7 | 6.7 | GO:0034163 | regulation of toll-like receptor 9 signaling pathway(GO:0034163) |
6.7 | 20.0 | GO:0035754 | B cell chemotaxis(GO:0035754) |
6.5 | 19.6 | GO:0006203 | dGTP catabolic process(GO:0006203) |
6.5 | 19.6 | GO:0089700 | protein kinase D signaling(GO:0089700) |
6.5 | 19.4 | GO:2000870 | regulation of progesterone secretion(GO:2000870) |
6.5 | 32.3 | GO:0086064 | cell communication by electrical coupling involved in cardiac conduction(GO:0086064) |
6.4 | 6.4 | GO:1904502 | regulation of lipophagy(GO:1904502) positive regulation of lipophagy(GO:1904504) |
6.4 | 19.1 | GO:0007525 | somatic muscle development(GO:0007525) |
6.2 | 24.9 | GO:0050904 | diapedesis(GO:0050904) |
6.2 | 18.6 | GO:2000670 | positive regulation of dendritic cell apoptotic process(GO:2000670) |
6.2 | 43.1 | GO:2000051 | negative regulation of non-canonical Wnt signaling pathway(GO:2000051) |
6.1 | 24.5 | GO:2001181 | positive regulation of interleukin-10 secretion(GO:2001181) |
6.1 | 30.6 | GO:0046642 | negative regulation of alpha-beta T cell proliferation(GO:0046642) |
6.1 | 24.4 | GO:0097460 | ferrous iron import into cell(GO:0097460) |
6.0 | 24.0 | GO:1903519 | apoptotic process involved in mammary gland involution(GO:0060057) positive regulation of apoptotic process involved in mammary gland involution(GO:0060058) positive regulation of apoptotic process involved in morphogenesis(GO:1902339) regulation of mammary gland involution(GO:1903519) positive regulation of mammary gland involution(GO:1903521) positive regulation of apoptotic process involved in development(GO:1904747) |
6.0 | 12.0 | GO:0014858 | positive regulation of skeletal muscle cell proliferation(GO:0014858) |
6.0 | 17.9 | GO:0007039 | protein catabolic process in the vacuole(GO:0007039) |
6.0 | 167.0 | GO:0045071 | negative regulation of viral genome replication(GO:0045071) |
6.0 | 17.9 | GO:0033668 | negative regulation by symbiont of host apoptotic process(GO:0033668) negative regulation by symbiont of host programmed cell death(GO:0052041) negative regulation by organism of programmed cell death in other organism involved in symbiotic interaction(GO:0052490) |
6.0 | 17.9 | GO:0010956 | negative regulation of calcidiol 1-monooxygenase activity(GO:0010956) |
5.9 | 5.9 | GO:0070627 | ferrous iron import(GO:0070627) |
5.9 | 17.8 | GO:0006556 | S-adenosylmethionine biosynthetic process(GO:0006556) |
5.9 | 17.8 | GO:0036023 | limb joint morphogenesis(GO:0036022) embryonic skeletal limb joint morphogenesis(GO:0036023) |
5.8 | 28.8 | GO:0006686 | sphingomyelin biosynthetic process(GO:0006686) |
5.7 | 5.7 | GO:1904177 | regulation of adipose tissue development(GO:1904177) |
5.6 | 22.3 | GO:0010649 | regulation of cell communication by electrical coupling(GO:0010649) |
5.6 | 11.1 | GO:0070460 | thyroid-stimulating hormone secretion(GO:0070460) |
5.5 | 32.8 | GO:0039530 | MDA-5 signaling pathway(GO:0039530) |
5.4 | 16.3 | GO:0033159 | negative regulation of protein import into nucleus, translocation(GO:0033159) |
5.4 | 21.7 | GO:0008228 | opsonization(GO:0008228) |
5.4 | 16.2 | GO:0061113 | pancreas morphogenesis(GO:0061113) |
5.2 | 15.6 | GO:0019626 | short-chain fatty acid catabolic process(GO:0019626) |
5.2 | 20.8 | GO:0034154 | toll-like receptor 7 signaling pathway(GO:0034154) |
5.2 | 15.6 | GO:0019254 | carnitine metabolic process, CoA-linked(GO:0019254) |
5.1 | 15.2 | GO:0090258 | negative regulation of mitochondrial fission(GO:0090258) |
5.1 | 20.2 | GO:0046645 | positive regulation of gamma-delta T cell differentiation(GO:0045588) positive regulation of gamma-delta T cell activation(GO:0046645) |
5.1 | 10.1 | GO:2000338 | chemokine (C-X-C motif) ligand 1 production(GO:0072566) regulation of chemokine (C-X-C motif) ligand 1 production(GO:2000338) |
5.0 | 15.1 | GO:0021564 | vagus nerve development(GO:0021564) |
5.0 | 15.0 | GO:0010725 | regulation of primitive erythrocyte differentiation(GO:0010725) |
5.0 | 19.9 | GO:0045629 | negative regulation of T-helper 2 cell differentiation(GO:0045629) |
5.0 | 5.0 | GO:0035771 | interleukin-4-mediated signaling pathway(GO:0035771) |
5.0 | 9.9 | GO:0072162 | metanephric mesenchymal cell differentiation(GO:0072162) |
5.0 | 14.9 | GO:0003032 | detection of oxygen(GO:0003032) |
4.9 | 19.6 | GO:0019805 | quinolinate biosynthetic process(GO:0019805) |
4.9 | 9.8 | GO:0098910 | regulation of atrial cardiac muscle cell action potential(GO:0098910) |
4.9 | 19.5 | GO:0048023 | positive regulation of melanin biosynthetic process(GO:0048023) positive regulation of secondary metabolite biosynthetic process(GO:1900378) |
4.8 | 19.2 | GO:0010756 | positive regulation of plasminogen activation(GO:0010756) |
4.8 | 23.9 | GO:0034242 | negative regulation of syncytium formation by plasma membrane fusion(GO:0034242) |
4.7 | 9.5 | GO:0043152 | induction of bacterial agglutination(GO:0043152) |
4.7 | 14.1 | GO:0060298 | positive regulation of sarcomere organization(GO:0060298) |
4.7 | 9.4 | GO:1904469 | positive regulation of tumor necrosis factor secretion(GO:1904469) |
4.7 | 14.0 | GO:0070427 | nucleotide-binding oligomerization domain containing 1 signaling pathway(GO:0070427) |
4.6 | 18.5 | GO:0090086 | negative regulation of protein deubiquitination(GO:0090086) |
4.6 | 18.5 | GO:0010897 | negative regulation of triglyceride catabolic process(GO:0010897) |
4.5 | 22.5 | GO:0046501 | protoporphyrinogen IX metabolic process(GO:0046501) |
4.5 | 13.4 | GO:0000960 | mitochondrial RNA catabolic process(GO:0000957) regulation of mitochondrial RNA catabolic process(GO:0000960) |
4.4 | 17.7 | GO:0006083 | acetate metabolic process(GO:0006083) |
4.4 | 13.1 | GO:0009730 | detection of carbohydrate stimulus(GO:0009730) detection of hexose stimulus(GO:0009732) detection of monosaccharide stimulus(GO:0034287) detection of glucose(GO:0051594) |
4.3 | 29.8 | GO:0002072 | optic cup morphogenesis involved in camera-type eye development(GO:0002072) |
4.3 | 12.8 | GO:1904154 | positive regulation of retrograde protein transport, ER to cytosol(GO:1904154) |
4.3 | 17.0 | GO:0086023 | adrenergic receptor signaling pathway involved in heart process(GO:0086023) |
4.2 | 12.7 | GO:2000346 | negative regulation of hepatocyte proliferation(GO:2000346) |
4.2 | 16.8 | GO:0051919 | positive regulation of fibrinolysis(GO:0051919) |
4.2 | 16.7 | GO:0038165 | oncostatin-M-mediated signaling pathway(GO:0038165) |
4.1 | 4.1 | GO:1903977 | positive regulation of glial cell migration(GO:1903977) |
4.1 | 12.4 | GO:0030886 | negative regulation of myeloid dendritic cell activation(GO:0030886) |
4.1 | 41.3 | GO:0016540 | protein autoprocessing(GO:0016540) |
4.1 | 12.4 | GO:0043578 | nuclear matrix organization(GO:0043578) nuclear matrix anchoring at nuclear membrane(GO:0090292) |
4.1 | 65.7 | GO:0051205 | protein insertion into membrane(GO:0051205) |
4.1 | 8.2 | GO:0002282 | microglial cell activation involved in immune response(GO:0002282) |
4.1 | 12.3 | GO:0035694 | mitochondrial protein catabolic process(GO:0035694) |
4.1 | 20.4 | GO:0071447 | cellular response to hydroperoxide(GO:0071447) |
4.1 | 12.2 | GO:0002584 | negative regulation of antigen processing and presentation of peptide antigen(GO:0002584) |
4.0 | 12.1 | GO:0061470 | T follicular helper cell differentiation(GO:0061470) |
4.0 | 36.2 | GO:0043569 | negative regulation of insulin-like growth factor receptor signaling pathway(GO:0043569) |
4.0 | 16.1 | GO:0060665 | regulation of branching involved in salivary gland morphogenesis by mesenchymal-epithelial signaling(GO:0060665) |
4.0 | 16.0 | GO:0030309 | poly-N-acetyllactosamine metabolic process(GO:0030309) poly-N-acetyllactosamine biosynthetic process(GO:0030311) |
4.0 | 4.0 | GO:0071351 | cellular response to interleukin-18(GO:0071351) |
4.0 | 35.7 | GO:0030953 | astral microtubule organization(GO:0030953) |
3.9 | 23.7 | GO:0090527 | actin filament reorganization(GO:0090527) |
3.9 | 3.9 | GO:2000564 | regulation of CD8-positive, alpha-beta T cell proliferation(GO:2000564) |
3.9 | 11.7 | GO:0071225 | cellular response to muramyl dipeptide(GO:0071225) |
3.9 | 7.7 | GO:0030240 | skeletal muscle thin filament assembly(GO:0030240) |
3.8 | 7.7 | GO:0050427 | 3'-phosphoadenosine 5'-phosphosulfate metabolic process(GO:0050427) |
3.8 | 7.7 | GO:0038028 | insulin receptor signaling pathway via phosphatidylinositol 3-kinase(GO:0038028) |
3.8 | 19.1 | GO:0046485 | ether lipid metabolic process(GO:0046485) |
3.8 | 11.3 | GO:0006768 | biotin metabolic process(GO:0006768) |
3.7 | 3.7 | GO:0098869 | cellular oxidant detoxification(GO:0098869) |
3.7 | 18.3 | GO:0032237 | activation of store-operated calcium channel activity(GO:0032237) |
3.6 | 14.6 | GO:0072656 | maintenance of protein location in mitochondrion(GO:0072656) |
3.6 | 10.9 | GO:0006741 | NADP biosynthetic process(GO:0006741) |
3.6 | 10.8 | GO:2000504 | positive regulation of blood vessel remodeling(GO:2000504) |
3.6 | 21.5 | GO:0071763 | nuclear membrane organization(GO:0071763) |
3.6 | 10.7 | GO:0051902 | negative regulation of mitochondrial depolarization(GO:0051902) |
3.6 | 7.2 | GO:0035995 | detection of muscle stretch(GO:0035995) |
3.6 | 14.3 | GO:0032264 | IMP salvage(GO:0032264) |
3.6 | 17.8 | GO:1900454 | positive regulation of long term synaptic depression(GO:1900454) |
3.5 | 31.8 | GO:0051444 | negative regulation of ubiquitin-protein transferase activity(GO:0051444) |
3.5 | 3.5 | GO:1904706 | negative regulation of vascular smooth muscle cell proliferation(GO:1904706) |
3.5 | 3.5 | GO:1900211 | mesenchymal cell apoptotic process involved in metanephros development(GO:1900200) regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900211) negative regulation of mesenchymal cell apoptotic process involved in metanephros development(GO:1900212) |
3.5 | 10.5 | GO:0035526 | retrograde transport, plasma membrane to Golgi(GO:0035526) |
3.5 | 17.5 | GO:0071918 | urea transmembrane transport(GO:0071918) |
3.5 | 10.5 | GO:0000820 | regulation of glutamine family amino acid metabolic process(GO:0000820) |
3.5 | 13.8 | GO:0061074 | regulation of neural retina development(GO:0061074) |
3.4 | 6.9 | GO:0032058 | positive regulation of translational initiation in response to stress(GO:0032058) |
3.4 | 10.3 | GO:2000048 | negative regulation of cell-cell adhesion mediated by cadherin(GO:2000048) |
3.4 | 6.9 | GO:0042167 | heme catabolic process(GO:0042167) pigment catabolic process(GO:0046149) |
3.4 | 27.4 | GO:1902715 | positive regulation of interferon-gamma secretion(GO:1902715) |
3.4 | 20.6 | GO:0090336 | positive regulation of brown fat cell differentiation(GO:0090336) |
3.4 | 10.2 | GO:0065001 | specification of axis polarity(GO:0065001) |
3.4 | 10.1 | GO:0048388 | endosomal lumen acidification(GO:0048388) |
3.4 | 10.1 | GO:0043490 | malate-aspartate shuttle(GO:0043490) |
3.3 | 6.6 | GO:0002019 | regulation of renal output by angiotensin(GO:0002019) |
3.3 | 6.6 | GO:0034196 | acylglycerol transport(GO:0034196) triglyceride transport(GO:0034197) |
3.2 | 6.5 | GO:2000729 | positive regulation of mesenchymal cell proliferation involved in ureter development(GO:2000729) |
3.2 | 9.7 | GO:1990086 | lens fiber cell apoptotic process(GO:1990086) |
3.2 | 6.4 | GO:0032831 | positive regulation of CD4-positive, CD25-positive, alpha-beta regulatory T cell differentiation(GO:0032831) |
3.2 | 25.3 | GO:0060352 | cell adhesion molecule production(GO:0060352) |
3.2 | 9.5 | GO:0045658 | regulation of neutrophil differentiation(GO:0045658) |
3.2 | 12.6 | GO:0060264 | regulation of respiratory burst involved in inflammatory response(GO:0060264) |
3.2 | 9.5 | GO:0001920 | negative regulation of receptor recycling(GO:0001920) |
3.1 | 3.1 | GO:2000611 | positive regulation of thyroid hormone generation(GO:2000611) |
3.1 | 15.6 | GO:0047484 | regulation of response to osmotic stress(GO:0047484) |
3.1 | 3.1 | GO:0033091 | positive regulation of immature T cell proliferation(GO:0033091) positive regulation of immature T cell proliferation in thymus(GO:0033092) |
3.1 | 3.1 | GO:0098904 | regulation of AV node cell action potential(GO:0098904) |
3.1 | 9.3 | GO:0050689 | negative regulation of defense response to virus by host(GO:0050689) |
3.1 | 12.4 | GO:1903278 | positive regulation of sodium ion export(GO:1903275) positive regulation of sodium ion export from cell(GO:1903278) |
3.1 | 37.1 | GO:0001542 | ovulation from ovarian follicle(GO:0001542) |
3.1 | 6.1 | GO:0030035 | microspike assembly(GO:0030035) |
3.1 | 3.1 | GO:0044793 | negative regulation by host of viral process(GO:0044793) |
3.1 | 24.5 | GO:0060396 | growth hormone receptor signaling pathway(GO:0060396) cellular response to growth hormone stimulus(GO:0071378) |
3.1 | 6.1 | GO:0002036 | regulation of L-glutamate transport(GO:0002036) |
3.1 | 6.1 | GO:1903377 | negative regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903377) |
3.1 | 12.2 | GO:0032849 | positive regulation of cellular pH reduction(GO:0032849) |
3.0 | 21.3 | GO:2001214 | positive regulation of vasculogenesis(GO:2001214) |
3.0 | 6.1 | GO:0046874 | quinolinate metabolic process(GO:0046874) |
3.0 | 15.2 | GO:0044336 | canonical Wnt signaling pathway involved in negative regulation of apoptotic process(GO:0044336) |
3.0 | 9.1 | GO:0035483 | gastric emptying(GO:0035483) |
3.0 | 54.4 | GO:0090200 | positive regulation of release of cytochrome c from mitochondria(GO:0090200) |
3.0 | 3.0 | GO:0032289 | central nervous system myelin formation(GO:0032289) |
3.0 | 6.0 | GO:0035564 | regulation of kidney size(GO:0035564) |
3.0 | 6.0 | GO:1990705 | cholangiocyte proliferation(GO:1990705) |
3.0 | 14.9 | GO:0061032 | visceral serous pericardium development(GO:0061032) |
3.0 | 9.0 | GO:0009139 | dUDP biosynthetic process(GO:0006227) pyrimidine nucleoside diphosphate biosynthetic process(GO:0009139) pyrimidine deoxyribonucleoside diphosphate metabolic process(GO:0009196) pyrimidine deoxyribonucleoside diphosphate biosynthetic process(GO:0009197) dUDP metabolic process(GO:0046077) |
3.0 | 6.0 | GO:0051890 | regulation of cardioblast differentiation(GO:0051890) |
3.0 | 17.8 | GO:0019934 | cGMP-mediated signaling(GO:0019934) |
3.0 | 11.9 | GO:0071281 | cellular response to iron ion(GO:0071281) |
3.0 | 5.9 | GO:0018171 | peptidyl-cysteine oxidation(GO:0018171) |
3.0 | 14.8 | GO:0035610 | protein side chain deglutamylation(GO:0035610) |
2.9 | 8.8 | GO:0010760 | negative regulation of macrophage chemotaxis(GO:0010760) |
2.9 | 8.8 | GO:0006068 | ethanol catabolic process(GO:0006068) |
2.9 | 14.5 | GO:0051987 | positive regulation of attachment of spindle microtubules to kinetochore(GO:0051987) |
2.9 | 17.4 | GO:0036462 | TRAIL-activated apoptotic signaling pathway(GO:0036462) |
2.9 | 5.8 | GO:0015691 | cadmium ion transport(GO:0015691) cadmium ion transmembrane transport(GO:0070574) |
2.9 | 5.7 | GO:0032290 | peripheral nervous system myelin formation(GO:0032290) |
2.8 | 2.8 | GO:0070885 | negative regulation of calcineurin-NFAT signaling cascade(GO:0070885) |
2.8 | 14.2 | GO:0048194 | Golgi vesicle budding(GO:0048194) |
2.8 | 8.5 | GO:0001692 | histamine metabolic process(GO:0001692) |
2.8 | 14.1 | GO:0097459 | iron ion import into cell(GO:0097459) |
2.8 | 5.6 | GO:2000483 | negative regulation of interleukin-8 secretion(GO:2000483) |
2.8 | 14.1 | GO:0090435 | protein localization to nuclear envelope(GO:0090435) |
2.8 | 11.3 | GO:0042270 | protection from natural killer cell mediated cytotoxicity(GO:0042270) |
2.8 | 22.5 | GO:0031953 | negative regulation of protein autophosphorylation(GO:0031953) |
2.8 | 8.4 | GO:0003062 | regulation of heart rate by chemical signal(GO:0003062) |
2.8 | 11.2 | GO:0002457 | T cell antigen processing and presentation(GO:0002457) |
2.8 | 13.9 | GO:0032727 | positive regulation of interferon-alpha production(GO:0032727) |
2.8 | 5.6 | GO:0002767 | immune response-inhibiting cell surface receptor signaling pathway(GO:0002767) |
2.8 | 5.5 | GO:0001787 | natural killer cell proliferation(GO:0001787) |
2.8 | 8.3 | GO:0061092 | regulation of phospholipid translocation(GO:0061091) positive regulation of phospholipid translocation(GO:0061092) |
2.7 | 11.0 | GO:0002291 | T cell activation via T cell receptor contact with antigen bound to MHC molecule on antigen presenting cell(GO:0002291) |
2.7 | 10.9 | GO:0001712 | ectodermal cell fate commitment(GO:0001712) |
2.7 | 21.7 | GO:0009437 | carnitine metabolic process(GO:0009437) |
2.7 | 32.6 | GO:1902187 | negative regulation of viral release from host cell(GO:1902187) |
2.7 | 10.8 | GO:0070966 | nuclear-transcribed mRNA catabolic process, no-go decay(GO:0070966) |
2.7 | 5.4 | GO:0018992 | germ-line sex determination(GO:0018992) |
2.7 | 2.7 | GO:0045914 | negative regulation of catecholamine metabolic process(GO:0045914) negative regulation of dopamine metabolic process(GO:0045963) |
2.7 | 2.7 | GO:0052055 | modulation by symbiont of host molecular function(GO:0052055) |
2.7 | 5.4 | GO:1900221 | regulation of beta-amyloid clearance(GO:1900221) |
2.7 | 5.4 | GO:0061029 | eyelid development in camera-type eye(GO:0061029) |
2.7 | 5.4 | GO:1901509 | regulation of endothelial tube morphogenesis(GO:1901509) |
2.7 | 8.0 | GO:0045719 | negative regulation of glycogen biosynthetic process(GO:0045719) |
2.7 | 8.0 | GO:0051105 | regulation of DNA ligation(GO:0051105) positive regulation of DNA ligation(GO:0051106) |
2.7 | 8.0 | GO:0038128 | ERBB2 signaling pathway(GO:0038128) |
2.7 | 8.0 | GO:0010749 | regulation of nitric oxide mediated signal transduction(GO:0010749) |
2.6 | 13.2 | GO:0010961 | cellular magnesium ion homeostasis(GO:0010961) |
2.6 | 13.1 | GO:0034116 | positive regulation of heterotypic cell-cell adhesion(GO:0034116) |
2.6 | 18.3 | GO:0019368 | fatty acid elongation, saturated fatty acid(GO:0019367) fatty acid elongation, unsaturated fatty acid(GO:0019368) fatty acid elongation, monounsaturated fatty acid(GO:0034625) fatty acid elongation, polyunsaturated fatty acid(GO:0034626) |
2.6 | 33.9 | GO:0050860 | negative regulation of T cell receptor signaling pathway(GO:0050860) |
2.6 | 7.8 | GO:0060741 | prostate gland stromal morphogenesis(GO:0060741) |
2.6 | 10.4 | GO:1900747 | negative regulation of vascular endothelial growth factor signaling pathway(GO:1900747) negative regulation of cellular response to vascular endothelial growth factor stimulus(GO:1902548) |
2.6 | 15.5 | GO:0042590 | antigen processing and presentation of exogenous peptide antigen via MHC class I(GO:0042590) |
2.6 | 5.2 | GO:0032803 | low-density lipoprotein particle receptor catabolic process(GO:0032802) regulation of low-density lipoprotein particle receptor catabolic process(GO:0032803) |
2.6 | 7.7 | GO:0033030 | negative regulation of neutrophil apoptotic process(GO:0033030) |
2.6 | 5.1 | GO:0042701 | progesterone secretion(GO:0042701) |
2.6 | 20.4 | GO:0098911 | regulation of ventricular cardiac muscle cell action potential(GO:0098911) |
2.5 | 5.1 | GO:0031999 | negative regulation of fatty acid beta-oxidation(GO:0031999) |
2.5 | 7.6 | GO:0001915 | negative regulation of T cell mediated cytotoxicity(GO:0001915) |
2.5 | 10.1 | GO:0072383 | plus-end-directed vesicle transport along microtubule(GO:0072383) plus-end-directed organelle transport along microtubule(GO:0072386) |
2.5 | 2.5 | GO:0045764 | positive regulation of cellular amino acid metabolic process(GO:0045764) |
2.5 | 9.9 | GO:1903887 | motile primary cilium assembly(GO:1903887) |
2.5 | 49.7 | GO:0042832 | defense response to protozoan(GO:0042832) |
2.5 | 14.9 | GO:0010815 | bradykinin catabolic process(GO:0010815) |
2.5 | 5.0 | GO:0071930 | negative regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0071930) |
2.5 | 7.4 | GO:0031118 | rRNA pseudouridine synthesis(GO:0031118) |
2.5 | 17.3 | GO:0030644 | cellular chloride ion homeostasis(GO:0030644) |
2.5 | 12.3 | GO:0003241 | growth involved in heart morphogenesis(GO:0003241) |
2.4 | 4.9 | GO:0042494 | detection of bacterial lipoprotein(GO:0042494) |
2.4 | 9.8 | GO:0018343 | protein farnesylation(GO:0018343) |
2.4 | 4.9 | GO:0010612 | regulation of cardiac muscle adaptation(GO:0010612) regulation of cardiac muscle hypertrophy in response to stress(GO:1903242) |
2.4 | 4.9 | GO:0007182 | common-partner SMAD protein phosphorylation(GO:0007182) |
2.4 | 9.7 | GO:2000659 | regulation of interleukin-1-mediated signaling pathway(GO:2000659) |
2.4 | 7.3 | GO:0061110 | dense core granule biogenesis(GO:0061110) |
2.4 | 16.9 | GO:0007021 | tubulin complex assembly(GO:0007021) |
2.4 | 12.1 | GO:0050882 | voluntary musculoskeletal movement(GO:0050882) |
2.4 | 4.8 | GO:0001306 | age-dependent response to oxidative stress(GO:0001306) age-dependent general metabolic decline(GO:0007571) |
2.4 | 7.2 | GO:0071394 | cellular response to testosterone stimulus(GO:0071394) |
2.4 | 2.4 | GO:0070368 | positive regulation of hepatocyte differentiation(GO:0070368) |
2.4 | 9.5 | GO:0060391 | positive regulation of SMAD protein import into nucleus(GO:0060391) |
2.4 | 2.4 | GO:0002904 | positive regulation of B cell apoptotic process(GO:0002904) |
2.4 | 7.1 | GO:0034379 | very-low-density lipoprotein particle assembly(GO:0034379) |
2.4 | 4.7 | GO:2000828 | regulation of parathyroid hormone secretion(GO:2000828) |
2.4 | 11.8 | GO:2000096 | positive regulation of Wnt signaling pathway, planar cell polarity pathway(GO:2000096) |
2.4 | 2.4 | GO:1904193 | cholangiocyte apoptotic process(GO:1902488) regulation of cholangiocyte apoptotic process(GO:1904192) negative regulation of cholangiocyte apoptotic process(GO:1904193) |
2.4 | 4.7 | GO:0030885 | regulation of myeloid dendritic cell activation(GO:0030885) |
2.4 | 7.1 | GO:0015842 | aminergic neurotransmitter loading into synaptic vesicle(GO:0015842) neurotransmitter loading into synaptic vesicle(GO:0098700) |
2.4 | 4.7 | GO:1905065 | positive regulation of vascular smooth muscle cell differentiation(GO:1905065) |
2.4 | 4.7 | GO:2000409 | positive regulation of T cell extravasation(GO:2000409) |
2.4 | 7.1 | GO:0045041 | protein import into mitochondrial intermembrane space(GO:0045041) |
2.3 | 42.3 | GO:0033014 | porphyrin-containing compound biosynthetic process(GO:0006779) tetrapyrrole biosynthetic process(GO:0033014) |
2.3 | 9.4 | GO:0001969 | activation of membrane attack complex(GO:0001905) regulation of activation of membrane attack complex(GO:0001969) |
2.3 | 4.7 | GO:0034635 | glutathione transport(GO:0034635) tripeptide transport(GO:0042939) |
2.3 | 9.3 | GO:0060414 | aorta smooth muscle tissue morphogenesis(GO:0060414) |
2.3 | 18.5 | GO:0043249 | erythrocyte maturation(GO:0043249) |
2.3 | 6.9 | GO:0006931 | substrate-dependent cell migration, cell attachment to substrate(GO:0006931) |
2.3 | 13.8 | GO:0071073 | positive regulation of phospholipid biosynthetic process(GO:0071073) |
2.3 | 4.6 | GO:0048007 | antigen processing and presentation of lipid antigen via MHC class Ib(GO:0048003) antigen processing and presentation, exogenous lipid antigen via MHC class Ib(GO:0048007) |
2.3 | 36.3 | GO:0043171 | peptide catabolic process(GO:0043171) |
2.3 | 2.3 | GO:0006059 | hexitol metabolic process(GO:0006059) |
2.3 | 15.8 | GO:0046069 | cGMP catabolic process(GO:0046069) |
2.3 | 2.3 | GO:0002554 | serotonin secretion by platelet(GO:0002554) |
2.3 | 4.5 | GO:0097039 | protein linear polyubiquitination(GO:0097039) |
2.3 | 20.3 | GO:0002024 | diet induced thermogenesis(GO:0002024) adaptive thermogenesis(GO:1990845) |
2.2 | 11.2 | GO:2001256 | regulation of store-operated calcium entry(GO:2001256) |
2.2 | 11.2 | GO:0032876 | negative regulation of DNA endoreduplication(GO:0032876) |
2.2 | 4.5 | GO:0018076 | N-terminal peptidyl-lysine acetylation(GO:0018076) |
2.2 | 4.5 | GO:0046121 | deoxyribonucleoside catabolic process(GO:0046121) |
2.2 | 11.1 | GO:0060693 | regulation of branching involved in salivary gland morphogenesis(GO:0060693) |
2.2 | 4.4 | GO:0061687 | detoxification of copper ion(GO:0010273) detoxification of inorganic compound(GO:0061687) stress response to copper ion(GO:1990169) |
2.2 | 2.2 | GO:0003289 | atrial septum primum morphogenesis(GO:0003289) |
2.2 | 11.0 | GO:0098908 | regulation of neuronal action potential(GO:0098908) |
2.2 | 6.6 | GO:0015014 | heparan sulfate proteoglycan biosynthetic process, polysaccharide chain biosynthetic process(GO:0015014) |
2.2 | 13.1 | GO:0071985 | multivesicular body sorting pathway(GO:0071985) |
2.2 | 6.6 | GO:0035405 | histone-threonine phosphorylation(GO:0035405) |
2.2 | 4.4 | GO:0003104 | positive regulation of glomerular filtration(GO:0003104) |
2.2 | 2.2 | GO:0070447 | positive regulation of oligodendrocyte progenitor proliferation(GO:0070447) |
2.2 | 6.5 | GO:0042908 | xenobiotic transport(GO:0042908) |
2.2 | 6.5 | GO:0002727 | natural killer cell cytokine production(GO:0002370) regulation of natural killer cell cytokine production(GO:0002727) |
2.2 | 15.2 | GO:0032534 | regulation of microvillus assembly(GO:0032534) |
2.2 | 4.3 | GO:0045053 | protein retention in Golgi apparatus(GO:0045053) |
2.2 | 10.8 | GO:0018101 | protein citrullination(GO:0018101) |
2.2 | 4.3 | GO:0070120 | ciliary neurotrophic factor-mediated signaling pathway(GO:0070120) |
2.1 | 2.1 | GO:0035898 | parathyroid hormone secretion(GO:0035898) |
2.1 | 19.3 | GO:0031272 | regulation of pseudopodium assembly(GO:0031272) |
2.1 | 4.3 | GO:0061009 | intrahepatic bile duct development(GO:0035622) common bile duct development(GO:0061009) |
2.1 | 4.3 | GO:0044068 | modulation by symbiont of host cellular process(GO:0044068) |
2.1 | 17.1 | GO:0032060 | bleb assembly(GO:0032060) |
2.1 | 4.3 | GO:1902534 | lysosomal microautophagy(GO:0016237) piecemeal microautophagy of nucleus(GO:0034727) late nucleophagy(GO:0044805) single-organism membrane invagination(GO:1902534) |
2.1 | 8.5 | GO:0003383 | apical constriction(GO:0003383) |
2.1 | 6.4 | GO:0035973 | aggrephagy(GO:0035973) |
2.1 | 2.1 | GO:0001907 | killing by symbiont of host cells(GO:0001907) disruption by symbiont of host cell(GO:0044004) |
2.1 | 4.2 | GO:2001286 | regulation of caveolin-mediated endocytosis(GO:2001286) |
2.1 | 8.3 | GO:0050861 | positive regulation of B cell receptor signaling pathway(GO:0050861) |
2.1 | 18.7 | GO:0034058 | endosomal vesicle fusion(GO:0034058) |
2.1 | 6.2 | GO:0043101 | purine-containing compound salvage(GO:0043101) |
2.1 | 8.3 | GO:0031665 | negative regulation of lipopolysaccharide-mediated signaling pathway(GO:0031665) |
2.1 | 31.1 | GO:0007202 | activation of phospholipase C activity(GO:0007202) |
2.1 | 10.3 | GO:0031666 | positive regulation of lipopolysaccharide-mediated signaling pathway(GO:0031666) |
2.1 | 6.2 | GO:0031017 | exocrine pancreas development(GO:0031017) |
2.1 | 10.3 | GO:0072488 | ammonium transmembrane transport(GO:0072488) |
2.1 | 2.1 | GO:0045586 | regulation of gamma-delta T cell differentiation(GO:0045586) regulation of gamma-delta T cell activation(GO:0046643) |
2.1 | 2.1 | GO:0061419 | positive regulation of transcription from RNA polymerase II promoter in response to hypoxia(GO:0061419) |
2.1 | 8.2 | GO:0044351 | macropinocytosis(GO:0044351) |
2.0 | 8.2 | GO:0019482 | beta-alanine metabolic process(GO:0019482) |
2.0 | 20.4 | GO:0032801 | receptor catabolic process(GO:0032801) |
2.0 | 28.5 | GO:0006144 | purine nucleobase metabolic process(GO:0006144) |
2.0 | 4.1 | GO:0060800 | regulation of cell differentiation involved in embryonic placenta development(GO:0060800) |
2.0 | 4.1 | GO:0061010 | gall bladder development(GO:0061010) |
2.0 | 12.2 | GO:0006152 | purine nucleoside catabolic process(GO:0006152) purine ribonucleoside catabolic process(GO:0046130) |
2.0 | 4.0 | GO:0060948 | cardiac vascular smooth muscle cell development(GO:0060948) |
2.0 | 2.0 | GO:2001028 | positive regulation of endothelial cell chemotaxis(GO:2001028) |
2.0 | 6.0 | GO:1904996 | positive regulation of leukocyte adhesion to vascular endothelial cell(GO:1904996) |
2.0 | 9.9 | GO:0036289 | peptidyl-serine autophosphorylation(GO:0036289) |
2.0 | 2.0 | GO:0019859 | pyrimidine nucleobase catabolic process(GO:0006208) thymine catabolic process(GO:0006210) thymine metabolic process(GO:0019859) |
2.0 | 5.9 | GO:0055009 | atrial cardiac muscle tissue development(GO:0003228) atrial cardiac muscle tissue morphogenesis(GO:0055009) |
2.0 | 15.8 | GO:0003179 | heart valve morphogenesis(GO:0003179) |
2.0 | 2.0 | GO:0035887 | aortic smooth muscle cell differentiation(GO:0035887) |
2.0 | 9.8 | GO:1904970 | brush border assembly(GO:1904970) |
2.0 | 5.9 | GO:0070102 | interleukin-6-mediated signaling pathway(GO:0070102) |
2.0 | 5.9 | GO:0050847 | progesterone receptor signaling pathway(GO:0050847) |
1.9 | 17.5 | GO:0040015 | negative regulation of multicellular organism growth(GO:0040015) |
1.9 | 3.9 | GO:0060762 | regulation of branching involved in mammary gland duct morphogenesis(GO:0060762) |
1.9 | 7.8 | GO:0035589 | G-protein coupled purinergic nucleotide receptor signaling pathway(GO:0035589) |
1.9 | 1.9 | GO:0071883 | activation of MAPK activity by adrenergic receptor signaling pathway(GO:0071883) |
1.9 | 5.8 | GO:0006681 | galactosylceramide metabolic process(GO:0006681) |
1.9 | 15.5 | GO:0018026 | peptidyl-lysine monomethylation(GO:0018026) |
1.9 | 5.8 | GO:0045348 | positive regulation of MHC class II biosynthetic process(GO:0045348) |
1.9 | 1.9 | GO:0032099 | negative regulation of appetite(GO:0032099) |
1.9 | 1.9 | GO:0042998 | positive regulation of Golgi to plasma membrane protein transport(GO:0042998) |
1.9 | 9.6 | GO:0009256 | 10-formyltetrahydrofolate metabolic process(GO:0009256) |
1.9 | 17.3 | GO:0051044 | positive regulation of membrane protein ectodomain proteolysis(GO:0051044) |
1.9 | 5.8 | GO:0034421 | post-translational protein acetylation(GO:0034421) |
1.9 | 40.3 | GO:0046854 | phosphatidylinositol phosphorylation(GO:0046854) |
1.9 | 1.9 | GO:0048294 | negative regulation of isotype switching to IgE isotypes(GO:0048294) |
1.9 | 19.0 | GO:0046085 | adenosine metabolic process(GO:0046085) |
1.9 | 5.7 | GO:0061511 | centriole elongation(GO:0061511) |
1.9 | 3.8 | GO:0010990 | regulation of SMAD protein complex assembly(GO:0010990) negative regulation of SMAD protein complex assembly(GO:0010991) |
1.9 | 3.8 | GO:0021938 | smoothened signaling pathway involved in regulation of cerebellar granule cell precursor cell proliferation(GO:0021938) |
1.9 | 5.6 | GO:1905155 | positive regulation of phagocytosis, engulfment(GO:0060100) positive regulation of membrane invagination(GO:1905155) |
1.9 | 33.7 | GO:0000305 | response to oxygen radical(GO:0000305) |
1.9 | 9.4 | GO:0010898 | positive regulation of triglyceride catabolic process(GO:0010898) |
1.9 | 1.9 | GO:0002826 | negative regulation of T-helper 1 type immune response(GO:0002826) |
1.9 | 20.6 | GO:0070266 | necroptotic process(GO:0070266) |
1.9 | 9.3 | GO:0045654 | positive regulation of megakaryocyte differentiation(GO:0045654) |
1.9 | 16.8 | GO:0046697 | decidualization(GO:0046697) |
1.9 | 11.2 | GO:0051639 | actin filament network formation(GO:0051639) |
1.9 | 3.7 | GO:0002337 | B-1a B cell differentiation(GO:0002337) |
1.9 | 11.2 | GO:0032494 | response to peptidoglycan(GO:0032494) |
1.9 | 3.7 | GO:1903026 | negative regulation of RNA polymerase II regulatory region sequence-specific DNA binding(GO:1903026) |
1.9 | 11.1 | GO:0033314 | mitotic DNA replication checkpoint(GO:0033314) |
1.8 | 5.5 | GO:0071863 | regulation of cell proliferation in bone marrow(GO:0071863) |
1.8 | 1.8 | GO:0002669 | positive regulation of T cell anergy(GO:0002669) positive regulation of lymphocyte anergy(GO:0002913) |
1.8 | 5.5 | GO:0060527 | prostate glandular acinus morphogenesis(GO:0060526) prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis(GO:0060527) |
1.8 | 21.8 | GO:0060445 | branching involved in salivary gland morphogenesis(GO:0060445) |
1.8 | 3.6 | GO:0010963 | regulation of L-arginine import(GO:0010963) |
1.8 | 5.4 | GO:2000343 | positive regulation of chemokine (C-X-C motif) ligand 2 production(GO:2000343) |
1.8 | 3.6 | GO:1901421 | positive regulation of response to alcohol(GO:1901421) |
1.8 | 1.8 | GO:0032497 | detection of lipopolysaccharide(GO:0032497) |
1.8 | 5.4 | GO:0045404 | positive regulation of interleukin-4 biosynthetic process(GO:0045404) |
1.8 | 3.6 | GO:0070836 | caveola assembly(GO:0070836) |
1.8 | 5.4 | GO:0043379 | memory T cell differentiation(GO:0043379) |
1.8 | 8.9 | GO:0042359 | vitamin D metabolic process(GO:0042359) |
1.8 | 7.2 | GO:0050858 | negative regulation of antigen receptor-mediated signaling pathway(GO:0050858) |
1.8 | 28.6 | GO:0048525 | negative regulation of viral process(GO:0048525) |
1.8 | 23.1 | GO:0033081 | regulation of T cell differentiation in thymus(GO:0033081) regulation of thymocyte aggregation(GO:2000398) |
1.8 | 3.5 | GO:0033133 | positive regulation of glucokinase activity(GO:0033133) |
1.8 | 10.6 | GO:1902895 | positive regulation of pri-miRNA transcription from RNA polymerase II promoter(GO:1902895) |
1.8 | 5.3 | GO:0042695 | thelarche(GO:0042695) mammary gland branching involved in thelarche(GO:0060744) |
1.8 | 1.8 | GO:1902896 | terminal web assembly(GO:1902896) |
1.8 | 5.3 | GO:0090080 | positive regulation of MAPKKK cascade by fibroblast growth factor receptor signaling pathway(GO:0090080) |
1.8 | 5.3 | GO:0002540 | leukotriene production involved in inflammatory response(GO:0002540) |
1.8 | 3.5 | GO:2000416 | regulation of eosinophil migration(GO:2000416) |
1.7 | 19.2 | GO:0006047 | UDP-N-acetylglucosamine metabolic process(GO:0006047) |
1.7 | 5.2 | GO:0032483 | regulation of Rab protein signal transduction(GO:0032483) |
1.7 | 1.7 | GO:0019377 | glycolipid catabolic process(GO:0019377) |
1.7 | 15.6 | GO:0006670 | sphingosine metabolic process(GO:0006670) |
1.7 | 3.4 | GO:1900126 | negative regulation of hyaluronan biosynthetic process(GO:1900126) |
1.7 | 3.4 | GO:1901492 | positive regulation of lymphangiogenesis(GO:1901492) |
1.7 | 6.9 | GO:1903059 | regulation of protein lipidation(GO:1903059) |
1.7 | 12.0 | GO:0030502 | negative regulation of bone mineralization(GO:0030502) |
1.7 | 20.5 | GO:0042088 | T-helper 1 type immune response(GO:0042088) |
1.7 | 5.1 | GO:0055093 | cellular response to increased oxygen levels(GO:0036295) response to increased oxygen levels(GO:0036296) response to hyperoxia(GO:0055093) cellular response to hyperoxia(GO:0071455) |
1.7 | 5.1 | GO:0035812 | renal sodium excretion(GO:0035812) regulation of renal sodium excretion(GO:0035813) |
1.7 | 37.4 | GO:0006730 | one-carbon metabolic process(GO:0006730) |
1.7 | 1.7 | GO:0019673 | GDP-mannose metabolic process(GO:0019673) |
1.7 | 5.1 | GO:0006391 | transcription initiation from mitochondrial promoter(GO:0006391) |
1.7 | 38.9 | GO:0046463 | neutral lipid biosynthetic process(GO:0046460) acylglycerol biosynthetic process(GO:0046463) |
1.7 | 5.1 | GO:0006543 | glutamine catabolic process(GO:0006543) |
1.7 | 1.7 | GO:0002432 | granuloma formation(GO:0002432) |
1.7 | 1.7 | GO:0060018 | astrocyte fate commitment(GO:0060018) |
1.7 | 3.4 | GO:0006678 | glucosylceramide metabolic process(GO:0006678) |
1.7 | 13.4 | GO:0061299 | retina vasculature morphogenesis in camera-type eye(GO:0061299) |
1.7 | 8.4 | GO:0001553 | luteinization(GO:0001553) |
1.7 | 8.3 | GO:0030949 | positive regulation of vascular endothelial growth factor receptor signaling pathway(GO:0030949) |
1.7 | 1.7 | GO:0038161 | prolactin signaling pathway(GO:0038161) |
1.7 | 11.6 | GO:0035413 | positive regulation of catenin import into nucleus(GO:0035413) |
1.7 | 6.6 | GO:0000727 | double-strand break repair via break-induced replication(GO:0000727) |
1.7 | 6.6 | GO:0046112 | nucleobase biosynthetic process(GO:0046112) |
1.7 | 11.6 | GO:0046415 | urate metabolic process(GO:0046415) |
1.7 | 13.2 | GO:0042953 | lipoprotein transport(GO:0042953) lipoprotein localization(GO:0044872) |
1.6 | 9.9 | GO:0033601 | positive regulation of mammary gland epithelial cell proliferation(GO:0033601) |
1.6 | 3.3 | GO:0070358 | actin polymerization-dependent cell motility(GO:0070358) |
1.6 | 3.3 | GO:0070863 | positive regulation of protein exit from endoplasmic reticulum(GO:0070863) |
1.6 | 1.6 | GO:0030538 | embryonic genitalia morphogenesis(GO:0030538) |
1.6 | 4.9 | GO:0070837 | dehydroascorbic acid transport(GO:0070837) |
1.6 | 9.8 | GO:0006983 | ER overload response(GO:0006983) |
1.6 | 8.1 | GO:0001914 | regulation of T cell mediated cytotoxicity(GO:0001914) |
1.6 | 9.7 | GO:0090050 | positive regulation of cell migration involved in sprouting angiogenesis(GO:0090050) |
1.6 | 1.6 | GO:2001185 | regulation of CD8-positive, alpha-beta T cell activation(GO:2001185) |
1.6 | 1.6 | GO:0098902 | regulation of membrane depolarization during action potential(GO:0098902) |
1.6 | 1.6 | GO:0002752 | cell surface pattern recognition receptor signaling pathway(GO:0002752) |
1.6 | 3.2 | GO:0016480 | negative regulation of transcription from RNA polymerase III promoter(GO:0016480) |
1.6 | 4.8 | GO:0006172 | ADP biosynthetic process(GO:0006172) |
1.6 | 4.8 | GO:0090219 | negative regulation of lipid kinase activity(GO:0090219) |
1.6 | 1.6 | GO:0071360 | cellular response to exogenous dsRNA(GO:0071360) |
1.6 | 1.6 | GO:0009804 | coumarin metabolic process(GO:0009804) |
1.6 | 30.5 | GO:0045214 | sarcomere organization(GO:0045214) |
1.6 | 1.6 | GO:1903596 | regulation of gap junction assembly(GO:1903596) |
1.6 | 8.0 | GO:0010758 | regulation of macrophage chemotaxis(GO:0010758) |
1.6 | 1.6 | GO:2000586 | regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000586) negative regulation of platelet-derived growth factor receptor-beta signaling pathway(GO:2000587) |
1.6 | 6.4 | GO:0050812 | regulation of acyl-CoA biosynthetic process(GO:0050812) |
1.6 | 4.8 | GO:1990036 | calcium ion import into sarcoplasmic reticulum(GO:1990036) |
1.6 | 1.6 | GO:0035983 | response to trichostatin A(GO:0035983) cellular response to trichostatin A(GO:0035984) |
1.6 | 1.6 | GO:0051964 | negative regulation of synapse assembly(GO:0051964) |
1.6 | 1.6 | GO:0090084 | negative regulation of inclusion body assembly(GO:0090084) |
1.6 | 4.7 | GO:0035630 | bone mineralization involved in bone maturation(GO:0035630) |
1.6 | 1.6 | GO:0003100 | regulation of systemic arterial blood pressure by endothelin(GO:0003100) |
1.6 | 4.7 | GO:0035507 | regulation of myosin-light-chain-phosphatase activity(GO:0035507) |
1.6 | 1.6 | GO:0051684 | maintenance of Golgi location(GO:0051684) |
1.6 | 7.8 | GO:0090383 | phagosome acidification(GO:0090383) |
1.6 | 3.1 | GO:0070236 | negative regulation of activation-induced cell death of T cells(GO:0070236) |
1.6 | 53.0 | GO:0048146 | positive regulation of fibroblast proliferation(GO:0048146) |
1.6 | 9.3 | GO:0050995 | negative regulation of lipid catabolic process(GO:0050995) |
1.5 | 4.6 | GO:0006533 | aspartate catabolic process(GO:0006533) |
1.5 | 4.6 | GO:0048241 | epinephrine transport(GO:0048241) epinephrine secretion(GO:0048242) |
1.5 | 9.3 | GO:0045647 | negative regulation of erythrocyte differentiation(GO:0045647) |
1.5 | 6.2 | GO:0032304 | negative regulation of icosanoid secretion(GO:0032304) |
1.5 | 6.1 | GO:0000707 | meiotic DNA recombinase assembly(GO:0000707) |
1.5 | 16.9 | GO:0071260 | cellular response to mechanical stimulus(GO:0071260) |
1.5 | 6.1 | GO:0097428 | protein maturation by iron-sulfur cluster transfer(GO:0097428) |
1.5 | 1.5 | GO:0046544 | development of secondary male sexual characteristics(GO:0046544) |
1.5 | 4.6 | GO:2001271 | negative regulation of cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:2001271) |
1.5 | 9.2 | GO:0001835 | blastocyst hatching(GO:0001835) hatching(GO:0035188) organism emergence from protective structure(GO:0071684) |
1.5 | 4.6 | GO:0060754 | positive regulation of mast cell chemotaxis(GO:0060754) |
1.5 | 12.2 | GO:0031954 | positive regulation of protein autophosphorylation(GO:0031954) |
1.5 | 4.6 | GO:0001955 | blood vessel maturation(GO:0001955) |
1.5 | 6.1 | GO:0007221 | positive regulation of transcription of Notch receptor target(GO:0007221) |
1.5 | 4.5 | GO:0000087 | mitotic M phase(GO:0000087) |
1.5 | 36.3 | GO:0046825 | regulation of protein export from nucleus(GO:0046825) |
1.5 | 3.0 | GO:0045054 | constitutive secretory pathway(GO:0045054) |
1.5 | 26.9 | GO:0090162 | establishment of epithelial cell polarity(GO:0090162) |
1.5 | 3.0 | GO:0060462 | lung lobe development(GO:0060462) lung lobe morphogenesis(GO:0060463) |
1.5 | 4.4 | GO:0016344 | meiotic chromosome movement towards spindle pole(GO:0016344) chromosome movement towards spindle pole(GO:0051305) |
1.5 | 1.5 | GO:0007494 | midgut development(GO:0007494) |
1.5 | 7.4 | GO:0070493 | thrombin receptor signaling pathway(GO:0070493) |
1.5 | 67.9 | GO:0002286 | T cell activation involved in immune response(GO:0002286) |
1.5 | 8.9 | GO:0060330 | regulation of response to interferon-gamma(GO:0060330) |
1.5 | 4.4 | GO:1904017 | response to Thyroglobulin triiodothyronine(GO:1904016) cellular response to Thyroglobulin triiodothyronine(GO:1904017) |
1.5 | 17.7 | GO:0002026 | regulation of the force of heart contraction(GO:0002026) |
1.5 | 2.9 | GO:0036135 | Schwann cell migration(GO:0036135) regulation of Schwann cell migration(GO:1900147) |
1.5 | 5.9 | GO:0030091 | protein repair(GO:0030091) |
1.5 | 2.9 | GO:0097286 | iron ion import(GO:0097286) |
1.5 | 4.4 | GO:1900095 | regulation of dosage compensation by inactivation of X chromosome(GO:1900095) |
1.4 | 5.8 | GO:0031581 | hemidesmosome assembly(GO:0031581) |
1.4 | 2.9 | GO:0033634 | positive regulation of cell-cell adhesion mediated by integrin(GO:0033634) |
1.4 | 5.7 | GO:0006857 | oligopeptide transport(GO:0006857) |
1.4 | 2.9 | GO:0090271 | positive regulation of fibroblast growth factor production(GO:0090271) |
1.4 | 2.9 | GO:0033632 | regulation of cell-cell adhesion mediated by integrin(GO:0033632) |
1.4 | 18.6 | GO:0010718 | positive regulation of epithelial to mesenchymal transition(GO:0010718) |
1.4 | 4.3 | GO:0032780 | negative regulation of ATPase activity(GO:0032780) |
1.4 | 7.1 | GO:0001561 | fatty acid alpha-oxidation(GO:0001561) |
1.4 | 1.4 | GO:1904587 | glycoprotein ERAD pathway(GO:0097466) response to glycoprotein(GO:1904587) |
1.4 | 7.0 | GO:0008090 | retrograde axonal transport(GO:0008090) |
1.4 | 2.8 | GO:0048014 | Tie signaling pathway(GO:0048014) |
1.4 | 5.6 | GO:0032466 | negative regulation of cytokinesis(GO:0032466) |
1.4 | 4.2 | GO:0006848 | pyruvate transport(GO:0006848) |
1.4 | 2.8 | GO:0019240 | citrulline biosynthetic process(GO:0019240) |
1.4 | 5.6 | GO:0070633 | transepithelial transport(GO:0070633) |
1.4 | 55.6 | GO:0045576 | mast cell activation(GO:0045576) |
1.4 | 2.8 | GO:0014707 | branchiomeric skeletal muscle development(GO:0014707) |
1.4 | 29.1 | GO:0030195 | negative regulation of blood coagulation(GO:0030195) negative regulation of hemostasis(GO:1900047) |
1.4 | 8.3 | GO:1903140 | regulation of endothelial cell development(GO:1901550) regulation of establishment of endothelial barrier(GO:1903140) |
1.4 | 5.5 | GO:0006547 | histidine metabolic process(GO:0006547) |
1.4 | 12.4 | GO:0046835 | carbohydrate phosphorylation(GO:0046835) |
1.4 | 5.4 | GO:0000972 | transcription-dependent tethering of RNA polymerase II gene DNA at nuclear periphery(GO:0000972) |
1.4 | 5.4 | GO:0002934 | desmosome organization(GO:0002934) |
1.4 | 36.5 | GO:0002474 | antigen processing and presentation of peptide antigen via MHC class I(GO:0002474) |
1.4 | 1.4 | GO:0015677 | copper ion import(GO:0015677) |
1.4 | 6.8 | GO:0090286 | cytoskeletal anchoring at nuclear membrane(GO:0090286) |
1.4 | 1.4 | GO:0034434 | steroid esterification(GO:0034433) sterol esterification(GO:0034434) cholesterol esterification(GO:0034435) |
1.3 | 4.0 | GO:0032825 | positive regulation of natural killer cell differentiation(GO:0032825) |
1.3 | 2.7 | GO:0002883 | regulation of hypersensitivity(GO:0002883) |
1.3 | 1.3 | GO:1903371 | regulation of endoplasmic reticulum tubular network organization(GO:1903371) |
1.3 | 2.7 | GO:1902075 | cellular response to salt(GO:1902075) |
1.3 | 10.7 | GO:0048821 | erythrocyte development(GO:0048821) |
1.3 | 9.3 | GO:0051292 | nuclear pore complex assembly(GO:0051292) |
1.3 | 1.3 | GO:0044778 | meiotic DNA integrity checkpoint(GO:0044778) |
1.3 | 9.3 | GO:0009214 | cyclic nucleotide catabolic process(GO:0009214) |
1.3 | 2.6 | GO:0051088 | PMA-inducible membrane protein ectodomain proteolysis(GO:0051088) |
1.3 | 3.9 | GO:0051151 | negative regulation of smooth muscle cell differentiation(GO:0051151) |
1.3 | 1.3 | GO:0072282 | metanephric nephron tubule morphogenesis(GO:0072282) |
1.3 | 6.5 | GO:0030449 | regulation of complement activation(GO:0030449) |
1.3 | 2.6 | GO:0032439 | endosome localization(GO:0032439) |
1.3 | 5.2 | GO:0021785 | branchiomotor neuron axon guidance(GO:0021785) |
1.3 | 3.9 | GO:0045351 | type I interferon biosynthetic process(GO:0045351) |
1.3 | 2.6 | GO:0006001 | fructose catabolic process(GO:0006001) fructose catabolic process to hydroxyacetone phosphate and glyceraldehyde-3-phosphate(GO:0061624) glycolytic process through fructose-1-phosphate(GO:0061625) |
1.3 | 6.5 | GO:0042985 | negative regulation of amyloid precursor protein biosynthetic process(GO:0042985) |
1.3 | 7.8 | GO:0005981 | regulation of glycogen catabolic process(GO:0005981) |
1.3 | 7.8 | GO:0003299 | muscle hypertrophy in response to stress(GO:0003299) cardiac muscle adaptation(GO:0014887) cardiac muscle hypertrophy in response to stress(GO:0014898) |
1.3 | 2.6 | GO:1904354 | negative regulation of telomere capping(GO:1904354) |
1.3 | 3.9 | GO:0043504 | mitochondrial DNA repair(GO:0043504) |
1.3 | 2.6 | GO:0044546 | NLRP3 inflammasome complex assembly(GO:0044546) |
1.3 | 3.9 | GO:0045636 | positive regulation of melanocyte differentiation(GO:0045636) |
1.3 | 6.4 | GO:0010818 | T cell chemotaxis(GO:0010818) |
1.3 | 5.1 | GO:0070572 | positive regulation of axon regeneration(GO:0048680) positive regulation of neuron projection regeneration(GO:0070572) |
1.3 | 3.8 | GO:0048386 | positive regulation of retinoic acid receptor signaling pathway(GO:0048386) |
1.3 | 3.8 | GO:0006662 | glycerol ether metabolic process(GO:0006662) |
1.3 | 1.3 | GO:0042268 | regulation of cytolysis(GO:0042268) |
1.3 | 3.8 | GO:0035743 | CD4-positive, alpha-beta T cell cytokine production(GO:0035743) T-helper 2 cell cytokine production(GO:0035745) |
1.3 | 1.3 | GO:0042524 | negative regulation of tyrosine phosphorylation of Stat5 protein(GO:0042524) |
1.3 | 5.1 | GO:0006907 | pinocytosis(GO:0006907) |
1.3 | 6.3 | GO:0001778 | plasma membrane repair(GO:0001778) |
1.3 | 12.7 | GO:0007250 | activation of NF-kappaB-inducing kinase activity(GO:0007250) |
1.3 | 2.5 | GO:0006003 | fructose 2,6-bisphosphate metabolic process(GO:0006003) |
1.3 | 3.8 | GO:0045713 | low-density lipoprotein receptor particle metabolic process(GO:0032799) low-density lipoprotein particle receptor biosynthetic process(GO:0045713) regulation of low-density lipoprotein particle receptor biosynthetic process(GO:0045714) |
1.3 | 10.1 | GO:0030239 | myofibril assembly(GO:0030239) |
1.3 | 3.8 | GO:0042447 | hormone catabolic process(GO:0042447) |
1.3 | 7.6 | GO:0001913 | T cell mediated cytotoxicity(GO:0001913) |
1.3 | 6.3 | GO:0070475 | rRNA base methylation(GO:0070475) |
1.3 | 1.3 | GO:1903795 | regulation of inorganic anion transmembrane transport(GO:1903795) regulation of chloride transport(GO:2001225) |
1.3 | 1.3 | GO:0070343 | white fat cell proliferation(GO:0070343) regulation of white fat cell proliferation(GO:0070350) |
1.3 | 2.5 | GO:0046865 | retinol transport(GO:0034633) isoprenoid transport(GO:0046864) terpenoid transport(GO:0046865) |
1.2 | 2.5 | GO:0034372 | very-low-density lipoprotein particle remodeling(GO:0034372) |
1.2 | 2.5 | GO:0035087 | siRNA loading onto RISC involved in RNA interference(GO:0035087) |
1.2 | 5.0 | GO:0010032 | meiotic chromosome condensation(GO:0010032) |
1.2 | 5.0 | GO:0046640 | regulation of alpha-beta T cell proliferation(GO:0046640) positive regulation of alpha-beta T cell proliferation(GO:0046641) |
1.2 | 3.7 | GO:0070537 | histone H2A K63-linked deubiquitination(GO:0070537) |
1.2 | 7.5 | GO:0042905 | 9-cis-retinoic acid biosynthetic process(GO:0042904) 9-cis-retinoic acid metabolic process(GO:0042905) |
1.2 | 8.7 | GO:0006689 | ganglioside catabolic process(GO:0006689) |
1.2 | 2.5 | GO:0045196 | establishment or maintenance of neuroblast polarity(GO:0045196) establishment of neuroblast polarity(GO:0045200) |
1.2 | 2.5 | GO:0006295 | nucleotide-excision repair, DNA incision, 3'-to lesion(GO:0006295) |
1.2 | 4.9 | GO:0035635 | entry of bacterium into host cell(GO:0035635) regulation of entry of bacterium into host cell(GO:2000535) |
1.2 | 15.9 | GO:0055090 | acylglycerol homeostasis(GO:0055090) triglyceride homeostasis(GO:0070328) |
1.2 | 6.1 | GO:0044247 | glycogen catabolic process(GO:0005980) glucan catabolic process(GO:0009251) cellular polysaccharide catabolic process(GO:0044247) |
1.2 | 2.4 | GO:0038108 | negative regulation of appetite by leptin-mediated signaling pathway(GO:0038108) |
1.2 | 19.5 | GO:0006491 | N-glycan processing(GO:0006491) |
1.2 | 12.2 | GO:0006855 | drug transmembrane transport(GO:0006855) |
1.2 | 2.4 | GO:0033860 | regulation of NAD(P)H oxidase activity(GO:0033860) |
1.2 | 1.2 | GO:0033239 | negative regulation of cellular amine metabolic process(GO:0033239) |
1.2 | 3.7 | GO:0036302 | atrioventricular canal development(GO:0036302) |
1.2 | 9.7 | GO:0000183 | chromatin silencing at rDNA(GO:0000183) |
1.2 | 3.6 | GO:0006677 | glycosylceramide metabolic process(GO:0006677) |
1.2 | 3.6 | GO:0043456 | regulation of pentose-phosphate shunt(GO:0043456) |
1.2 | 4.8 | GO:1904994 | regulation of leukocyte adhesion to vascular endothelial cell(GO:1904994) |
1.2 | 6.0 | GO:0042789 | mRNA transcription from RNA polymerase II promoter(GO:0042789) |
1.2 | 4.8 | GO:1902414 | protein localization to cell junction(GO:1902414) |
1.2 | 24.0 | GO:0050853 | B cell receptor signaling pathway(GO:0050853) |
1.2 | 3.6 | GO:0036112 | medium-chain fatty-acyl-CoA metabolic process(GO:0036112) |
1.2 | 1.2 | GO:0034310 | primary alcohol catabolic process(GO:0034310) |
1.2 | 3.6 | GO:0046125 | pyrimidine deoxyribonucleoside metabolic process(GO:0046125) |
1.2 | 20.3 | GO:0006998 | nuclear envelope organization(GO:0006998) |
1.2 | 1.2 | GO:0042518 | negative regulation of tyrosine phosphorylation of Stat3 protein(GO:0042518) |
1.2 | 1.2 | GO:0097501 | stress response to metal ion(GO:0097501) |
1.2 | 3.6 | GO:0070488 | neutrophil aggregation(GO:0070488) |
1.2 | 3.6 | GO:1904752 | vascular associated smooth muscle cell migration(GO:1904738) regulation of vascular associated smooth muscle cell migration(GO:1904752) positive regulation of vascular associated smooth muscle cell migration(GO:1904754) |
1.2 | 8.3 | GO:0016338 | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules(GO:0016338) |
1.2 | 1.2 | GO:0048319 | axial mesoderm morphogenesis(GO:0048319) |
1.2 | 4.7 | GO:2000353 | positive regulation of endothelial cell apoptotic process(GO:2000353) |
1.2 | 2.3 | GO:0035457 | cellular response to interferon-alpha(GO:0035457) |
1.2 | 15.2 | GO:0060575 | intestinal epithelial cell differentiation(GO:0060575) |
1.2 | 4.7 | GO:0030836 | positive regulation of actin filament depolymerization(GO:0030836) |
1.2 | 3.5 | GO:0042346 | positive regulation of NF-kappaB import into nucleus(GO:0042346) |
1.2 | 4.7 | GO:0018406 | protein C-linked glycosylation(GO:0018103) peptidyl-tryptophan modification(GO:0018211) protein C-linked glycosylation via tryptophan(GO:0018317) protein C-linked glycosylation via 2'-alpha-mannosyl-L-tryptophan(GO:0018406) |
1.2 | 2.3 | GO:0006624 | vacuolar protein processing(GO:0006624) |
1.2 | 2.3 | GO:0043353 | enucleate erythrocyte differentiation(GO:0043353) |
1.2 | 4.6 | GO:0001672 | regulation of chromatin assembly or disassembly(GO:0001672) |
1.2 | 5.8 | GO:0071468 | cellular response to acidic pH(GO:0071468) |
1.2 | 8.1 | GO:0035845 | photoreceptor cell outer segment organization(GO:0035845) |
1.2 | 4.6 | GO:0060236 | regulation of mitotic spindle organization(GO:0060236) regulation of spindle organization(GO:0090224) |
1.1 | 3.4 | GO:0045651 | positive regulation of macrophage differentiation(GO:0045651) |
1.1 | 17.1 | GO:0006471 | protein ADP-ribosylation(GO:0006471) |
1.1 | 49.0 | GO:0007569 | cell aging(GO:0007569) |
1.1 | 2.3 | GO:0051315 | attachment of mitotic spindle microtubules to kinetochore(GO:0051315) |
1.1 | 9.1 | GO:0000083 | regulation of transcription involved in G1/S transition of mitotic cell cycle(GO:0000083) |
1.1 | 5.7 | GO:0036336 | dendritic cell migration(GO:0036336) |
1.1 | 4.5 | GO:0060050 | positive regulation of protein glycosylation(GO:0060050) |
1.1 | 3.4 | GO:0001765 | membrane raft assembly(GO:0001765) |
1.1 | 2.3 | GO:0002711 | positive regulation of T cell mediated immunity(GO:0002711) |
1.1 | 1.1 | GO:0018904 | ether metabolic process(GO:0018904) |
1.1 | 4.5 | GO:1902170 | cellular response to reactive nitrogen species(GO:1902170) |
1.1 | 1.1 | GO:0036092 | phosphatidylinositol-3-phosphate biosynthetic process(GO:0036092) |
1.1 | 3.4 | GO:0043536 | positive regulation of blood vessel endothelial cell migration(GO:0043536) |
1.1 | 4.5 | GO:0015838 | amino-acid betaine transport(GO:0015838) |
1.1 | 3.3 | GO:0045585 | regulation of cytotoxic T cell differentiation(GO:0045583) positive regulation of cytotoxic T cell differentiation(GO:0045585) |
1.1 | 1.1 | GO:0021943 | formation of radial glial scaffolds(GO:0021943) |
1.1 | 4.4 | GO:0051988 | regulation of attachment of spindle microtubules to kinetochore(GO:0051988) |
1.1 | 1.1 | GO:0032489 | regulation of Cdc42 protein signal transduction(GO:0032489) |
1.1 | 1.1 | GO:0009177 | deoxyribonucleoside monophosphate biosynthetic process(GO:0009157) pyrimidine deoxyribonucleoside monophosphate biosynthetic process(GO:0009177) |
1.1 | 6.6 | GO:0071801 | regulation of podosome assembly(GO:0071801) |
1.1 | 2.2 | GO:0021797 | forebrain anterior/posterior pattern specification(GO:0021797) |
1.1 | 5.5 | GO:0048661 | positive regulation of smooth muscle cell proliferation(GO:0048661) |
1.1 | 1.1 | GO:1902455 | negative regulation of stem cell population maintenance(GO:1902455) |
1.1 | 51.4 | GO:0031532 | actin cytoskeleton reorganization(GO:0031532) |
1.1 | 1.1 | GO:1904751 | regulation of protein localization to nucleolus(GO:1904749) positive regulation of protein localization to nucleolus(GO:1904751) |
1.1 | 5.4 | GO:0015671 | oxygen transport(GO:0015671) |
1.1 | 2.2 | GO:0007016 | cytoskeletal anchoring at plasma membrane(GO:0007016) |
1.1 | 3.3 | GO:0032570 | response to progesterone(GO:0032570) |
1.1 | 4.3 | GO:0060252 | positive regulation of glial cell proliferation(GO:0060252) |
1.1 | 29.1 | GO:0071346 | cellular response to interferon-gamma(GO:0071346) |
1.1 | 7.5 | GO:0070995 | NADPH oxidation(GO:0070995) |
1.1 | 1.1 | GO:0003011 | diaphragm contraction(GO:0002086) involuntary skeletal muscle contraction(GO:0003011) |
1.1 | 2.2 | GO:0048012 | hepatocyte growth factor receptor signaling pathway(GO:0048012) |
1.1 | 1.1 | GO:2000286 | receptor internalization involved in canonical Wnt signaling pathway(GO:2000286) |
1.1 | 4.3 | GO:0033623 | regulation of integrin activation(GO:0033623) |
1.1 | 3.2 | GO:0031584 | activation of phospholipase D activity(GO:0031584) |
1.1 | 1.1 | GO:0033087 | negative regulation of immature T cell proliferation(GO:0033087) |
1.1 | 11.8 | GO:0051601 | exocyst localization(GO:0051601) |
1.1 | 5.3 | GO:0042761 | very long-chain fatty acid biosynthetic process(GO:0042761) |
1.1 | 2.1 | GO:1903774 | positive regulation of viral budding via host ESCRT complex(GO:1903774) |
1.1 | 5.3 | GO:2000042 | negative regulation of double-strand break repair via homologous recombination(GO:2000042) |
1.1 | 4.3 | GO:0030213 | hyaluronan biosynthetic process(GO:0030213) |
1.1 | 8.5 | GO:0090136 | epithelial cell-cell adhesion(GO:0090136) |
1.1 | 10.6 | GO:0033687 | osteoblast proliferation(GO:0033687) |
1.1 | 10.6 | GO:0015727 | lactate transport(GO:0015727) lactate transmembrane transport(GO:0035873) plasma membrane lactate transport(GO:0035879) |
1.1 | 4.3 | GO:0042780 | tRNA 3'-end processing(GO:0042780) |
1.1 | 12.7 | GO:0043153 | entrainment of circadian clock by photoperiod(GO:0043153) |
1.1 | 3.2 | GO:0070561 | vitamin D receptor signaling pathway(GO:0070561) |
1.1 | 1.1 | GO:0036010 | protein localization to endosome(GO:0036010) |
1.1 | 3.2 | GO:0002317 | plasma cell differentiation(GO:0002317) |
1.1 | 4.2 | GO:0044827 | modulation by host of viral genome replication(GO:0044827) positive regulation by host of viral genome replication(GO:0044829) |
1.1 | 9.5 | GO:0042347 | negative regulation of NF-kappaB import into nucleus(GO:0042347) |
1.1 | 9.5 | GO:0035855 | megakaryocyte development(GO:0035855) |
1.1 | 7.4 | GO:0035520 | monoubiquitinated protein deubiquitination(GO:0035520) |
1.0 | 3.1 | GO:0061484 | hematopoietic stem cell homeostasis(GO:0061484) |
1.0 | 2.1 | GO:0070423 | nucleotide-binding oligomerization domain containing signaling pathway(GO:0070423) nucleotide-binding oligomerization domain containing 2 signaling pathway(GO:0070431) |
1.0 | 1.0 | GO:0051791 | medium-chain fatty acid metabolic process(GO:0051791) |
1.0 | 2.1 | GO:0043589 | skin morphogenesis(GO:0043589) |
1.0 | 3.1 | GO:0002154 | thyroid hormone mediated signaling pathway(GO:0002154) |
1.0 | 7.3 | GO:2001241 | positive regulation of extrinsic apoptotic signaling pathway in absence of ligand(GO:2001241) |
1.0 | 1.0 | GO:0060448 | dichotomous subdivision of terminal units involved in lung branching(GO:0060448) |
1.0 | 1.0 | GO:0042994 | cytoplasmic sequestering of transcription factor(GO:0042994) |
1.0 | 2.1 | GO:0002051 | osteoblast fate commitment(GO:0002051) |
1.0 | 2.1 | GO:0039536 | negative regulation of RIG-I signaling pathway(GO:0039536) |
1.0 | 3.1 | GO:2000628 | regulation of miRNA metabolic process(GO:2000628) |
1.0 | 5.1 | GO:0006646 | phosphatidylethanolamine biosynthetic process(GO:0006646) |
1.0 | 1.0 | GO:0031284 | positive regulation of guanylate cyclase activity(GO:0031284) |
1.0 | 3.1 | GO:1990928 | response to amino acid starvation(GO:1990928) |
1.0 | 7.2 | GO:0015825 | L-serine transport(GO:0015825) |
1.0 | 16.4 | GO:0001574 | ganglioside biosynthetic process(GO:0001574) |
1.0 | 1.0 | GO:0015884 | folic acid transport(GO:0015884) |
1.0 | 1.0 | GO:0090526 | regulation of gluconeogenesis involved in cellular glucose homeostasis(GO:0090526) |
1.0 | 1.0 | GO:0090209 | negative regulation of triglyceride metabolic process(GO:0090209) |
1.0 | 19.3 | GO:0007029 | endoplasmic reticulum organization(GO:0007029) |
1.0 | 1.0 | GO:0015886 | heme transport(GO:0015886) |
1.0 | 5.1 | GO:0007175 | negative regulation of epidermal growth factor-activated receptor activity(GO:0007175) |
1.0 | 4.0 | GO:0033211 | adiponectin-activated signaling pathway(GO:0033211) |
1.0 | 3.0 | GO:0031087 | nuclear-transcribed mRNA catabolic process, deadenylation-independent decay(GO:0031086) deadenylation-independent decapping of nuclear-transcribed mRNA(GO:0031087) |
1.0 | 2.0 | GO:0010459 | negative regulation of heart rate(GO:0010459) |
1.0 | 1.0 | GO:0014057 | positive regulation of acetylcholine secretion, neurotransmission(GO:0014057) |
1.0 | 17.1 | GO:0050873 | brown fat cell differentiation(GO:0050873) |
1.0 | 9.1 | GO:0036159 | inner dynein arm assembly(GO:0036159) |
1.0 | 3.0 | GO:0007567 | parturition(GO:0007567) |
1.0 | 2.0 | GO:0046473 | phosphatidic acid metabolic process(GO:0046473) |
1.0 | 5.0 | GO:1904668 | positive regulation of ubiquitin protein ligase activity(GO:1904668) |
1.0 | 1.0 | GO:0030223 | neutrophil differentiation(GO:0030223) |
1.0 | 3.0 | GO:0046292 | formaldehyde metabolic process(GO:0046292) |
1.0 | 6.0 | GO:0048312 | intracellular distribution of mitochondria(GO:0048312) |
1.0 | 11.0 | GO:0001829 | trophectodermal cell differentiation(GO:0001829) |
1.0 | 6.0 | GO:0046688 | response to copper ion(GO:0046688) |
1.0 | 3.0 | GO:0051354 | negative regulation of oxidoreductase activity(GO:0051354) |
1.0 | 1.0 | GO:0010735 | positive regulation of transcription via serum response element binding(GO:0010735) |
1.0 | 2.0 | GO:0001660 | fever generation(GO:0001660) positive regulation of heat generation(GO:0031652) |
1.0 | 2.9 | GO:0030718 | germ-line stem cell population maintenance(GO:0030718) |
1.0 | 15.7 | GO:0070527 | platelet aggregation(GO:0070527) |
1.0 | 3.9 | GO:0010039 | response to iron ion(GO:0010039) |
1.0 | 11.8 | GO:0014911 | positive regulation of smooth muscle cell migration(GO:0014911) |
1.0 | 1.0 | GO:2000370 | positive regulation of clathrin-mediated endocytosis(GO:2000370) |
1.0 | 2.9 | GO:0051818 | disruption of cells of other organism involved in symbiotic interaction(GO:0051818) disruption by host of symbiont cells(GO:0051852) killing by host of symbiont cells(GO:0051873) killing of cells in other organism involved in symbiotic interaction(GO:0051883) |
1.0 | 4.9 | GO:0009052 | pentose-phosphate shunt, non-oxidative branch(GO:0009052) |
1.0 | 2.9 | GO:0048739 | cardiac muscle fiber development(GO:0048739) |
1.0 | 17.5 | GO:0061014 | positive regulation of mRNA catabolic process(GO:0061014) |
1.0 | 2.9 | GO:0021590 | cerebellum maturation(GO:0021590) cerebellar cortex maturation(GO:0021699) |
1.0 | 1.0 | GO:0019184 | nonribosomal peptide biosynthetic process(GO:0019184) |
1.0 | 4.8 | GO:0006307 | DNA dealkylation involved in DNA repair(GO:0006307) |
1.0 | 5.8 | GO:0007076 | mitotic chromosome condensation(GO:0007076) |
1.0 | 1.9 | GO:0046882 | negative regulation of follicle-stimulating hormone secretion(GO:0046882) |
1.0 | 2.9 | GO:0044838 | cell quiescence(GO:0044838) |
1.0 | 1.0 | GO:0030859 | polarized epithelial cell differentiation(GO:0030859) |
1.0 | 5.7 | GO:0043983 | histone H4-K12 acetylation(GO:0043983) |
1.0 | 1.9 | GO:0070200 | establishment of protein localization to chromosome(GO:0070199) establishment of protein localization to telomere(GO:0070200) |
0.9 | 2.8 | GO:0042483 | negative regulation of odontogenesis(GO:0042483) |
0.9 | 1.9 | GO:0048087 | positive regulation of developmental pigmentation(GO:0048087) positive regulation of pigment cell differentiation(GO:0050942) |
0.9 | 0.9 | GO:0006015 | 5-phosphoribose 1-diphosphate biosynthetic process(GO:0006015) 5-phosphoribose 1-diphosphate metabolic process(GO:0046391) |
0.9 | 8.4 | GO:0030212 | hyaluronan metabolic process(GO:0030212) |
0.9 | 3.7 | GO:0042997 | negative regulation of Golgi to plasma membrane protein transport(GO:0042997) |
0.9 | 0.9 | GO:0086103 | G-protein coupled receptor signaling pathway involved in heart process(GO:0086103) |
0.9 | 1.8 | GO:0055098 | response to low-density lipoprotein particle(GO:0055098) |
0.9 | 1.8 | GO:0031579 | membrane raft organization(GO:0031579) |
0.9 | 0.9 | GO:1900044 | regulation of protein K63-linked ubiquitination(GO:1900044) |
0.9 | 4.6 | GO:0018401 | peptidyl-proline hydroxylation to 4-hydroxy-L-proline(GO:0018401) |
0.9 | 7.4 | GO:0032728 | positive regulation of interferon-beta production(GO:0032728) |
0.9 | 2.8 | GO:0007217 | tachykinin receptor signaling pathway(GO:0007217) |
0.9 | 1.8 | GO:0010992 | ubiquitin homeostasis(GO:0010992) |
0.9 | 3.7 | GO:0070126 | mitochondrial translational termination(GO:0070126) |
0.9 | 0.9 | GO:0070242 | thymocyte apoptotic process(GO:0070242) |
0.9 | 7.3 | GO:0010216 | maintenance of DNA methylation(GO:0010216) |
0.9 | 3.7 | GO:0061154 | endothelial tube morphogenesis(GO:0061154) |
0.9 | 41.8 | GO:0007599 | hemostasis(GO:0007599) |
0.9 | 3.6 | GO:0070307 | lens fiber cell development(GO:0070307) |
0.9 | 6.3 | GO:0060158 | phospholipase C-activating dopamine receptor signaling pathway(GO:0060158) |
0.9 | 7.2 | GO:0032674 | regulation of interleukin-5 production(GO:0032674) |
0.9 | 3.6 | GO:0006572 | tyrosine catabolic process(GO:0006572) |
0.9 | 1.8 | GO:0097284 | hepatocyte apoptotic process(GO:0097284) |
0.9 | 1.8 | GO:0048102 | autophagic cell death(GO:0048102) |
0.9 | 4.5 | GO:0006968 | cellular defense response(GO:0006968) |
0.9 | 2.7 | GO:0048341 | paraxial mesoderm formation(GO:0048341) |
0.9 | 1.8 | GO:0033299 | secretion of lysosomal enzymes(GO:0033299) |
0.9 | 2.7 | GO:0035582 | sequestering of BMP in extracellular matrix(GO:0035582) |
0.9 | 4.5 | GO:0048148 | behavioral response to cocaine(GO:0048148) |
0.9 | 0.9 | GO:0072718 | response to cisplatin(GO:0072718) |
0.9 | 3.6 | GO:0060449 | bud elongation involved in lung branching(GO:0060449) |
0.9 | 1.8 | GO:0035519 | protein K29-linked ubiquitination(GO:0035519) |
0.9 | 4.4 | GO:0007549 | dosage compensation(GO:0007549) dosage compensation by inactivation of X chromosome(GO:0009048) |
0.9 | 0.9 | GO:1903376 | neuron intrinsic apoptotic signaling pathway in response to oxidative stress(GO:0036480) regulation of oxidative stress-induced neuron intrinsic apoptotic signaling pathway(GO:1903376) |
0.9 | 5.3 | GO:0031670 | cellular response to nutrient(GO:0031670) |
0.9 | 10.6 | GO:0060712 | spongiotrophoblast layer development(GO:0060712) |
0.9 | 1.8 | GO:0072672 | neutrophil extravasation(GO:0072672) |
0.9 | 1.8 | GO:1902166 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:1902166) |
0.9 | 2.6 | GO:0001732 | formation of cytoplasmic translation initiation complex(GO:0001732) |
0.9 | 0.9 | GO:0009138 | pyrimidine nucleoside diphosphate metabolic process(GO:0009138) |
0.9 | 3.5 | GO:0020027 | hemoglobin metabolic process(GO:0020027) |
0.9 | 3.5 | GO:0042737 | drug catabolic process(GO:0042737) |
0.9 | 4.4 | GO:0008298 | intracellular mRNA localization(GO:0008298) |
0.9 | 0.9 | GO:1901674 | histone H3-K27 acetylation(GO:0043974) regulation of histone H3-K27 acetylation(GO:1901674) |
0.9 | 0.9 | GO:0045059 | positive thymic T cell selection(GO:0045059) |
0.9 | 1.7 | GO:0050710 | negative regulation of cytokine secretion(GO:0050710) |
0.9 | 4.3 | GO:1900745 | positive regulation of p38MAPK cascade(GO:1900745) |
0.9 | 0.9 | GO:0032816 | positive regulation of natural killer cell activation(GO:0032816) |
0.9 | 0.9 | GO:0031282 | regulation of guanylate cyclase activity(GO:0031282) |
0.9 | 2.6 | GO:0033622 | integrin activation(GO:0033622) |
0.9 | 4.3 | GO:0035331 | negative regulation of hippo signaling(GO:0035331) |
0.9 | 2.6 | GO:1902306 | negative regulation of sodium ion transmembrane transport(GO:1902306) |
0.9 | 6.9 | GO:0045910 | negative regulation of DNA recombination(GO:0045910) |
0.9 | 6.9 | GO:0015893 | drug transport(GO:0015893) |
0.9 | 6.0 | GO:0046541 | saliva secretion(GO:0046541) |
0.9 | 4.3 | GO:0000055 | ribosomal large subunit export from nucleus(GO:0000055) |
0.9 | 0.9 | GO:0043117 | positive regulation of vascular permeability(GO:0043117) |
0.9 | 12.8 | GO:0071108 | protein K48-linked deubiquitination(GO:0071108) |
0.9 | 5.1 | GO:0006384 | transcription initiation from RNA polymerase III promoter(GO:0006384) |
0.8 | 3.4 | GO:0070072 | vacuolar proton-transporting V-type ATPase complex assembly(GO:0070072) |
0.8 | 2.5 | GO:0032908 | transforming growth factor beta1 production(GO:0032905) regulation of transforming growth factor beta1 production(GO:0032908) |
0.8 | 0.8 | GO:0010958 | regulation of amino acid import(GO:0010958) |
0.8 | 1.7 | GO:0042723 | thiamine metabolic process(GO:0006772) thiamine-containing compound metabolic process(GO:0042723) |
0.8 | 4.2 | GO:0006620 | posttranslational protein targeting to membrane(GO:0006620) |
0.8 | 2.5 | GO:0071712 | ER-associated misfolded protein catabolic process(GO:0071712) |
0.8 | 3.4 | GO:0071357 | cellular response to type I interferon(GO:0071357) |
0.8 | 2.5 | GO:0071494 | cellular response to UV-C(GO:0071494) |
0.8 | 1.7 | GO:0015780 | nucleotide-sugar transport(GO:0015780) pyrimidine nucleotide-sugar transport(GO:0015781) |
0.8 | 3.3 | GO:0090169 | regulation of spindle assembly(GO:0090169) |
0.8 | 8.3 | GO:0032515 | negative regulation of phosphoprotein phosphatase activity(GO:0032515) |
0.8 | 4.2 | GO:0090023 | positive regulation of neutrophil chemotaxis(GO:0090023) |
0.8 | 15.8 | GO:0007032 | endosome organization(GO:0007032) |
0.8 | 10.0 | GO:0051642 | centrosome localization(GO:0051642) |
0.8 | 0.8 | GO:1901896 | positive regulation of calcium-transporting ATPase activity(GO:1901896) |
0.8 | 2.5 | GO:0010801 | negative regulation of peptidyl-threonine phosphorylation(GO:0010801) |
0.8 | 3.3 | GO:0072678 | T cell migration(GO:0072678) |
0.8 | 2.5 | GO:0060023 | soft palate development(GO:0060023) |
0.8 | 1.6 | GO:1903299 | regulation of hexokinase activity(GO:1903299) |
0.8 | 5.7 | GO:0030277 | maintenance of gastrointestinal epithelium(GO:0030277) |
0.8 | 3.2 | GO:0051256 | mitotic spindle elongation(GO:0000022) spindle elongation(GO:0051231) mitotic spindle midzone assembly(GO:0051256) |
0.8 | 14.6 | GO:0050829 | defense response to Gram-negative bacterium(GO:0050829) |
0.8 | 1.6 | GO:0030812 | negative regulation of nucleotide catabolic process(GO:0030812) |
0.8 | 0.8 | GO:0019371 | cyclooxygenase pathway(GO:0019371) |
0.8 | 1.6 | GO:0048069 | eye pigmentation(GO:0048069) |
0.8 | 5.7 | GO:0034501 | protein localization to kinetochore(GO:0034501) |
0.8 | 11.3 | GO:0045737 | positive regulation of cyclin-dependent protein serine/threonine kinase activity(GO:0045737) |
0.8 | 0.8 | GO:1904688 | regulation of cap-independent translational initiation(GO:1903677) positive regulation of cap-independent translational initiation(GO:1903679) regulation of cytoplasmic translational initiation(GO:1904688) positive regulation of cytoplasmic translational initiation(GO:1904690) |
0.8 | 1.6 | GO:1903232 | melanosome assembly(GO:1903232) |
0.8 | 2.4 | GO:0045743 | positive regulation of fibroblast growth factor receptor signaling pathway(GO:0045743) |
0.8 | 32.1 | GO:0006749 | glutathione metabolic process(GO:0006749) |
0.8 | 14.4 | GO:0006611 | protein export from nucleus(GO:0006611) |
0.8 | 2.4 | GO:0071318 | cellular response to ATP(GO:0071318) |
0.8 | 1.6 | GO:0035811 | negative regulation of urine volume(GO:0035811) |
0.8 | 4.0 | GO:0051451 | myoblast migration(GO:0051451) |
0.8 | 2.4 | GO:0046341 | CDP-diacylglycerol metabolic process(GO:0046341) |
0.8 | 4.7 | GO:0010614 | negative regulation of cardiac muscle hypertrophy(GO:0010614) |
0.8 | 5.5 | GO:0019800 | peptide cross-linking via chondroitin 4-sulfate glycosaminoglycan(GO:0019800) |
0.8 | 18.1 | GO:1901184 | regulation of ERBB signaling pathway(GO:1901184) |
0.8 | 1.6 | GO:0072606 | interleukin-8 secretion(GO:0072606) |
0.8 | 1.6 | GO:0035562 | negative regulation of chromatin binding(GO:0035562) |
0.8 | 2.3 | GO:0046208 | spermine catabolic process(GO:0046208) |
0.8 | 3.1 | GO:0051697 | protein delipidation(GO:0051697) |
0.8 | 3.1 | GO:0046135 | pyrimidine nucleoside catabolic process(GO:0046135) |
0.8 | 4.6 | GO:0017196 | N-terminal peptidyl-methionine acetylation(GO:0017196) |
0.8 | 1.5 | GO:0006577 | amino-acid betaine metabolic process(GO:0006577) |
0.8 | 1.5 | GO:0051572 | negative regulation of histone H3-K4 methylation(GO:0051572) |
0.8 | 3.1 | GO:0006656 | phosphatidylcholine biosynthetic process(GO:0006656) |
0.8 | 10.0 | GO:0010972 | negative regulation of G2/M transition of mitotic cell cycle(GO:0010972) |
0.8 | 2.3 | GO:0060586 | multicellular organismal iron ion homeostasis(GO:0060586) |
0.8 | 2.3 | GO:1900028 | negative regulation of ruffle assembly(GO:1900028) |
0.8 | 2.3 | GO:0014043 | negative regulation of neuron maturation(GO:0014043) |
0.8 | 1.5 | GO:0010875 | positive regulation of cholesterol efflux(GO:0010875) |
0.7 | 0.7 | GO:0006069 | ethanol metabolic process(GO:0006067) ethanol oxidation(GO:0006069) |
0.7 | 1.5 | GO:0045792 | negative regulation of cell size(GO:0045792) |
0.7 | 2.2 | GO:1902237 | positive regulation of endoplasmic reticulum stress-induced intrinsic apoptotic signaling pathway(GO:1902237) |
0.7 | 3.0 | GO:2000778 | positive regulation of interleukin-6 secretion(GO:2000778) |
0.7 | 9.7 | GO:0006801 | superoxide metabolic process(GO:0006801) |
0.7 | 3.7 | GO:0060613 | fat pad development(GO:0060613) |
0.7 | 2.2 | GO:0048199 | vesicle targeting, to, from or within Golgi(GO:0048199) |
0.7 | 3.0 | GO:0072673 | lamellipodium morphogenesis(GO:0072673) |
0.7 | 1.5 | GO:0033127 | regulation of histone phosphorylation(GO:0033127) |
0.7 | 1.5 | GO:0019346 | homoserine metabolic process(GO:0009092) transsulfuration(GO:0019346) |
0.7 | 0.7 | GO:0035860 | glial cell-derived neurotrophic factor receptor signaling pathway(GO:0035860) |
0.7 | 0.7 | GO:0032616 | interleukin-13 production(GO:0032616) |
0.7 | 4.4 | GO:0034105 | positive regulation of tissue remodeling(GO:0034105) |
0.7 | 3.7 | GO:0035767 | endothelial cell chemotaxis(GO:0035767) |
0.7 | 1.5 | GO:0071364 | cellular response to epidermal growth factor stimulus(GO:0071364) |
0.7 | 2.9 | GO:0043619 | regulation of transcription from RNA polymerase II promoter in response to oxidative stress(GO:0043619) |
0.7 | 1.5 | GO:2000651 | positive regulation of sodium ion transmembrane transport(GO:1902307) positive regulation of sodium ion transmembrane transporter activity(GO:2000651) |
0.7 | 5.9 | GO:0042149 | cellular response to glucose starvation(GO:0042149) |
0.7 | 0.7 | GO:1902956 | regulation of mitochondrial electron transport, NADH to ubiquinone(GO:1902956) |
0.7 | 5.1 | GO:0032119 | sequestering of zinc ion(GO:0032119) regulation of sequestering of zinc ion(GO:0061088) |
0.7 | 2.2 | GO:0032463 | negative regulation of protein homooligomerization(GO:0032463) |
0.7 | 2.9 | GO:0034080 | CENP-A containing nucleosome assembly(GO:0034080) CENP-A containing chromatin organization(GO:0061641) |
0.7 | 2.9 | GO:0010838 | positive regulation of keratinocyte proliferation(GO:0010838) |
0.7 | 3.6 | GO:0048702 | embryonic neurocranium morphogenesis(GO:0048702) |
0.7 | 2.9 | GO:0009186 | deoxyribonucleoside diphosphate metabolic process(GO:0009186) |
0.7 | 4.3 | GO:0006957 | complement activation, alternative pathway(GO:0006957) |
0.7 | 3.6 | GO:0031848 | protection from non-homologous end joining at telomere(GO:0031848) |
0.7 | 2.2 | GO:0036444 | calcium ion transmembrane import into mitochondrion(GO:0036444) |
0.7 | 1.4 | GO:0045925 | positive regulation of female receptivity(GO:0045925) |
0.7 | 1.4 | GO:0034383 | low-density lipoprotein particle clearance(GO:0034383) |
0.7 | 2.9 | GO:0000480 | endonucleolytic cleavage in 5'-ETS of tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000480) |
0.7 | 7.9 | GO:0042572 | retinol metabolic process(GO:0042572) |
0.7 | 4.3 | GO:0051383 | kinetochore organization(GO:0051383) |
0.7 | 1.4 | GO:0006481 | C-terminal protein methylation(GO:0006481) |
0.7 | 22.8 | GO:0071391 | cellular response to estrogen stimulus(GO:0071391) |
0.7 | 10.0 | GO:0042771 | intrinsic apoptotic signaling pathway in response to DNA damage by p53 class mediator(GO:0042771) |
0.7 | 2.8 | GO:0045943 | positive regulation of transcription from RNA polymerase I promoter(GO:0045943) |
0.7 | 0.7 | GO:0006266 | DNA ligation(GO:0006266) |
0.7 | 1.4 | GO:0009624 | response to nematode(GO:0009624) |
0.7 | 1.4 | GO:1902031 | regulation of NADP metabolic process(GO:1902031) |
0.7 | 7.7 | GO:0050830 | defense response to Gram-positive bacterium(GO:0050830) |
0.7 | 2.1 | GO:0042713 | sperm ejaculation(GO:0042713) |
0.7 | 1.4 | GO:0015722 | canalicular bile acid transport(GO:0015722) |
0.7 | 6.3 | GO:0061515 | myeloid cell development(GO:0061515) |
0.7 | 0.7 | GO:0045908 | negative regulation of vasodilation(GO:0045908) |
0.7 | 2.1 | GO:0014842 | regulation of skeletal muscle satellite cell proliferation(GO:0014842) |
0.7 | 0.7 | GO:0010694 | positive regulation of alkaline phosphatase activity(GO:0010694) |
0.7 | 1.4 | GO:0060671 | epithelial cell differentiation involved in embryonic placenta development(GO:0060671) epithelial cell morphogenesis involved in placental branching(GO:0060672) |
0.7 | 5.5 | GO:0070166 | enamel mineralization(GO:0070166) |
0.7 | 2.1 | GO:0001887 | selenium compound metabolic process(GO:0001887) |
0.7 | 0.7 | GO:0034392 | negative regulation of smooth muscle cell apoptotic process(GO:0034392) |
0.7 | 5.5 | GO:1901739 | regulation of myoblast fusion(GO:1901739) positive regulation of myoblast fusion(GO:1901741) |
0.7 | 2.7 | GO:0046500 | S-adenosylmethionine metabolic process(GO:0046500) |
0.7 | 2.1 | GO:0098789 | pre-mRNA cleavage required for polyadenylation(GO:0098789) |
0.7 | 2.1 | GO:0015755 | fructose transport(GO:0015755) |
0.7 | 2.0 | GO:0019478 | D-amino acid catabolic process(GO:0019478) |
0.7 | 1.4 | GO:0061055 | myotome development(GO:0061055) |
0.7 | 10.9 | GO:0002224 | toll-like receptor signaling pathway(GO:0002224) |
0.7 | 2.0 | GO:1904424 | regulation of GTP binding(GO:1904424) |
0.7 | 4.1 | GO:0043545 | Mo-molybdopterin cofactor biosynthetic process(GO:0006777) Mo-molybdopterin cofactor metabolic process(GO:0019720) molybdopterin cofactor biosynthetic process(GO:0032324) molybdopterin cofactor metabolic process(GO:0043545) prosthetic group metabolic process(GO:0051189) |
0.7 | 6.8 | GO:0006883 | cellular sodium ion homeostasis(GO:0006883) |
0.7 | 7.4 | GO:0072525 | pyridine-containing compound biosynthetic process(GO:0072525) |
0.7 | 2.7 | GO:0015871 | choline transport(GO:0015871) |
0.7 | 1.3 | GO:0060056 | mammary gland involution(GO:0060056) |
0.7 | 0.7 | GO:0045091 | regulation of single stranded viral RNA replication via double stranded DNA intermediate(GO:0045091) |
0.7 | 0.7 | GO:0036124 | histone H3-K9 trimethylation(GO:0036124) |
0.7 | 1.3 | GO:0051031 | tRNA transport(GO:0051031) |
0.7 | 1.3 | GO:2000675 | negative regulation of type B pancreatic cell apoptotic process(GO:2000675) |
0.7 | 3.3 | GO:0000237 | leptotene(GO:0000237) |
0.7 | 0.7 | GO:0090309 | positive regulation of methylation-dependent chromatin silencing(GO:0090309) |
0.7 | 2.0 | GO:0060005 | vestibular reflex(GO:0060005) |
0.7 | 7.9 | GO:0016578 | histone deubiquitination(GO:0016578) |
0.7 | 2.6 | GO:2000210 | positive regulation of anoikis(GO:2000210) |
0.7 | 2.0 | GO:0051461 | positive regulation of corticotropin secretion(GO:0051461) |
0.7 | 0.7 | GO:0030889 | negative regulation of B cell proliferation(GO:0030889) |
0.7 | 2.6 | GO:0033273 | response to vitamin(GO:0033273) |
0.7 | 0.7 | GO:0045342 | MHC class II biosynthetic process(GO:0045342) |
0.6 | 0.6 | GO:2001279 | regulation of prostaglandin biosynthetic process(GO:0031392) regulation of unsaturated fatty acid biosynthetic process(GO:2001279) |
0.6 | 0.6 | GO:0010571 | positive regulation of nuclear cell cycle DNA replication(GO:0010571) |
0.6 | 1.3 | GO:0035404 | histone-serine phosphorylation(GO:0035404) histone H3-S10 phosphorylation(GO:0043987) |
0.6 | 2.6 | GO:1902626 | assembly of large subunit precursor of preribosome(GO:1902626) |
0.6 | 2.6 | GO:0010714 | positive regulation of collagen metabolic process(GO:0010714) positive regulation of collagen biosynthetic process(GO:0032967) positive regulation of multicellular organismal metabolic process(GO:0044253) |
0.6 | 3.9 | GO:0051026 | chiasma assembly(GO:0051026) |
0.6 | 12.2 | GO:0001783 | B cell apoptotic process(GO:0001783) |
0.6 | 0.6 | GO:0098763 | mitotic cell cycle phase(GO:0098763) |
0.6 | 5.1 | GO:0030811 | regulation of nucleotide catabolic process(GO:0030811) |
0.6 | 2.6 | GO:0008295 | spermidine biosynthetic process(GO:0008295) |
0.6 | 2.5 | GO:0034227 | tRNA thio-modification(GO:0034227) |
0.6 | 3.8 | GO:0031952 | regulation of protein autophosphorylation(GO:0031952) |
0.6 | 1.9 | GO:0002386 | immune response in mucosal-associated lymphoid tissue(GO:0002386) |
0.6 | 0.6 | GO:0046271 | phenylpropanoid metabolic process(GO:0009698) phenylpropanoid catabolic process(GO:0046271) |
0.6 | 1.9 | GO:0015959 | diadenosine polyphosphate metabolic process(GO:0015959) |
0.6 | 1.9 | GO:0045653 | negative regulation of megakaryocyte differentiation(GO:0045653) |
0.6 | 5.7 | GO:0045671 | negative regulation of osteoclast differentiation(GO:0045671) |
0.6 | 0.6 | GO:0071694 | protein localization to extracellular region(GO:0071692) maintenance of protein location in extracellular region(GO:0071694) |
0.6 | 12.6 | GO:0030218 | erythrocyte differentiation(GO:0030218) |
0.6 | 1.3 | GO:0032224 | positive regulation of synaptic transmission, cholinergic(GO:0032224) |
0.6 | 6.3 | GO:0050774 | negative regulation of dendrite morphogenesis(GO:0050774) |
0.6 | 3.1 | GO:0048535 | lymph node development(GO:0048535) |
0.6 | 3.7 | GO:0070233 | negative regulation of T cell apoptotic process(GO:0070233) |
0.6 | 0.6 | GO:0071139 | resolution of recombination intermediates(GO:0071139) |
0.6 | 3.7 | GO:0006610 | ribosomal protein import into nucleus(GO:0006610) |
0.6 | 1.2 | GO:0042374 | phylloquinone metabolic process(GO:0042374) phylloquinone catabolic process(GO:0042376) quinone catabolic process(GO:1901662) |
0.6 | 5.6 | GO:0060716 | labyrinthine layer blood vessel development(GO:0060716) |
0.6 | 0.6 | GO:0006990 | positive regulation of transcription from RNA polymerase II promoter involved in unfolded protein response(GO:0006990) |
0.6 | 2.5 | GO:0007097 | nuclear migration(GO:0007097) |
0.6 | 1.9 | GO:0019471 | 4-hydroxyproline metabolic process(GO:0019471) |
0.6 | 1.2 | GO:0044375 | regulation of peroxisome size(GO:0044375) |
0.6 | 1.8 | GO:0071042 | U1 snRNA 3'-end processing(GO:0034473) U5 snRNA 3'-end processing(GO:0034476) polyadenylation-dependent RNA catabolic process(GO:0043633) polyadenylation-dependent ncRNA catabolic process(GO:0043634) nuclear ncRNA surveillance(GO:0071029) nuclear polyadenylation-dependent rRNA catabolic process(GO:0071035) nuclear polyadenylation-dependent tRNA catabolic process(GO:0071038) nuclear polyadenylation-dependent mRNA catabolic process(GO:0071042) nuclear polyadenylation-dependent ncRNA catabolic process(GO:0071046) polyadenylation-dependent mRNA catabolic process(GO:0071047) |
0.6 | 1.8 | GO:0090188 | negative regulation of pancreatic juice secretion(GO:0090188) |
0.6 | 3.1 | GO:0070389 | chaperone cofactor-dependent protein refolding(GO:0070389) |
0.6 | 2.4 | GO:0007143 | female meiotic division(GO:0007143) |
0.6 | 2.4 | GO:0019682 | pentose-phosphate shunt(GO:0006098) glyceraldehyde-3-phosphate metabolic process(GO:0019682) |
0.6 | 0.6 | GO:0051304 | chromosome separation(GO:0051304) |
0.6 | 1.8 | GO:0000459 | exonucleolytic trimming involved in rRNA processing(GO:0000459) exonucleolytic trimming to generate mature 3'-end of 5.8S rRNA from tricistronic rRNA transcript (SSU-rRNA, 5.8S rRNA, LSU-rRNA)(GO:0000467) |
0.6 | 3.0 | GO:0034472 | snRNA 3'-end processing(GO:0034472) |
0.6 | 1.8 | GO:0046602 | regulation of mitotic centrosome separation(GO:0046602) |
0.6 | 6.0 | GO:0051016 | barbed-end actin filament capping(GO:0051016) |
0.6 | 0.6 | GO:0032345 | negative regulation of aldosterone metabolic process(GO:0032345) negative regulation of aldosterone biosynthetic process(GO:0032348) regulation of cortisol biosynthetic process(GO:2000064) negative regulation of cortisol biosynthetic process(GO:2000065) |
0.6 | 3.6 | GO:0097194 | execution phase of apoptosis(GO:0097194) |
0.6 | 1.8 | GO:0010587 | miRNA catabolic process(GO:0010587) |
0.6 | 1.2 | GO:0072710 | response to hydroxyurea(GO:0072710) cellular response to hydroxyurea(GO:0072711) |
0.6 | 10.1 | GO:0030488 | tRNA methylation(GO:0030488) |
0.6 | 0.6 | GO:0046598 | positive regulation of viral entry into host cell(GO:0046598) |
0.6 | 2.4 | GO:0071168 | protein localization to chromatin(GO:0071168) |
0.6 | 0.6 | GO:2000427 | positive regulation of apoptotic cell clearance(GO:2000427) |
0.6 | 0.6 | GO:0000212 | meiotic spindle organization(GO:0000212) |
0.6 | 0.6 | GO:0000320 | re-entry into mitotic cell cycle(GO:0000320) |
0.6 | 0.6 | GO:0010586 | miRNA metabolic process(GO:0010586) |
0.6 | 1.2 | GO:0001560 | regulation of cell growth by extracellular stimulus(GO:0001560) |
0.6 | 1.2 | GO:2000810 | regulation of bicellular tight junction assembly(GO:2000810) |
0.6 | 0.6 | GO:0009396 | folic acid-containing compound biosynthetic process(GO:0009396) |
0.6 | 1.8 | GO:0006978 | DNA damage response, signal transduction by p53 class mediator resulting in transcription of p21 class mediator(GO:0006978) |
0.6 | 1.8 | GO:0051573 | negative regulation of histone H3-K9 methylation(GO:0051573) |
0.6 | 7.6 | GO:0051310 | metaphase plate congression(GO:0051310) |
0.6 | 1.2 | GO:0030852 | regulation of granulocyte differentiation(GO:0030852) |
0.6 | 4.1 | GO:1990126 | retrograde transport, endosome to plasma membrane(GO:1990126) |
0.6 | 6.9 | GO:0015693 | magnesium ion transport(GO:0015693) |
0.6 | 5.2 | GO:0006349 | regulation of gene expression by genetic imprinting(GO:0006349) |
0.6 | 1.2 | GO:0010712 | regulation of collagen metabolic process(GO:0010712) |
0.6 | 1.1 | GO:1900165 | negative regulation of interleukin-6 secretion(GO:1900165) |
0.6 | 1.7 | GO:1902035 | positive regulation of hematopoietic stem cell proliferation(GO:1902035) |
0.6 | 1.7 | GO:0007263 | nitric oxide mediated signal transduction(GO:0007263) |
0.6 | 2.9 | GO:0051496 | positive regulation of stress fiber assembly(GO:0051496) |
0.6 | 1.1 | GO:0090037 | positive regulation of protein kinase C signaling(GO:0090037) |
0.6 | 0.6 | GO:0045602 | negative regulation of endothelial cell differentiation(GO:0045602) |
0.6 | 1.7 | GO:0046007 | negative regulation of activated T cell proliferation(GO:0046007) |
0.6 | 0.6 | GO:0050849 | negative regulation of calcium-mediated signaling(GO:0050849) |
0.6 | 6.2 | GO:0000060 | protein import into nucleus, translocation(GO:0000060) |
0.6 | 0.6 | GO:0046514 | ceramide catabolic process(GO:0046514) |
0.6 | 0.6 | GO:0071947 | protein deubiquitination involved in ubiquitin-dependent protein catabolic process(GO:0071947) |
0.6 | 5.0 | GO:0034724 | DNA replication-independent nucleosome assembly(GO:0006336) DNA replication-independent nucleosome organization(GO:0034724) |
0.6 | 0.6 | GO:0044381 | glucose import in response to insulin stimulus(GO:0044381) regulation of glucose import in response to insulin stimulus(GO:2001273) |
0.6 | 65.7 | GO:0045087 | innate immune response(GO:0045087) |
0.6 | 0.6 | GO:1902023 | L-arginine import(GO:0043091) arginine import(GO:0090467) L-arginine transport(GO:1902023) |
0.6 | 1.7 | GO:0071596 | ubiquitin-dependent protein catabolic process via the N-end rule pathway(GO:0071596) |
0.6 | 3.3 | GO:0007135 | meiosis II(GO:0007135) |
0.6 | 0.6 | GO:0002314 | germinal center B cell differentiation(GO:0002314) |
0.5 | 1.1 | GO:0034723 | DNA replication-dependent nucleosome assembly(GO:0006335) DNA replication-dependent nucleosome organization(GO:0034723) |
0.5 | 0.5 | GO:0050667 | homocysteine metabolic process(GO:0050667) |
0.5 | 1.6 | GO:0002017 | regulation of blood volume by renal aldosterone(GO:0002017) |
0.5 | 24.1 | GO:0090630 | activation of GTPase activity(GO:0090630) |
0.5 | 0.5 | GO:0071034 | CUT catabolic process(GO:0071034) CUT metabolic process(GO:0071043) |
0.5 | 1.6 | GO:0007042 | lysosomal lumen acidification(GO:0007042) |
0.5 | 0.5 | GO:0072602 | interleukin-4 secretion(GO:0072602) |
0.5 | 0.5 | GO:1905154 | negative regulation of membrane invagination(GO:1905154) |
0.5 | 2.2 | GO:0019441 | tryptophan catabolic process(GO:0006569) tryptophan catabolic process to kynurenine(GO:0019441) indole-containing compound catabolic process(GO:0042436) indolalkylamine catabolic process(GO:0046218) |
0.5 | 0.5 | GO:0060528 | secretory columnal luminar epithelial cell differentiation involved in prostate glandular acinus development(GO:0060528) |
0.5 | 3.2 | GO:0034508 | centromere complex assembly(GO:0034508) |
0.5 | 1.6 | GO:0007290 | spermatid nucleus elongation(GO:0007290) |
0.5 | 1.1 | GO:1902230 | negative regulation of intrinsic apoptotic signaling pathway in response to DNA damage(GO:1902230) |
0.5 | 1.1 | GO:0015705 | iodide transport(GO:0015705) |
0.5 | 0.5 | GO:0060988 | lipid tube assembly(GO:0060988) |
0.5 | 1.6 | GO:0036066 | protein O-linked fucosylation(GO:0036066) |
0.5 | 4.2 | GO:0046627 | negative regulation of insulin receptor signaling pathway(GO:0046627) |
0.5 | 0.5 | GO:0000966 | RNA 5'-end processing(GO:0000966) |
0.5 | 0.5 | GO:0006933 | negative regulation of cell adhesion involved in substrate-bound cell migration(GO:0006933) |
0.5 | 1.1 | GO:0042754 | negative regulation of circadian rhythm(GO:0042754) |
0.5 | 0.5 | GO:0071044 | histone mRNA catabolic process(GO:0071044) |
0.5 | 8.9 | GO:0006376 | mRNA splice site selection(GO:0006376) |
0.5 | 1.0 | GO:0043518 | negative regulation of DNA damage response, signal transduction by p53 class mediator(GO:0043518) |
0.5 | 1.0 | GO:2000401 | regulation of lymphocyte migration(GO:2000401) |
0.5 | 4.7 | GO:0055069 | zinc ion homeostasis(GO:0055069) |
0.5 | 2.6 | GO:0006273 | lagging strand elongation(GO:0006273) |
0.5 | 25.1 | GO:0016579 | protein deubiquitination(GO:0016579) |
0.5 | 2.1 | GO:0002507 | tolerance induction(GO:0002507) |
0.5 | 2.1 | GO:0006369 | termination of RNA polymerase II transcription(GO:0006369) |
0.5 | 1.0 | GO:0060718 | chorionic trophoblast cell differentiation(GO:0060718) |
0.5 | 2.1 | GO:0042559 | pteridine-containing compound biosynthetic process(GO:0042559) |
0.5 | 1.6 | GO:0045579 | positive regulation of B cell differentiation(GO:0045579) |
0.5 | 0.5 | GO:0001834 | trophectodermal cell proliferation(GO:0001834) |
0.5 | 0.5 | GO:0070634 | transepithelial ammonium transport(GO:0070634) |
0.5 | 1.0 | GO:0031937 | positive regulation of chromatin silencing(GO:0031937) |
0.5 | 1.0 | GO:0010804 | negative regulation of tumor necrosis factor-mediated signaling pathway(GO:0010804) |
0.5 | 0.5 | GO:0001951 | intestinal D-glucose absorption(GO:0001951) |
0.5 | 0.5 | GO:0050994 | regulation of lipid catabolic process(GO:0050994) |
0.5 | 17.0 | GO:0006661 | phosphatidylinositol biosynthetic process(GO:0006661) |
0.5 | 1.5 | GO:0001522 | pseudouridine synthesis(GO:0001522) |
0.5 | 1.0 | GO:0061684 | chaperone-mediated autophagy(GO:0061684) |
0.5 | 3.1 | GO:0006104 | succinyl-CoA metabolic process(GO:0006104) |
0.5 | 1.5 | GO:0015809 | arginine transport(GO:0015809) |
0.5 | 3.6 | GO:0008211 | glucocorticoid metabolic process(GO:0008211) |
0.5 | 1.0 | GO:0060148 | positive regulation of posttranscriptional gene silencing(GO:0060148) |
0.5 | 1.5 | GO:0070345 | negative regulation of fat cell proliferation(GO:0070345) |
0.5 | 1.0 | GO:0014041 | regulation of neuron maturation(GO:0014041) |
0.5 | 5.1 | GO:0009081 | branched-chain amino acid metabolic process(GO:0009081) |
0.5 | 1.0 | GO:2000523 | regulation of T cell costimulation(GO:2000523) positive regulation of T cell costimulation(GO:2000525) |
0.5 | 1.5 | GO:2000018 | regulation of male gonad development(GO:2000018) |
0.5 | 6.0 | GO:0045292 | mRNA cis splicing, via spliceosome(GO:0045292) |
0.5 | 5.5 | GO:0050908 | detection of light stimulus involved in visual perception(GO:0050908) detection of light stimulus involved in sensory perception(GO:0050962) |
0.5 | 2.0 | GO:0001845 | phagolysosome assembly(GO:0001845) |
0.5 | 1.0 | GO:0070535 | histone H2A K63-linked ubiquitination(GO:0070535) |
0.5 | 1.0 | GO:0007227 | signal transduction downstream of smoothened(GO:0007227) |
0.5 | 2.5 | GO:0043029 | T cell homeostasis(GO:0043029) |
0.5 | 2.0 | GO:0009649 | entrainment of circadian clock(GO:0009649) |
0.5 | 2.5 | GO:0006370 | 7-methylguanosine mRNA capping(GO:0006370) |
0.5 | 2.0 | GO:0033137 | negative regulation of peptidyl-serine phosphorylation(GO:0033137) |
0.5 | 1.5 | GO:0034377 | plasma lipoprotein particle assembly(GO:0034377) |
0.5 | 2.5 | GO:1900017 | positive regulation of cytokine production involved in inflammatory response(GO:1900017) |
0.5 | 3.0 | GO:0032790 | ribosome disassembly(GO:0032790) |
0.5 | 1.0 | GO:0014878 | response to electrical stimulus involved in regulation of muscle adaptation(GO:0014878) |
0.5 | 1.0 | GO:2000834 | androgen secretion(GO:0035935) regulation of androgen secretion(GO:2000834) positive regulation of androgen secretion(GO:2000836) |
0.5 | 1.0 | GO:0090267 | positive regulation of mitotic cell cycle spindle assembly checkpoint(GO:0090267) |
0.5 | 2.0 | GO:0006531 | aspartate metabolic process(GO:0006531) |
0.5 | 1.5 | GO:1901524 | regulation of macromitophagy(GO:1901524) |
0.5 | 4.4 | GO:0042753 | positive regulation of circadian rhythm(GO:0042753) |
0.5 | 1.5 | GO:0097340 | inhibition of cysteine-type endopeptidase activity(GO:0097340) zymogen inhibition(GO:0097341) inhibition of cysteine-type endopeptidase activity involved in apoptotic process(GO:1990001) |
0.5 | 1.5 | GO:0002023 | reduction of food intake in response to dietary excess(GO:0002023) |
0.5 | 2.4 | GO:0071501 | response to sterol depletion(GO:0006991) SREBP signaling pathway(GO:0032933) cellular response to sterol depletion(GO:0071501) |
0.5 | 7.7 | GO:0043467 | regulation of generation of precursor metabolites and energy(GO:0043467) |
0.5 | 0.5 | GO:0036394 | amylase secretion(GO:0036394) |
0.5 | 0.5 | GO:0070973 | protein localization to endoplasmic reticulum exit site(GO:0070973) |
0.5 | 0.5 | GO:0032277 | negative regulation of gonadotropin secretion(GO:0032277) |
0.5 | 0.5 | GO:0000722 | telomere maintenance via recombination(GO:0000722) |
0.5 | 0.9 | GO:0033227 | dsRNA transport(GO:0033227) |
0.5 | 1.9 | GO:1900027 | regulation of ruffle assembly(GO:1900027) |
0.5 | 0.5 | GO:0042760 | very long-chain fatty acid catabolic process(GO:0042760) |
0.5 | 0.5 | GO:0060620 | regulation of cholesterol import(GO:0060620) regulation of sterol import(GO:2000909) |
0.5 | 2.3 | GO:1990440 | positive regulation of transcription from RNA polymerase II promoter in response to endoplasmic reticulum stress(GO:1990440) |
0.5 | 2.3 | GO:0014733 | regulation of skeletal muscle adaptation(GO:0014733) |
0.5 | 1.8 | GO:0008594 | photoreceptor cell morphogenesis(GO:0008594) |
0.5 | 1.4 | GO:0038026 | reelin-mediated signaling pathway(GO:0038026) |
0.5 | 0.9 | GO:0030421 | defecation(GO:0030421) |
0.5 | 0.5 | GO:0019068 | virion assembly(GO:0019068) |
0.5 | 0.5 | GO:0070601 | centromeric sister chromatid cohesion(GO:0070601) |
0.5 | 4.1 | GO:0018298 | protein-chromophore linkage(GO:0018298) |
0.5 | 6.8 | GO:1900087 | positive regulation of G1/S transition of mitotic cell cycle(GO:1900087) |
0.4 | 1.8 | GO:0033700 | phospholipid efflux(GO:0033700) |
0.4 | 0.4 | GO:0035330 | regulation of hippo signaling(GO:0035330) |
0.4 | 0.4 | GO:0001880 | Mullerian duct regression(GO:0001880) |
0.4 | 2.7 | GO:0000290 | deadenylation-dependent decapping of nuclear-transcribed mRNA(GO:0000290) |
0.4 | 0.9 | GO:0099515 | actin filament-based transport(GO:0099515) |
0.4 | 2.7 | GO:0006829 | zinc II ion transport(GO:0006829) |
0.4 | 0.9 | GO:0051602 | response to electrical stimulus(GO:0051602) |
0.4 | 5.3 | GO:0000186 | activation of MAPKK activity(GO:0000186) |
0.4 | 1.8 | GO:0050917 | sensory perception of umami taste(GO:0050917) |
0.4 | 0.9 | GO:1901874 | regulation of post-translational protein modification(GO:1901873) negative regulation of post-translational protein modification(GO:1901874) |
0.4 | 1.3 | GO:0040016 | embryonic cleavage(GO:0040016) |
0.4 | 0.4 | GO:0035434 | copper ion transmembrane transport(GO:0035434) |
0.4 | 0.4 | GO:0046520 | sphingoid biosynthetic process(GO:0046520) |
0.4 | 0.4 | GO:1901533 | negative regulation of hematopoietic progenitor cell differentiation(GO:1901533) |
0.4 | 0.4 | GO:2000047 | regulation of cell-cell adhesion mediated by cadherin(GO:2000047) positive regulation of cell-cell adhesion mediated by cadherin(GO:2000049) |
0.4 | 6.1 | GO:0030150 | protein import into mitochondrial matrix(GO:0030150) |
0.4 | 0.9 | GO:0051547 | regulation of keratinocyte migration(GO:0051547) positive regulation of keratinocyte migration(GO:0051549) |
0.4 | 0.4 | GO:0085020 | protein K6-linked ubiquitination(GO:0085020) |
0.4 | 0.4 | GO:0032960 | regulation of inositol trisphosphate biosynthetic process(GO:0032960) |
0.4 | 0.4 | GO:0061046 | regulation of branching involved in lung morphogenesis(GO:0061046) |
0.4 | 1.7 | GO:1902093 | positive regulation of sperm motility(GO:1902093) |
0.4 | 1.7 | GO:0071425 | hematopoietic stem cell proliferation(GO:0071425) |
0.4 | 2.1 | GO:0006027 | glycosaminoglycan catabolic process(GO:0006027) |
0.4 | 1.7 | GO:0009404 | toxin metabolic process(GO:0009404) |
0.4 | 2.1 | GO:1902583 | intracellular transport of virus(GO:0075733) multi-organism intracellular transport(GO:1902583) |
0.4 | 1.3 | GO:0001842 | neural fold formation(GO:0001842) |
0.4 | 1.3 | GO:0002347 | response to tumor cell(GO:0002347) |
0.4 | 1.3 | GO:0061086 | negative regulation of histone H3-K27 methylation(GO:0061086) |
0.4 | 0.9 | GO:0061635 | regulation of protein complex stability(GO:0061635) |
0.4 | 3.0 | GO:0015865 | purine nucleotide transport(GO:0015865) |
0.4 | 0.8 | GO:0072502 | cellular phosphate ion homeostasis(GO:0030643) cellular trivalent inorganic anion homeostasis(GO:0072502) |
0.4 | 1.3 | GO:0042168 | heme metabolic process(GO:0042168) |
0.4 | 6.3 | GO:0002757 | immune response-activating signal transduction(GO:0002757) |
0.4 | 3.8 | GO:0030206 | chondroitin sulfate biosynthetic process(GO:0030206) |
0.4 | 5.0 | GO:0000301 | retrograde transport, vesicle recycling within Golgi(GO:0000301) |
0.4 | 1.3 | GO:0035988 | chondrocyte proliferation(GO:0035988) |
0.4 | 0.4 | GO:0060760 | positive regulation of response to cytokine stimulus(GO:0060760) |
0.4 | 1.2 | GO:0008608 | attachment of spindle microtubules to kinetochore(GO:0008608) |
0.4 | 4.2 | GO:0044458 | motile cilium assembly(GO:0044458) |
0.4 | 2.9 | GO:0010324 | membrane invagination(GO:0010324) |
0.4 | 0.4 | GO:0051005 | negative regulation of lipoprotein lipase activity(GO:0051005) |
0.4 | 0.4 | GO:1902931 | negative regulation of alcohol biosynthetic process(GO:1902931) |
0.4 | 1.6 | GO:0034398 | telomere tethering at nuclear periphery(GO:0034398) meiotic telomere tethering at nuclear periphery(GO:0044821) meiotic attachment of telomere to nuclear envelope(GO:0070197) chromosome attachment to the nuclear envelope(GO:0097240) |
0.4 | 2.1 | GO:0031572 | G2 DNA damage checkpoint(GO:0031572) |
0.4 | 2.9 | GO:0010595 | positive regulation of endothelial cell migration(GO:0010595) |
0.4 | 2.5 | GO:0035563 | positive regulation of chromatin binding(GO:0035563) |
0.4 | 1.2 | GO:0009191 | ribonucleoside diphosphate catabolic process(GO:0009191) |
0.4 | 0.8 | GO:0044144 | regulation of growth of symbiont in host(GO:0044126) modulation of growth of symbiont involved in interaction with host(GO:0044144) |
0.4 | 0.8 | GO:0006659 | phosphatidylserine biosynthetic process(GO:0006659) |
0.4 | 0.8 | GO:0001827 | inner cell mass cell fate commitment(GO:0001827) inner cell mass cellular morphogenesis(GO:0001828) |
0.4 | 0.8 | GO:0010669 | epithelial structure maintenance(GO:0010669) |
0.4 | 1.6 | GO:0030225 | macrophage differentiation(GO:0030225) |
0.4 | 1.2 | GO:0051702 | interaction with symbiont(GO:0051702) |
0.4 | 0.4 | GO:0006449 | regulation of translational termination(GO:0006449) |
0.4 | 2.4 | GO:0009226 | nucleotide-sugar biosynthetic process(GO:0009226) |
0.4 | 1.2 | GO:0010793 | regulation of mRNA export from nucleus(GO:0010793) regulation of ribonucleoprotein complex localization(GO:2000197) |
0.4 | 2.4 | GO:0045851 | pH reduction(GO:0045851) |
0.4 | 0.4 | GO:0002579 | regulation of antigen processing and presentation(GO:0002577) positive regulation of antigen processing and presentation(GO:0002579) |
0.4 | 0.8 | GO:0050765 | negative regulation of phagocytosis(GO:0050765) |
0.4 | 2.4 | GO:2000001 | regulation of DNA damage checkpoint(GO:2000001) |
0.4 | 0.8 | GO:0051095 | regulation of helicase activity(GO:0051095) |
0.4 | 4.0 | GO:2000144 | positive regulation of DNA-templated transcription, initiation(GO:2000144) |
0.4 | 0.4 | GO:0060717 | chorion development(GO:0060717) extraembryonic membrane development(GO:1903867) |
0.4 | 2.4 | GO:0045724 | positive regulation of cilium assembly(GO:0045724) |
0.4 | 6.7 | GO:0060976 | coronary vasculature development(GO:0060976) |
0.4 | 0.4 | GO:0043330 | response to exogenous dsRNA(GO:0043330) |
0.4 | 2.0 | GO:0006851 | mitochondrial calcium ion transport(GO:0006851) |
0.4 | 0.4 | GO:0033152 | immunoglobulin V(D)J recombination(GO:0033152) |
0.4 | 1.9 | GO:0055070 | copper ion homeostasis(GO:0055070) |
0.4 | 0.8 | GO:0019676 | ammonia assimilation cycle(GO:0019676) |
0.4 | 0.8 | GO:0022616 | DNA strand elongation(GO:0022616) |
0.4 | 1.9 | GO:0030511 | positive regulation of transforming growth factor beta receptor signaling pathway(GO:0030511) positive regulation of cellular response to transforming growth factor beta stimulus(GO:1903846) |
0.4 | 2.3 | GO:0050729 | positive regulation of inflammatory response(GO:0050729) |
0.4 | 1.2 | GO:0007144 | female meiosis I(GO:0007144) |
0.4 | 1.5 | GO:1904251 | regulation of bile acid metabolic process(GO:1904251) |
0.4 | 0.4 | GO:0046885 | regulation of hormone biosynthetic process(GO:0046885) |
0.4 | 1.9 | GO:0052646 | alditol phosphate metabolic process(GO:0052646) |
0.4 | 0.8 | GO:0009313 | oligosaccharide catabolic process(GO:0009313) |
0.4 | 4.2 | GO:0044243 | multicellular organism catabolic process(GO:0044243) |
0.4 | 1.1 | GO:0048302 | regulation of isotype switching to IgG isotypes(GO:0048302) |
0.4 | 5.2 | GO:0015909 | long-chain fatty acid transport(GO:0015909) |
0.4 | 0.4 | GO:0045065 | cytotoxic T cell differentiation(GO:0045065) |
0.4 | 0.4 | GO:0008635 | activation of cysteine-type endopeptidase activity involved in apoptotic process by cytochrome c(GO:0008635) |
0.4 | 3.0 | GO:0009166 | nucleotide catabolic process(GO:0009166) |
0.4 | 3.0 | GO:0006123 | mitochondrial electron transport, cytochrome c to oxygen(GO:0006123) |
0.4 | 1.8 | GO:0090520 | sphingolipid mediated signaling pathway(GO:0090520) |
0.4 | 1.5 | GO:0046621 | negative regulation of organ growth(GO:0046621) |
0.4 | 1.1 | GO:0060468 | prevention of polyspermy(GO:0060468) |
0.4 | 1.1 | GO:0051386 | regulation of neurotrophin TRK receptor signaling pathway(GO:0051386) |
0.4 | 0.4 | GO:0006568 | tryptophan metabolic process(GO:0006568) indolalkylamine metabolic process(GO:0006586) |
0.4 | 1.1 | GO:0048318 | axial mesoderm development(GO:0048318) |
0.4 | 2.9 | GO:0030261 | chromosome condensation(GO:0030261) |
0.4 | 4.4 | GO:0008272 | sulfate transport(GO:0008272) |
0.4 | 0.4 | GO:0070989 | oxidative demethylation(GO:0070989) |
0.4 | 6.5 | GO:0015914 | phospholipid transport(GO:0015914) |
0.4 | 0.7 | GO:0032367 | intracellular cholesterol transport(GO:0032367) |
0.4 | 10.1 | GO:0051865 | protein autoubiquitination(GO:0051865) |
0.4 | 0.7 | GO:0000733 | DNA strand renaturation(GO:0000733) |
0.4 | 1.4 | GO:0050901 | leukocyte tethering or rolling(GO:0050901) |
0.4 | 5.4 | GO:0000413 | protein peptidyl-prolyl isomerization(GO:0000413) |
0.4 | 2.1 | GO:0031167 | rRNA methylation(GO:0031167) |
0.4 | 1.8 | GO:0032233 | positive regulation of actin filament bundle assembly(GO:0032233) |
0.4 | 3.6 | GO:0000271 | polysaccharide biosynthetic process(GO:0000271) |
0.4 | 1.4 | GO:0046782 | regulation of viral transcription(GO:0046782) |
0.3 | 1.7 | GO:0006102 | isocitrate metabolic process(GO:0006102) |
0.3 | 0.7 | GO:0007195 | adenylate cyclase-inhibiting dopamine receptor signaling pathway(GO:0007195) |
0.3 | 1.7 | GO:0016446 | somatic diversification of immune receptors via somatic mutation(GO:0002566) somatic hypermutation of immunoglobulin genes(GO:0016446) |
0.3 | 0.7 | GO:0071286 | cellular response to magnesium ion(GO:0071286) |
0.3 | 0.3 | GO:0090361 | platelet-derived growth factor production(GO:0090360) regulation of platelet-derived growth factor production(GO:0090361) |
0.3 | 0.3 | GO:0035795 | negative regulation of mitochondrial membrane permeability(GO:0035795) negative regulation of mitochondrial membrane permeability involved in apoptotic process(GO:1902109) |
0.3 | 6.9 | GO:0006284 | base-excision repair(GO:0006284) |
0.3 | 1.0 | GO:0042276 | error-prone translesion synthesis(GO:0042276) |
0.3 | 0.3 | GO:0048227 | plasma membrane to endosome transport(GO:0048227) |
0.3 | 1.4 | GO:0016266 | O-glycan processing(GO:0016266) |
0.3 | 1.7 | GO:0018344 | protein geranylgeranylation(GO:0018344) |
0.3 | 0.7 | GO:0061000 | negative regulation of dendritic spine development(GO:0061000) |
0.3 | 1.0 | GO:0060385 | axonogenesis involved in innervation(GO:0060385) |
0.3 | 1.7 | GO:0046599 | regulation of centriole replication(GO:0046599) |
0.3 | 3.1 | GO:0006465 | signal peptide processing(GO:0006465) |
0.3 | 0.7 | GO:0051973 | positive regulation of telomerase activity(GO:0051973) |
0.3 | 0.3 | GO:0034035 | purine ribonucleoside bisphosphate metabolic process(GO:0034035) |
0.3 | 7.7 | GO:0000387 | spliceosomal snRNP assembly(GO:0000387) |
0.3 | 1.7 | GO:0070228 | regulation of lymphocyte apoptotic process(GO:0070228) |
0.3 | 0.7 | GO:0006776 | vitamin A metabolic process(GO:0006776) |
0.3 | 0.7 | GO:0010966 | regulation of phosphate transport(GO:0010966) |
0.3 | 0.7 | GO:0034393 | positive regulation of smooth muscle cell apoptotic process(GO:0034393) |
0.3 | 0.3 | GO:0045822 | negative regulation of heart contraction(GO:0045822) |
0.3 | 1.0 | GO:0072385 | minus-end-directed organelle transport along microtubule(GO:0072385) |
0.3 | 0.3 | GO:0060112 | generation of ovulation cycle rhythm(GO:0060112) |
0.3 | 0.3 | GO:0001866 | NK T cell proliferation(GO:0001866) |
0.3 | 0.3 | GO:0010566 | regulation of ketone biosynthetic process(GO:0010566) |
0.3 | 1.0 | GO:0036089 | cleavage furrow formation(GO:0036089) |
0.3 | 1.0 | GO:0031065 | positive regulation of histone deacetylation(GO:0031065) |
0.3 | 0.3 | GO:1901678 | iron coordination entity transport(GO:1901678) |
0.3 | 0.7 | GO:0032988 | ribonucleoprotein complex disassembly(GO:0032988) |
0.3 | 4.2 | GO:0070373 | negative regulation of ERK1 and ERK2 cascade(GO:0070373) |
0.3 | 5.5 | GO:0006099 | tricarboxylic acid cycle(GO:0006099) |
0.3 | 0.3 | GO:0090365 | regulation of mRNA modification(GO:0090365) |
0.3 | 1.3 | GO:0097094 | craniofacial suture morphogenesis(GO:0097094) |
0.3 | 1.9 | GO:0045070 | positive regulation of viral genome replication(GO:0045070) |
0.3 | 1.3 | GO:0032720 | negative regulation of tumor necrosis factor production(GO:0032720) |
0.3 | 0.3 | GO:0021603 | cranial nerve formation(GO:0021603) |
0.3 | 2.2 | GO:0019400 | glycerol metabolic process(GO:0006071) alditol metabolic process(GO:0019400) |
0.3 | 5.1 | GO:0010107 | potassium ion import(GO:0010107) |
0.3 | 0.3 | GO:0051657 | maintenance of organelle location(GO:0051657) |
0.3 | 0.6 | GO:0033169 | histone H3-K9 demethylation(GO:0033169) |
0.3 | 0.9 | GO:0016075 | rRNA catabolic process(GO:0016075) |
0.3 | 0.9 | GO:1904262 | negative regulation of TORC1 signaling(GO:1904262) |
0.3 | 0.6 | GO:1903779 | regulation of cardiac conduction(GO:1903779) |
0.3 | 2.2 | GO:0043206 | extracellular fibril organization(GO:0043206) |
0.3 | 0.3 | GO:0061152 | trachea submucosa development(GO:0061152) trachea gland development(GO:0061153) |
0.3 | 1.5 | GO:0018231 | peptidyl-L-cysteine S-palmitoylation(GO:0018230) peptidyl-S-diacylglycerol-L-cysteine biosynthetic process from peptidyl-cysteine(GO:0018231) |
0.3 | 1.2 | GO:0042492 | gamma-delta T cell differentiation(GO:0042492) |
0.3 | 0.9 | GO:0003356 | regulation of cilium beat frequency(GO:0003356) |
0.3 | 8.9 | GO:0006635 | fatty acid beta-oxidation(GO:0006635) |
0.3 | 0.6 | GO:0060075 | regulation of resting membrane potential(GO:0060075) |
0.3 | 0.6 | GO:0031936 | negative regulation of chromatin silencing(GO:0031936) |
0.3 | 0.6 | GO:0010165 | response to X-ray(GO:0010165) |
0.3 | 2.4 | GO:0008053 | mitochondrial fusion(GO:0008053) |
0.3 | 0.6 | GO:0031642 | negative regulation of myelination(GO:0031642) |
0.3 | 4.8 | GO:0019882 | antigen processing and presentation(GO:0019882) |
0.3 | 0.3 | GO:0090186 | regulation of pancreatic juice secretion(GO:0090186) |
0.3 | 0.3 | GO:0002018 | renin-angiotensin regulation of aldosterone production(GO:0002018) |
0.3 | 2.1 | GO:0042135 | neurotransmitter catabolic process(GO:0042135) |
0.3 | 0.9 | GO:0006435 | threonyl-tRNA aminoacylation(GO:0006435) |
0.3 | 0.9 | GO:1900108 | negative regulation of nodal signaling pathway(GO:1900108) |
0.3 | 0.3 | GO:0072393 | microtubule anchoring at centrosome(GO:0034454) microtubule anchoring at microtubule organizing center(GO:0072393) |
0.3 | 6.5 | GO:0006304 | DNA modification(GO:0006304) |
0.3 | 1.2 | GO:0006458 | 'de novo' protein folding(GO:0006458) 'de novo' posttranslational protein folding(GO:0051084) |
0.3 | 3.6 | GO:0032873 | negative regulation of stress-activated MAPK cascade(GO:0032873) negative regulation of stress-activated protein kinase signaling cascade(GO:0070303) |
0.3 | 1.2 | GO:0033750 | ribosomal subunit export from nucleus(GO:0000054) ribosome localization(GO:0033750) establishment of ribosome localization(GO:0033753) |
0.3 | 0.3 | GO:0008054 | negative regulation of cyclin-dependent protein serine/threonine kinase by cyclin degradation(GO:0008054) |
0.3 | 0.6 | GO:0042226 | interleukin-6 biosynthetic process(GO:0042226) |
0.3 | 0.3 | GO:0051365 | cellular response to potassium ion starvation(GO:0051365) |
0.3 | 0.3 | GO:0030951 | establishment or maintenance of microtubule cytoskeleton polarity(GO:0030951) |
0.3 | 0.3 | GO:1902083 | negative regulation of peptidyl-cysteine S-nitrosylation(GO:1902083) |
0.3 | 1.2 | GO:0033013 | tetrapyrrole metabolic process(GO:0033013) |
0.3 | 0.6 | GO:0018206 | peptidyl-methionine modification(GO:0018206) |
0.3 | 3.7 | GO:0070936 | protein K48-linked ubiquitination(GO:0070936) |
0.3 | 1.1 | GO:0035721 | intraciliary retrograde transport(GO:0035721) |
0.3 | 0.6 | GO:0002002 | regulation of angiotensin levels in blood(GO:0002002) |
0.3 | 3.1 | GO:0008333 | endosome to lysosome transport(GO:0008333) |
0.3 | 0.6 | GO:0070900 | mitochondrial tRNA modification(GO:0070900) mitochondrial RNA modification(GO:1900864) |
0.3 | 0.6 | GO:0010893 | positive regulation of steroid biosynthetic process(GO:0010893) |
0.3 | 0.3 | GO:0018158 | protein oxidation(GO:0018158) |
0.3 | 0.6 | GO:0006297 | nucleotide-excision repair, DNA gap filling(GO:0006297) |
0.3 | 0.3 | GO:0010692 | regulation of alkaline phosphatase activity(GO:0010692) |
0.3 | 0.6 | GO:0046626 | regulation of insulin receptor signaling pathway(GO:0046626) |
0.3 | 0.3 | GO:0007512 | adult heart development(GO:0007512) |
0.3 | 1.1 | GO:0043277 | apoptotic cell clearance(GO:0043277) |
0.3 | 2.4 | GO:0071384 | cellular response to corticosteroid stimulus(GO:0071384) |
0.3 | 0.3 | GO:0009299 | mRNA transcription(GO:0009299) |
0.3 | 0.5 | GO:0046033 | AMP metabolic process(GO:0046033) |
0.3 | 0.3 | GO:0043173 | nucleotide salvage(GO:0043173) |
0.3 | 2.2 | GO:0006359 | regulation of transcription from RNA polymerase III promoter(GO:0006359) |
0.3 | 1.1 | GO:0042026 | protein refolding(GO:0042026) |
0.3 | 0.5 | GO:0000101 | sulfur amino acid transport(GO:0000101) |
0.3 | 0.3 | GO:0042523 | positive regulation of tyrosine phosphorylation of Stat5 protein(GO:0042523) |
0.3 | 0.5 | GO:0015766 | disaccharide transport(GO:0015766) sucrose transport(GO:0015770) oligosaccharide transport(GO:0015772) |
0.3 | 0.8 | GO:0019464 | glycine catabolic process(GO:0006546) glycine decarboxylation via glycine cleavage system(GO:0019464) |
0.3 | 0.3 | GO:0019695 | choline metabolic process(GO:0019695) |
0.3 | 1.1 | GO:2001260 | regulation of semaphorin-plexin signaling pathway(GO:2001260) |
0.3 | 1.3 | GO:0006012 | galactose metabolic process(GO:0006012) |
0.3 | 0.3 | GO:0090168 | intrinsic apoptotic signaling pathway in response to hydrogen peroxide(GO:0036481) Golgi reassembly(GO:0090168) |
0.3 | 0.3 | GO:0000963 | mitochondrial RNA processing(GO:0000963) |
0.3 | 0.3 | GO:0046184 | aldehyde biosynthetic process(GO:0046184) |
0.3 | 0.3 | GO:0044860 | protein transport into membrane raft(GO:0032596) protein localization to plasma membrane raft(GO:0044860) protein localization to membrane raft(GO:1903044) |
0.3 | 0.5 | GO:0097211 | response to gonadotropin-releasing hormone(GO:0097210) cellular response to gonadotropin-releasing hormone(GO:0097211) |
0.3 | 0.3 | GO:0005984 | disaccharide metabolic process(GO:0005984) |
0.3 | 1.8 | GO:0017144 | drug metabolic process(GO:0017144) |
0.3 | 0.3 | GO:0060971 | embryonic heart tube left/right pattern formation(GO:0060971) |
0.3 | 0.3 | GO:0032353 | negative regulation of hormone biosynthetic process(GO:0032353) |
0.3 | 0.3 | GO:0007060 | male meiosis chromosome segregation(GO:0007060) |
0.3 | 0.3 | GO:1903367 | positive regulation of fear response(GO:1903367) positive regulation of behavioral fear response(GO:2000987) |
0.3 | 0.8 | GO:0032958 | inositol phosphate biosynthetic process(GO:0032958) |
0.3 | 0.5 | GO:0006393 | termination of mitochondrial transcription(GO:0006393) |
0.3 | 3.1 | GO:0007131 | reciprocal meiotic recombination(GO:0007131) reciprocal DNA recombination(GO:0035825) |
0.3 | 0.5 | GO:0061073 | ciliary body morphogenesis(GO:0061073) |
0.3 | 0.8 | GO:0045793 | positive regulation of cell size(GO:0045793) |
0.3 | 0.8 | GO:0018094 | protein polyglycylation(GO:0018094) |
0.3 | 0.3 | GO:0007161 | calcium-independent cell-matrix adhesion(GO:0007161) |
0.3 | 16.2 | GO:0051607 | defense response to virus(GO:0051607) |
0.3 | 1.0 | GO:0007252 | I-kappaB phosphorylation(GO:0007252) |
0.3 | 0.8 | GO:0019262 | N-acetylneuraminate catabolic process(GO:0019262) |
0.3 | 0.3 | GO:0046689 | response to mercury ion(GO:0046689) |
0.2 | 1.5 | GO:0006309 | apoptotic DNA fragmentation(GO:0006309) |
0.2 | 1.0 | GO:0060017 | parathyroid gland development(GO:0060017) |
0.2 | 1.2 | GO:0009068 | aspartate family amino acid catabolic process(GO:0009068) |
0.2 | 1.2 | GO:0035278 | miRNA mediated inhibition of translation(GO:0035278) |
0.2 | 1.2 | GO:0035493 | SNARE complex assembly(GO:0035493) |
0.2 | 0.7 | GO:0042537 | benzene-containing compound metabolic process(GO:0042537) |
0.2 | 0.5 | GO:0048251 | elastic fiber assembly(GO:0048251) |
0.2 | 1.0 | GO:0032486 | Rap protein signal transduction(GO:0032486) |
0.2 | 0.7 | GO:0033326 | cerebrospinal fluid secretion(GO:0033326) |
0.2 | 0.2 | GO:0002551 | mast cell chemotaxis(GO:0002551) |
0.2 | 3.2 | GO:0031146 | SCF-dependent proteasomal ubiquitin-dependent protein catabolic process(GO:0031146) |
0.2 | 1.7 | GO:0006817 | phosphate ion transport(GO:0006817) |
0.2 | 1.0 | GO:0046466 | membrane lipid catabolic process(GO:0046466) |
0.2 | 4.6 | GO:0006818 | hydrogen transport(GO:0006818) |
0.2 | 0.5 | GO:2001199 | negative regulation of dendritic cell differentiation(GO:2001199) |
0.2 | 1.0 | GO:0000076 | DNA replication checkpoint(GO:0000076) |
0.2 | 0.2 | GO:0002693 | positive regulation of cellular extravasation(GO:0002693) |
0.2 | 1.7 | GO:0019079 | viral genome replication(GO:0019079) |
0.2 | 0.2 | GO:2001023 | regulation of response to drug(GO:2001023) |
0.2 | 4.7 | GO:0043627 | response to estrogen(GO:0043627) |
0.2 | 0.9 | GO:0045721 | negative regulation of gluconeogenesis(GO:0045721) |
0.2 | 2.8 | GO:0006953 | acute-phase response(GO:0006953) |
0.2 | 2.8 | GO:0006109 | regulation of carbohydrate metabolic process(GO:0006109) |
0.2 | 0.2 | GO:0097283 | keratinocyte apoptotic process(GO:0097283) regulation of keratinocyte apoptotic process(GO:1902172) |
0.2 | 0.5 | GO:0000711 | meiotic DNA repair synthesis(GO:0000711) |
0.2 | 0.2 | GO:1903998 | regulation of eating behavior(GO:1903998) negative regulation of eating behavior(GO:1903999) |
0.2 | 0.2 | GO:0097709 | connective tissue replacement involved in inflammatory response wound healing(GO:0002248) connective tissue replacement(GO:0097709) |
0.2 | 0.5 | GO:0045923 | positive regulation of fatty acid metabolic process(GO:0045923) |
0.2 | 1.6 | GO:0006308 | DNA catabolic process(GO:0006308) |
0.2 | 0.7 | GO:1903069 | regulation of ER-associated ubiquitin-dependent protein catabolic process(GO:1903069) |
0.2 | 0.2 | GO:1901894 | regulation of calcium-transporting ATPase activity(GO:1901894) |
0.2 | 1.8 | GO:0006388 | tRNA splicing, via endonucleolytic cleavage and ligation(GO:0006388) |
0.2 | 0.4 | GO:0016139 | glycoside catabolic process(GO:0016139) |
0.2 | 6.9 | GO:0010811 | positive regulation of cell-substrate adhesion(GO:0010811) |
0.2 | 1.3 | GO:0019321 | pentose metabolic process(GO:0019321) |
0.2 | 0.7 | GO:0000272 | polysaccharide catabolic process(GO:0000272) |
0.2 | 2.6 | GO:0006805 | xenobiotic metabolic process(GO:0006805) |
0.2 | 0.4 | GO:0043650 | dicarboxylic acid biosynthetic process(GO:0043650) |
0.2 | 3.9 | GO:0009813 | flavonoid biosynthetic process(GO:0009813) flavonoid glucuronidation(GO:0052696) |
0.2 | 0.4 | GO:0034982 | mitochondrial protein processing(GO:0034982) |
0.2 | 0.9 | GO:0060765 | regulation of androgen receptor signaling pathway(GO:0060765) |
0.2 | 0.2 | GO:0042510 | regulation of tyrosine phosphorylation of Stat1 protein(GO:0042510) |
0.2 | 0.4 | GO:0035247 | peptidyl-arginine methylation, to asymmetrical-dimethyl arginine(GO:0019919) peptidyl-arginine N-methylation(GO:0035246) peptidyl-arginine omega-N-methylation(GO:0035247) |
0.2 | 0.6 | GO:0038171 | cannabinoid signaling pathway(GO:0038171) endocannabinoid signaling pathway(GO:0071926) |
0.2 | 0.9 | GO:0033148 | positive regulation of intracellular estrogen receptor signaling pathway(GO:0033148) |
0.2 | 0.2 | GO:1902445 | regulation of mitochondrial membrane permeability involved in programmed necrotic cell death(GO:1902445) |
0.2 | 0.2 | GO:0001779 | natural killer cell differentiation(GO:0001779) |
0.2 | 0.8 | GO:0010640 | regulation of platelet-derived growth factor receptor signaling pathway(GO:0010640) |
0.2 | 0.2 | GO:1904479 | negative regulation of intestinal absorption(GO:1904479) |
0.2 | 0.4 | GO:0042640 | anagen(GO:0042640) |
0.2 | 0.6 | GO:0043011 | myeloid dendritic cell differentiation(GO:0043011) |
0.2 | 0.8 | GO:0006398 | mRNA 3'-end processing by stem-loop binding and cleavage(GO:0006398) |
0.2 | 0.2 | GO:0036260 | 7-methylguanosine RNA capping(GO:0009452) RNA capping(GO:0036260) |
0.2 | 1.0 | GO:0018095 | protein polyglutamylation(GO:0018095) |
0.2 | 1.0 | GO:0048520 | positive regulation of behavior(GO:0048520) |
0.2 | 1.2 | GO:0045056 | transcytosis(GO:0045056) |
0.2 | 0.8 | GO:0006032 | chitin metabolic process(GO:0006030) chitin catabolic process(GO:0006032) |
0.2 | 4.4 | GO:0000027 | ribosomal large subunit assembly(GO:0000027) |
0.2 | 0.2 | GO:0042304 | regulation of fatty acid biosynthetic process(GO:0042304) |
0.2 | 0.4 | GO:0060768 | regulation of epithelial cell proliferation involved in prostate gland development(GO:0060768) |
0.2 | 0.4 | GO:0072530 | purine nucleoside transmembrane transport(GO:0015860) purine-containing compound transmembrane transport(GO:0072530) nucleoside transmembrane transport(GO:1901642) |
0.2 | 0.6 | GO:0071971 | extracellular exosome assembly(GO:0071971) |
0.2 | 1.4 | GO:0036342 | post-anal tail morphogenesis(GO:0036342) |
0.2 | 1.2 | GO:0031119 | tRNA pseudouridine synthesis(GO:0031119) |
0.2 | 0.8 | GO:0046470 | phosphatidylcholine metabolic process(GO:0046470) |
0.2 | 1.5 | GO:0000245 | spliceosomal complex assembly(GO:0000245) |
0.2 | 0.4 | GO:0000715 | nucleotide-excision repair, DNA damage recognition(GO:0000715) |
0.2 | 0.2 | GO:0050869 | negative regulation of B cell activation(GO:0050869) |
0.2 | 0.4 | GO:0023035 | CD40 signaling pathway(GO:0023035) |
0.2 | 0.4 | GO:0090073 | positive regulation of protein homodimerization activity(GO:0090073) |
0.2 | 1.3 | GO:0097034 | mitochondrial respiratory chain complex IV assembly(GO:0033617) mitochondrial respiratory chain complex IV biogenesis(GO:0097034) |
0.2 | 0.4 | GO:0002318 | myeloid progenitor cell differentiation(GO:0002318) |
0.2 | 0.2 | GO:0010042 | response to manganese ion(GO:0010042) |
0.2 | 0.2 | GO:0033599 | regulation of mammary gland epithelial cell proliferation(GO:0033599) |
0.2 | 0.4 | GO:0042637 | catagen(GO:0042637) |
0.2 | 0.4 | GO:0070682 | proteasome regulatory particle assembly(GO:0070682) |
0.2 | 16.1 | GO:0006399 | tRNA metabolic process(GO:0006399) |
0.2 | 0.2 | GO:0002331 | pre-B cell allelic exclusion(GO:0002331) |
0.2 | 3.1 | GO:0003009 | skeletal muscle contraction(GO:0003009) |
0.2 | 0.2 | GO:0002921 | negative regulation of humoral immune response(GO:0002921) |
0.2 | 0.9 | GO:0006693 | prostanoid metabolic process(GO:0006692) prostaglandin metabolic process(GO:0006693) |
0.2 | 0.2 | GO:0002720 | positive regulation of cytokine production involved in immune response(GO:0002720) |
0.2 | 0.4 | GO:0015808 | L-alanine transport(GO:0015808) |
0.2 | 0.2 | GO:0032800 | receptor biosynthetic process(GO:0032800) |
0.2 | 0.7 | GO:1901660 | calcium ion export(GO:1901660) |
0.2 | 0.7 | GO:0001510 | RNA methylation(GO:0001510) |
0.2 | 0.2 | GO:0034204 | lipid translocation(GO:0034204) |
0.2 | 3.0 | GO:0010950 | positive regulation of endopeptidase activity(GO:0010950) |
0.2 | 0.2 | GO:0060416 | response to growth hormone(GO:0060416) |
0.2 | 0.2 | GO:1903332 | regulation of protein folding(GO:1903332) positive regulation of protein folding(GO:1903334) |
0.2 | 0.2 | GO:0042635 | positive regulation of hair cycle(GO:0042635) |
0.2 | 0.5 | GO:0042795 | snRNA transcription from RNA polymerase II promoter(GO:0042795) |
0.2 | 0.5 | GO:0045002 | DNA double-strand break processing involved in repair via single-strand annealing(GO:0010792) double-strand break repair via single-strand annealing(GO:0045002) |
0.2 | 0.3 | GO:0019511 | peptidyl-proline hydroxylation(GO:0019511) |
0.2 | 0.3 | GO:0006269 | DNA replication, synthesis of RNA primer(GO:0006269) |
0.2 | 0.2 | GO:0035524 | proline transmembrane transport(GO:0035524) |
0.2 | 0.2 | GO:0046834 | lipid phosphorylation(GO:0046834) |
0.2 | 7.6 | GO:0042742 | defense response to bacterium(GO:0042742) |
0.2 | 0.3 | GO:0007262 | STAT protein import into nucleus(GO:0007262) |
0.2 | 2.8 | GO:0015988 | energy coupled proton transmembrane transport, against electrochemical gradient(GO:0015988) ATP hydrolysis coupled proton transport(GO:0015991) ATP hydrolysis coupled transmembrane transport(GO:0090662) |
0.2 | 0.8 | GO:0051013 | microtubule severing(GO:0051013) |
0.2 | 0.5 | GO:0046490 | isopentenyl diphosphate biosynthetic process(GO:0009240) isopentenyl diphosphate biosynthetic process, mevalonate pathway(GO:0019287) isopentenyl diphosphate metabolic process(GO:0046490) |
0.2 | 0.2 | GO:0033630 | positive regulation of cell adhesion mediated by integrin(GO:0033630) |
0.2 | 0.2 | GO:0031935 | regulation of chromatin silencing(GO:0031935) |
0.2 | 0.8 | GO:0007341 | penetration of zona pellucida(GO:0007341) |
0.2 | 2.0 | GO:0032092 | positive regulation of protein binding(GO:0032092) |
0.2 | 0.2 | GO:0032957 | inositol trisphosphate metabolic process(GO:0032957) |
0.2 | 1.6 | GO:1900004 | regulation of serine-type endopeptidase activity(GO:1900003) negative regulation of serine-type endopeptidase activity(GO:1900004) regulation of serine-type peptidase activity(GO:1902571) negative regulation of serine-type peptidase activity(GO:1902572) |
0.2 | 0.2 | GO:1990035 | positive regulation of oxidative stress-induced neuron death(GO:1903223) calcium ion import into cell(GO:1990035) |
0.2 | 1.6 | GO:0009615 | response to virus(GO:0009615) |
0.2 | 0.2 | GO:0035963 | response to interleukin-13(GO:0035962) cellular response to interleukin-13(GO:0035963) |
0.2 | 1.0 | GO:0051415 | interphase microtubule nucleation by interphase microtubule organizing center(GO:0051415) microtubule nucleation by microtubule organizing center(GO:0051418) |
0.2 | 0.8 | GO:0007064 | mitotic sister chromatid cohesion(GO:0007064) |
0.2 | 0.2 | GO:0014831 | gastro-intestinal system smooth muscle contraction(GO:0014831) |
0.2 | 0.8 | GO:0006020 | inositol metabolic process(GO:0006020) |
0.2 | 0.3 | GO:0009650 | UV protection(GO:0009650) |
0.1 | 0.3 | GO:0042420 | dopamine catabolic process(GO:0042420) |
0.1 | 0.3 | GO:0000012 | single strand break repair(GO:0000012) |
0.1 | 0.1 | GO:0007199 | G-protein coupled receptor signaling pathway coupled to cGMP nucleotide second messenger(GO:0007199) |
0.1 | 0.1 | GO:0002238 | response to molecule of fungal origin(GO:0002238) |
0.1 | 0.3 | GO:0048254 | snoRNA localization(GO:0048254) |
0.1 | 0.1 | GO:0045738 | negative regulation of DNA repair(GO:0045738) |
0.1 | 1.1 | GO:0048599 | oocyte development(GO:0048599) |
0.1 | 0.4 | GO:0006383 | transcription from RNA polymerase III promoter(GO:0006383) |
0.1 | 0.3 | GO:0018377 | protein myristoylation(GO:0018377) |
0.1 | 0.6 | GO:0007168 | receptor guanylyl cyclase signaling pathway(GO:0007168) |
0.1 | 2.2 | GO:0006493 | protein O-linked glycosylation(GO:0006493) |
0.1 | 0.3 | GO:0097011 | cellular response to granulocyte macrophage colony-stimulating factor stimulus(GO:0097011) |
0.1 | 1.0 | GO:0030521 | androgen receptor signaling pathway(GO:0030521) |
0.1 | 1.5 | GO:0009060 | aerobic respiration(GO:0009060) |
0.1 | 0.7 | GO:0034063 | stress granule assembly(GO:0034063) |
0.1 | 0.1 | GO:0070972 | protein localization to endoplasmic reticulum(GO:0070972) |
0.1 | 0.1 | GO:0051132 | NK T cell activation(GO:0051132) |
0.1 | 0.1 | GO:1903587 | regulation of blood vessel endothelial cell proliferation involved in sprouting angiogenesis(GO:1903587) |
0.1 | 0.3 | GO:0010889 | regulation of sequestering of triglyceride(GO:0010889) sequestering of triglyceride(GO:0030730) |
0.1 | 0.1 | GO:0022615 | protein to membrane docking(GO:0022615) |
0.1 | 2.9 | GO:0008654 | phospholipid biosynthetic process(GO:0008654) |
0.1 | 0.1 | GO:0086043 | bundle of His cell to Purkinje myocyte signaling(GO:0086028) bundle of His cell action potential(GO:0086043) |
0.1 | 0.1 | GO:1904478 | regulation of intestinal absorption(GO:1904478) |
0.1 | 0.7 | GO:0006702 | androgen biosynthetic process(GO:0006702) |
0.1 | 0.2 | GO:0015697 | quaternary ammonium group transport(GO:0015697) |
0.1 | 1.0 | GO:0016973 | poly(A)+ mRNA export from nucleus(GO:0016973) |
0.1 | 0.1 | GO:2000653 | regulation of genetic imprinting(GO:2000653) |
0.1 | 0.1 | GO:0060455 | negative regulation of gastric acid secretion(GO:0060455) |
0.1 | 1.1 | GO:0072599 | establishment of protein localization to endoplasmic reticulum(GO:0072599) |
0.1 | 0.2 | GO:0042373 | vitamin K metabolic process(GO:0042373) |
0.1 | 0.4 | GO:0071218 | cellular response to misfolded protein(GO:0071218) |
0.1 | 1.1 | GO:0031069 | hair follicle morphogenesis(GO:0031069) |
0.1 | 9.5 | GO:0010466 | negative regulation of peptidase activity(GO:0010466) |
0.1 | 0.2 | GO:0031145 | anaphase-promoting complex-dependent catabolic process(GO:0031145) |
0.1 | 0.1 | GO:0031663 | lipopolysaccharide-mediated signaling pathway(GO:0031663) |
0.1 | 1.4 | GO:0000070 | mitotic sister chromatid segregation(GO:0000070) |
0.1 | 0.1 | GO:0072224 | metanephric glomerulus development(GO:0072224) |
0.1 | 0.1 | GO:1903525 | regulation of membrane tubulation(GO:1903525) |
0.1 | 0.1 | GO:0050955 | thermoception(GO:0050955) |
0.1 | 0.2 | GO:0042636 | negative regulation of hair cycle(GO:0042636) |
0.1 | 0.4 | GO:0035735 | intraciliary transport involved in cilium morphogenesis(GO:0035735) |
0.1 | 0.1 | GO:0060054 | positive regulation of epithelial cell proliferation involved in wound healing(GO:0060054) |
0.1 | 0.1 | GO:0035166 | post-embryonic hemopoiesis(GO:0035166) |
0.1 | 0.3 | GO:0032484 | Ral protein signal transduction(GO:0032484) |
0.1 | 0.3 | GO:0016572 | histone phosphorylation(GO:0016572) |
0.1 | 0.2 | GO:0031054 | pre-miRNA processing(GO:0031054) |
0.1 | 0.2 | GO:0007468 | regulation of rhodopsin gene expression(GO:0007468) |
0.1 | 0.3 | GO:0051560 | mitochondrial calcium ion homeostasis(GO:0051560) |
0.1 | 0.3 | GO:0071257 | cellular response to electrical stimulus(GO:0071257) |
0.1 | 1.0 | GO:0016180 | snRNA processing(GO:0016180) |
0.1 | 0.4 | GO:0033209 | tumor necrosis factor-mediated signaling pathway(GO:0033209) |
0.1 | 0.9 | GO:0006278 | RNA-dependent DNA biosynthetic process(GO:0006278) telomere maintenance via telomerase(GO:0007004) |
0.1 | 0.2 | GO:0032026 | response to magnesium ion(GO:0032026) |
0.1 | 0.2 | GO:0006691 | leukotriene metabolic process(GO:0006691) |
0.1 | 0.1 | GO:0072396 | response to cell cycle checkpoint signaling(GO:0072396) response to DNA integrity checkpoint signaling(GO:0072402) response to DNA damage checkpoint signaling(GO:0072423) response to intra-S DNA damage checkpoint signaling(GO:0072429) |
0.1 | 0.2 | GO:0002070 | epithelial cell maturation(GO:0002070) |
0.1 | 0.1 | GO:0015669 | gas transport(GO:0015669) |
0.1 | 0.2 | GO:0010166 | wax biosynthetic process(GO:0010025) wax metabolic process(GO:0010166) |
0.1 | 0.2 | GO:0006515 | misfolded or incompletely synthesized protein catabolic process(GO:0006515) |
0.1 | 0.1 | GO:1900738 | regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900736) positive regulation of phospholipase C-activating G-protein coupled receptor signaling pathway(GO:1900738) |
0.1 | 0.9 | GO:0006182 | cGMP biosynthetic process(GO:0006182) |
0.1 | 0.3 | GO:0000729 | DNA double-strand break processing(GO:0000729) |
0.1 | 0.8 | GO:0030316 | osteoclast differentiation(GO:0030316) |
0.1 | 1.3 | GO:0007229 | integrin-mediated signaling pathway(GO:0007229) |
0.1 | 0.2 | GO:0046475 | glycerophospholipid catabolic process(GO:0046475) |
0.1 | 0.1 | GO:0050832 | defense response to fungus(GO:0050832) |
0.1 | 0.1 | GO:0006498 | N-terminal protein lipidation(GO:0006498) |
0.1 | 8.6 | GO:0019236 | response to pheromone(GO:0019236) |
0.1 | 0.2 | GO:0003214 | cardiac left ventricle morphogenesis(GO:0003214) |
0.1 | 0.2 | GO:0032788 | saturated monocarboxylic acid metabolic process(GO:0032788) unsaturated monocarboxylic acid metabolic process(GO:0032789) |
0.1 | 0.1 | GO:1900135 | positive regulation of renin secretion into blood stream(GO:1900135) |
0.1 | 0.2 | GO:0051693 | actin filament capping(GO:0051693) |
0.1 | 0.5 | GO:0070129 | regulation of mitochondrial translation(GO:0070129) |
0.1 | 0.8 | GO:0072661 | protein targeting to plasma membrane(GO:0072661) |
0.1 | 0.1 | GO:0018208 | peptidyl-proline modification(GO:0018208) |
0.1 | 0.5 | GO:0043535 | regulation of blood vessel endothelial cell migration(GO:0043535) |
0.1 | 0.2 | GO:0006265 | DNA topological change(GO:0006265) |
0.1 | 0.2 | GO:0008340 | determination of adult lifespan(GO:0008340) |
0.1 | 0.5 | GO:0007130 | synaptonemal complex assembly(GO:0007130) |
0.1 | 1.9 | GO:0035036 | sperm-egg recognition(GO:0035036) |
0.1 | 0.1 | GO:1904031 | positive regulation of cyclin-dependent protein kinase activity(GO:1904031) |
0.1 | 0.1 | GO:0045060 | negative thymic T cell selection(GO:0045060) |
0.1 | 0.3 | GO:0097186 | amelogenesis(GO:0097186) |
0.1 | 0.2 | GO:0042182 | ketone catabolic process(GO:0042182) |
0.1 | 0.1 | GO:0051790 | short-chain fatty acid biosynthetic process(GO:0051790) |
0.1 | 0.1 | GO:0042983 | amyloid precursor protein biosynthetic process(GO:0042983) regulation of amyloid precursor protein biosynthetic process(GO:0042984) |
0.1 | 0.5 | GO:0006641 | triglyceride metabolic process(GO:0006641) |
0.1 | 76.5 | GO:0007608 | sensory perception of smell(GO:0007608) |
0.1 | 0.1 | GO:0098903 | regulation of membrane repolarization during action potential(GO:0098903) |
0.1 | 0.1 | GO:0044704 | single-organism reproductive behavior(GO:0044704) |
0.1 | 0.2 | GO:1901029 | negative regulation of mitochondrial outer membrane permeabilization involved in apoptotic signaling pathway(GO:1901029) |
0.1 | 0.1 | GO:0061343 | cell adhesion involved in heart morphogenesis(GO:0061343) |
0.1 | 0.1 | GO:0015874 | norepinephrine transport(GO:0015874) |
0.1 | 0.5 | GO:0099500 | synaptic vesicle fusion to presynaptic active zone membrane(GO:0031629) vesicle fusion to plasma membrane(GO:0099500) |
0.1 | 1.6 | GO:0019373 | epoxygenase P450 pathway(GO:0019373) |
0.1 | 0.1 | GO:0046851 | negative regulation of bone resorption(GO:0045779) negative regulation of bone remodeling(GO:0046851) |
0.1 | 0.1 | GO:0048096 | chromatin-mediated maintenance of transcription(GO:0048096) |
0.1 | 1.3 | GO:0006885 | regulation of pH(GO:0006885) |
0.1 | 0.1 | GO:0040009 | regulation of growth rate(GO:0040009) |
0.1 | 0.3 | GO:0030318 | melanocyte differentiation(GO:0030318) |
0.1 | 0.1 | GO:2000255 | negative regulation of male germ cell proliferation(GO:2000255) |
0.1 | 0.1 | GO:0045760 | positive regulation of action potential(GO:0045760) |
0.1 | 0.2 | GO:0006613 | cotranslational protein targeting to membrane(GO:0006613) |
0.1 | 0.1 | GO:0010880 | regulation of release of sequestered calcium ion into cytosol by sarcoplasmic reticulum(GO:0010880) |
0.1 | 0.1 | GO:0042535 | positive regulation of tumor necrosis factor biosynthetic process(GO:0042535) |
0.1 | 1.8 | GO:0050913 | sensory perception of bitter taste(GO:0050913) |
0.1 | 0.2 | GO:0006527 | arginine catabolic process(GO:0006527) |
0.0 | 0.4 | GO:0006959 | humoral immune response(GO:0006959) |
0.0 | 0.0 | GO:1903961 | positive regulation of anion channel activity(GO:1901529) positive regulation of anion transmembrane transport(GO:1903961) |
0.0 | 0.1 | GO:0075525 | viral translational termination-reinitiation(GO:0075525) |
0.0 | 1.6 | GO:0007059 | chromosome segregation(GO:0007059) |
0.0 | 0.0 | GO:0042533 | tumor necrosis factor biosynthetic process(GO:0042533) regulation of tumor necrosis factor biosynthetic process(GO:0042534) |
0.0 | 0.2 | GO:0051131 | chaperone-mediated protein complex assembly(GO:0051131) |
0.0 | 0.1 | GO:0051725 | protein de-ADP-ribosylation(GO:0051725) |
0.0 | 0.4 | GO:0051220 | cytoplasmic sequestering of protein(GO:0051220) |
0.0 | 0.0 | GO:0045589 | regulation of regulatory T cell differentiation(GO:0045589) |
0.0 | 0.1 | GO:0070086 | ubiquitin-dependent endocytosis(GO:0070086) |
0.0 | 0.1 | GO:0048711 | positive regulation of astrocyte differentiation(GO:0048711) |
0.0 | 0.0 | GO:0070459 | prolactin secretion(GO:0070459) |
0.0 | 0.0 | GO:0031914 | negative regulation of synaptic plasticity(GO:0031914) |
0.0 | 0.2 | GO:0000959 | mitochondrial RNA metabolic process(GO:0000959) |
0.0 | 0.2 | GO:1901571 | icosanoid transport(GO:0071715) fatty acid derivative transport(GO:1901571) |
0.0 | 0.2 | GO:0050892 | intestinal absorption(GO:0050892) |
0.0 | 0.0 | GO:0097502 | protein mannosylation(GO:0035268) mannosylation(GO:0097502) |
0.0 | 0.1 | GO:0090156 | negative regulation of sphingolipid biosynthetic process(GO:0090155) cellular sphingolipid homeostasis(GO:0090156) |
0.0 | 0.0 | GO:0009301 | snRNA transcription(GO:0009301) |
0.0 | 0.0 | GO:0032328 | alanine transport(GO:0032328) |
0.0 | 0.1 | GO:0034587 | piRNA metabolic process(GO:0034587) |
0.0 | 0.1 | GO:0034729 | histone H3-K79 methylation(GO:0034729) |
0.0 | 0.1 | GO:0018214 | protein carboxylation(GO:0018214) |
0.0 | 0.1 | GO:0009445 | putrescine metabolic process(GO:0009445) |
0.0 | 0.6 | GO:0006891 | intra-Golgi vesicle-mediated transport(GO:0006891) |
0.0 | 0.0 | GO:0008355 | olfactory learning(GO:0008355) |
0.0 | 0.0 | GO:0016556 | mRNA modification(GO:0016556) |
0.0 | 0.0 | GO:0046349 | amino sugar biosynthetic process(GO:0046349) |
0.0 | 0.1 | GO:0006363 | termination of RNA polymerase I transcription(GO:0006363) |
0.0 | 0.1 | GO:0048280 | vesicle fusion with Golgi apparatus(GO:0048280) |
0.0 | 0.8 | GO:0032436 | positive regulation of proteasomal ubiquitin-dependent protein catabolic process(GO:0032436) |
0.0 | 0.0 | GO:0051683 | establishment of Golgi localization(GO:0051683) |
0.0 | 0.0 | GO:0033505 | floor plate morphogenesis(GO:0033505) |
0.0 | 0.0 | GO:2000542 | negative regulation of gastrulation(GO:2000542) |
0.0 | 0.1 | GO:0015858 | nucleoside transport(GO:0015858) |
0.0 | 0.0 | GO:1904659 | glucose transmembrane transport(GO:1904659) |
0.0 | 0.1 | GO:0006474 | N-terminal protein amino acid acetylation(GO:0006474) |
0.0 | 0.0 | GO:0035902 | response to immobilization stress(GO:0035902) |
0.0 | 0.1 | GO:0018126 | protein hydroxylation(GO:0018126) |
0.0 | 0.0 | GO:0051341 | regulation of oxidoreductase activity(GO:0051341) |
0.0 | 0.0 | GO:0050916 | sensory perception of sweet taste(GO:0050916) |
0.0 | 0.0 | GO:0098535 | de novo centriole assembly(GO:0098535) |
0.0 | 0.0 | GO:0035864 | response to potassium ion(GO:0035864) cellular response to potassium ion(GO:0035865) |
0.0 | 0.3 | GO:0046165 | alcohol biosynthetic process(GO:0046165) |
0.0 | 0.1 | GO:0031163 | iron-sulfur cluster assembly(GO:0016226) metallo-sulfur cluster assembly(GO:0031163) |
0.0 | 0.0 | GO:0002523 | leukocyte migration involved in inflammatory response(GO:0002523) |
0.0 | 0.0 | GO:0032782 | bile acid secretion(GO:0032782) |
0.0 | 0.0 | GO:0071347 | cellular response to interleukin-1(GO:0071347) |
0.0 | 0.0 | GO:0099624 | regulation of atrial cardiac muscle cell membrane repolarization(GO:0060372) atrial cardiac muscle cell membrane repolarization(GO:0099624) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
15.7 | 141.3 | GO:0020003 | symbiont-containing vacuole(GO:0020003) |
12.3 | 73.8 | GO:0072557 | IPAF inflammasome complex(GO:0072557) |
10.5 | 31.4 | GO:0072559 | NLRP3 inflammasome complex(GO:0072559) |
8.7 | 52.4 | GO:0042629 | mast cell granule(GO:0042629) |
8.1 | 40.6 | GO:1990111 | spermatoproteasome complex(GO:1990111) |
7.3 | 7.3 | GO:0097169 | AIM2 inflammasome complex(GO:0097169) |
6.2 | 36.9 | GO:0014731 | spectrin-associated cytoskeleton(GO:0014731) |
5.9 | 29.3 | GO:1990712 | HFE-transferrin receptor complex(GO:1990712) |
5.7 | 84.8 | GO:0031430 | M band(GO:0031430) |
5.5 | 32.7 | GO:0031983 | vesicle lumen(GO:0031983) |
5.4 | 21.7 | GO:0031265 | CD95 death-inducing signaling complex(GO:0031265) |
5.3 | 16.0 | GO:0005944 | phosphatidylinositol 3-kinase complex, class IB(GO:0005944) |
5.3 | 16.0 | GO:0035355 | Toll-like receptor 2-Toll-like receptor 6 protein complex(GO:0035355) |
5.2 | 31.0 | GO:1990462 | omegasome(GO:1990462) |
5.0 | 25.2 | GO:0031838 | haptoglobin-hemoglobin complex(GO:0031838) |
4.6 | 27.6 | GO:0000138 | Golgi trans cisterna(GO:0000138) |
4.3 | 21.6 | GO:0030485 | smooth muscle contractile fiber(GO:0030485) |
4.3 | 17.2 | GO:0045293 | mRNA editing complex(GO:0045293) |
3.7 | 3.7 | GO:0031090 | organelle membrane(GO:0031090) |
3.6 | 14.6 | GO:0005947 | mitochondrial alpha-ketoglutarate dehydrogenase complex(GO:0005947) |
3.6 | 10.9 | GO:0031088 | platelet dense granule membrane(GO:0031088) |
3.6 | 10.8 | GO:0005914 | spot adherens junction(GO:0005914) |
3.6 | 10.7 | GO:0070552 | BRISC complex(GO:0070552) |
3.5 | 17.3 | GO:0042406 | extrinsic component of endoplasmic reticulum membrane(GO:0042406) |
3.5 | 13.8 | GO:0031313 | extrinsic component of endosome membrane(GO:0031313) |
3.4 | 58.4 | GO:0005614 | interstitial matrix(GO:0005614) |
3.4 | 33.7 | GO:0001931 | uropod(GO:0001931) cell trailing edge(GO:0031254) |
3.3 | 6.7 | GO:0065010 | extracellular membrane-bounded organelle(GO:0065010) |
3.1 | 6.2 | GO:0001726 | ruffle(GO:0001726) |
3.1 | 12.4 | GO:0044316 | cone cell pedicle(GO:0044316) |
3.1 | 21.6 | GO:0032009 | early phagosome(GO:0032009) |
3.1 | 33.8 | GO:0042405 | nuclear inclusion body(GO:0042405) |
2.8 | 31.3 | GO:0042612 | MHC class I protein complex(GO:0042612) |
2.8 | 8.4 | GO:0097418 | neurofibrillary tangle(GO:0097418) |
2.7 | 5.4 | GO:0000306 | extrinsic component of vacuolar membrane(GO:0000306) |
2.7 | 13.5 | GO:0031232 | extrinsic component of external side of plasma membrane(GO:0031232) |
2.6 | 44.8 | GO:0035327 | transcriptionally active chromatin(GO:0035327) |
2.6 | 10.5 | GO:0042825 | TAP complex(GO:0042825) |
2.6 | 12.8 | GO:0005579 | membrane attack complex(GO:0005579) |
2.5 | 10.1 | GO:0071141 | SMAD protein complex(GO:0071141) |
2.5 | 7.5 | GO:0005905 | clathrin-coated pit(GO:0005905) |
2.5 | 7.4 | GO:0090661 | box H/ACA telomerase RNP complex(GO:0090661) |
2.4 | 7.3 | GO:0097386 | glial cell projection(GO:0097386) |
2.4 | 2.4 | GO:0097651 | phosphatidylinositol 3-kinase complex, class I(GO:0097651) |
2.4 | 9.7 | GO:0030478 | actin cap(GO:0030478) |
2.4 | 4.8 | GO:0005652 | nuclear lamina(GO:0005652) |
2.4 | 19.2 | GO:0036157 | outer dynein arm(GO:0036157) |
2.4 | 7.2 | GO:0005745 | m-AAA complex(GO:0005745) |
2.4 | 2.4 | GO:0035867 | alphav-beta3 integrin-IGF-1-IGF1R complex(GO:0035867) |
2.3 | 16.3 | GO:0070971 | endoplasmic reticulum exit site(GO:0070971) |
2.3 | 7.0 | GO:0005658 | alpha DNA polymerase:primase complex(GO:0005658) |
2.3 | 6.9 | GO:0005742 | mitochondrial outer membrane translocase complex(GO:0005742) |
2.3 | 18.3 | GO:0034992 | microtubule organizing center attachment site(GO:0034992) LINC complex(GO:0034993) |
2.3 | 31.6 | GO:0000421 | autophagosome membrane(GO:0000421) |
2.3 | 6.8 | GO:0060053 | neurofilament cytoskeleton(GO:0060053) |
2.2 | 11.2 | GO:0005828 | kinetochore microtubule(GO:0005828) |
2.2 | 10.8 | GO:0001651 | dense fibrillar component(GO:0001651) |
2.1 | 8.6 | GO:0031466 | Cul5-RING ubiquitin ligase complex(GO:0031466) |
2.1 | 14.5 | GO:0005577 | fibrinogen complex(GO:0005577) |
2.1 | 16.5 | GO:0019898 | extrinsic component of membrane(GO:0019898) |
2.1 | 45.3 | GO:0005865 | striated muscle thin filament(GO:0005865) |
2.1 | 8.2 | GO:0030313 | cell outer membrane(GO:0009279) cell envelope(GO:0030313) external encapsulating structure part(GO:0044462) |
2.0 | 6.1 | GO:0043511 | inhibin complex(GO:0043511) |
2.0 | 53.8 | GO:0015030 | Cajal body(GO:0015030) |
2.0 | 9.9 | GO:0033093 | Weibel-Palade body(GO:0033093) |
2.0 | 7.8 | GO:0097422 | tubular endosome(GO:0097422) |
1.9 | 1.9 | GO:0002142 | stereocilia ankle link complex(GO:0002142) |
1.9 | 17.1 | GO:0032045 | guanyl-nucleotide exchange factor complex(GO:0032045) |
1.9 | 3.8 | GO:0097487 | multivesicular body, internal vesicle(GO:0097487) |
1.8 | 7.4 | GO:0070876 | SOSS complex(GO:0070876) |
1.8 | 119.4 | GO:0042641 | actomyosin(GO:0042641) |
1.8 | 12.7 | GO:0008385 | IkappaB kinase complex(GO:0008385) |
1.8 | 5.4 | GO:0034666 | integrin alpha2-beta1 complex(GO:0034666) |
1.8 | 3.6 | GO:0044614 | nuclear pore cytoplasmic filaments(GO:0044614) |
1.8 | 1.8 | GO:0033596 | TSC1-TSC2 complex(GO:0033596) |
1.8 | 1.8 | GO:0005832 | chaperonin-containing T-complex(GO:0005832) |
1.8 | 3.5 | GO:0097057 | TRAF2-GSTP1 complex(GO:0097057) |
1.8 | 8.8 | GO:0005638 | lamin filament(GO:0005638) |
1.7 | 7.0 | GO:0031988 | membrane-bounded vesicle(GO:0031988) |
1.7 | 5.2 | GO:0031092 | platelet alpha granule membrane(GO:0031092) |
1.7 | 20.8 | GO:0002102 | podosome(GO:0002102) |
1.7 | 22.5 | GO:0000940 | condensed chromosome outer kinetochore(GO:0000940) |
1.7 | 6.9 | GO:0030670 | phagocytic vesicle membrane(GO:0030670) |
1.7 | 12.0 | GO:0033256 | I-kappaB/NF-kappaB complex(GO:0033256) |
1.7 | 1.7 | GO:0036488 | CHOP-C/EBP complex(GO:0036488) |
1.7 | 5.0 | GO:0005833 | hemoglobin complex(GO:0005833) |
1.7 | 21.8 | GO:0005942 | phosphatidylinositol 3-kinase complex(GO:0005942) |
1.7 | 35.0 | GO:0031307 | integral component of mitochondrial outer membrane(GO:0031307) |
1.7 | 28.2 | GO:0031672 | A band(GO:0031672) |
1.6 | 9.8 | GO:0097197 | tetraspanin-enriched microdomain(GO:0097197) |
1.6 | 17.8 | GO:0005916 | fascia adherens(GO:0005916) |
1.6 | 22.7 | GO:0016471 | vacuolar proton-transporting V-type ATPase complex(GO:0016471) |
1.6 | 4.8 | GO:0005955 | calcineurin complex(GO:0005955) |
1.6 | 4.7 | GO:0000805 | X chromosome(GO:0000805) |
1.6 | 6.2 | GO:0031298 | replication fork protection complex(GO:0031298) |
1.5 | 6.2 | GO:0033553 | rDNA heterochromatin(GO:0033553) |
1.5 | 4.5 | GO:0016459 | myosin complex(GO:0016459) |
1.5 | 4.5 | GO:0008282 | ATP-sensitive potassium channel complex(GO:0008282) |
1.5 | 24.1 | GO:0000145 | exocyst(GO:0000145) |
1.5 | 6.0 | GO:0033269 | internode region of axon(GO:0033269) |
1.5 | 5.9 | GO:1990604 | IRE1-TRAF2-ASK1 complex(GO:1990604) |
1.5 | 10.4 | GO:0032797 | SMN complex(GO:0032797) |
1.5 | 1.5 | GO:0045120 | pronucleus(GO:0045120) |
1.5 | 4.4 | GO:0044354 | pinosome(GO:0044352) macropinosome(GO:0044354) |
1.5 | 5.8 | GO:0072487 | MSL complex(GO:0072487) |
1.4 | 21.6 | GO:0000159 | protein phosphatase type 2A complex(GO:0000159) |
1.4 | 5.8 | GO:0005610 | laminin-5 complex(GO:0005610) |
1.4 | 4.3 | GO:0070820 | tertiary granule(GO:0070820) |
1.4 | 39.8 | GO:0001772 | immunological synapse(GO:0001772) |
1.4 | 11.4 | GO:0042587 | glycogen granule(GO:0042587) |
1.4 | 2.8 | GO:0034464 | BBSome(GO:0034464) |
1.4 | 4.2 | GO:0071203 | WASH complex(GO:0071203) |
1.4 | 5.5 | GO:0035189 | Rb-E2F complex(GO:0035189) |
1.4 | 4.1 | GO:0034715 | pICln-Sm protein complex(GO:0034715) |
1.4 | 12.2 | GO:0042101 | T cell receptor complex(GO:0042101) |
1.3 | 6.7 | GO:0033063 | Rad51B-Rad51C-Rad51D-XRCC2 complex(GO:0033063) |
1.3 | 38.9 | GO:0005637 | nuclear inner membrane(GO:0005637) |
1.3 | 76.1 | GO:0005811 | lipid particle(GO:0005811) |
1.3 | 4.0 | GO:0005967 | mitochondrial pyruvate dehydrogenase complex(GO:0005967) |
1.3 | 40.7 | GO:0010494 | cytoplasmic stress granule(GO:0010494) |
1.3 | 10.4 | GO:0001520 | outer dense fiber(GO:0001520) |
1.3 | 3.8 | GO:0071438 | invadopodium membrane(GO:0071438) |
1.3 | 3.8 | GO:0070110 | ciliary neurotrophic factor receptor complex(GO:0070110) |
1.3 | 12.7 | GO:0008023 | transcription elongation factor complex(GO:0008023) |
1.3 | 3.8 | GO:0097427 | microtubule bundle(GO:0097427) |
1.3 | 46.8 | GO:0030864 | cortical actin cytoskeleton(GO:0030864) |
1.3 | 5.1 | GO:0031465 | Cul4B-RING E3 ubiquitin ligase complex(GO:0031465) |
1.3 | 3.8 | GO:0097431 | mitotic spindle pole(GO:0097431) |
1.2 | 41.2 | GO:0031985 | Golgi cisterna(GO:0031985) |
1.2 | 36.1 | GO:0045335 | phagocytic vesicle(GO:0045335) |
1.2 | 3.7 | GO:0005912 | adherens junction(GO:0005912) |
1.2 | 1.2 | GO:0042575 | DNA polymerase complex(GO:0042575) |
1.2 | 12.4 | GO:0035253 | ciliary rootlet(GO:0035253) |
1.2 | 12.3 | GO:0042627 | chylomicron(GO:0042627) |
1.2 | 12.2 | GO:0031588 | nucleotide-activated protein kinase complex(GO:0031588) |
1.2 | 1.2 | GO:0005869 | dynactin complex(GO:0005869) |
1.2 | 6.0 | GO:0046696 | lipopolysaccharide receptor complex(GO:0046696) |
1.2 | 25.3 | GO:0035861 | site of double-strand break(GO:0035861) |
1.2 | 3.6 | GO:0098636 | protein complex involved in cell adhesion(GO:0098636) |
1.2 | 3.5 | GO:0031523 | Myb complex(GO:0031523) |
1.2 | 2.4 | GO:0034673 | inhibin-betaglycan-ActRII complex(GO:0034673) |
1.2 | 4.7 | GO:0030027 | lamellipodium(GO:0030027) |
1.2 | 8.2 | GO:0046930 | pore complex(GO:0046930) |
1.2 | 2.3 | GO:0098554 | cytoplasmic side of endoplasmic reticulum membrane(GO:0098554) |
1.2 | 49.7 | GO:0017053 | transcriptional repressor complex(GO:0017053) |
1.2 | 4.6 | GO:0042583 | chromaffin granule(GO:0042583) |
1.1 | 3.4 | GO:0097452 | GAIT complex(GO:0097452) |
1.1 | 93.8 | GO:0072562 | blood microparticle(GO:0072562) |
1.1 | 13.7 | GO:0000177 | cytoplasmic exosome (RNase complex)(GO:0000177) |
1.1 | 3.4 | GO:0097136 | Bcl-2 family protein complex(GO:0097136) |
1.1 | 6.8 | GO:0000796 | condensin complex(GO:0000796) |
1.1 | 10.1 | GO:0000124 | SAGA complex(GO:0000124) |
1.1 | 3.4 | GO:0097524 | sperm plasma membrane(GO:0097524) |
1.1 | 3.3 | GO:0043220 | Schmidt-Lanterman incisure(GO:0043220) |
1.1 | 6.7 | GO:0098642 | collagen type IV trimer(GO:0005587) network-forming collagen trimer(GO:0098642) collagen network(GO:0098645) basement membrane collagen trimer(GO:0098651) |
1.1 | 3.3 | GO:0031933 | telomeric heterochromatin(GO:0031933) |
1.1 | 13.3 | GO:0031528 | microvillus membrane(GO:0031528) |
1.1 | 1.1 | GO:0043218 | compact myelin(GO:0043218) |
1.1 | 4.4 | GO:0044530 | supraspliceosomal complex(GO:0044530) |
1.1 | 4.4 | GO:0030056 | hemidesmosome(GO:0030056) |
1.1 | 86.7 | GO:0044449 | contractile fiber part(GO:0044449) |
1.1 | 1.1 | GO:0048786 | presynaptic active zone(GO:0048786) |
1.1 | 96.6 | GO:0031234 | extrinsic component of cytoplasmic side of plasma membrane(GO:0031234) |
1.1 | 7.4 | GO:0000798 | nuclear cohesin complex(GO:0000798) |
1.1 | 62.0 | GO:0000118 | histone deacetylase complex(GO:0000118) |
1.0 | 3.1 | GO:0035985 | senescence-associated heterochromatin focus(GO:0035985) |
1.0 | 16.7 | GO:0031233 | intrinsic component of external side of plasma membrane(GO:0031233) |
1.0 | 1.0 | GO:0002141 | stereocilia ankle link(GO:0002141) |
1.0 | 221.5 | GO:0009897 | external side of plasma membrane(GO:0009897) |
1.0 | 6.1 | GO:0031091 | platelet alpha granule(GO:0031091) |
1.0 | 7.1 | GO:0046581 | intercellular canaliculus(GO:0046581) |
1.0 | 4.0 | GO:0035748 | myelin sheath abaxonal region(GO:0035748) |
1.0 | 4.0 | GO:0001650 | fibrillar center(GO:0001650) |
1.0 | 9.1 | GO:0071782 | endoplasmic reticulum tubular network(GO:0071782) |
1.0 | 2.0 | GO:0000802 | transverse filament(GO:0000802) |
1.0 | 4.0 | GO:0000800 | lateral element(GO:0000800) |
1.0 | 14.9 | GO:0016327 | apicolateral plasma membrane(GO:0016327) |
1.0 | 1.9 | GO:0098588 | bounding membrane of organelle(GO:0098588) |
1.0 | 1.9 | GO:0000153 | cytoplasmic ubiquitin ligase complex(GO:0000153) |
1.0 | 3.8 | GO:0043296 | apical junction complex(GO:0043296) |
0.9 | 14.0 | GO:1990204 | oxidoreductase complex(GO:1990204) |
0.9 | 1.9 | GO:0098562 | cytoplasmic side of membrane(GO:0098562) |
0.9 | 5.6 | GO:0031415 | NatA complex(GO:0031415) |
0.9 | 3.7 | GO:0002079 | inner acrosomal membrane(GO:0002079) |
0.9 | 79.0 | GO:0005923 | bicellular tight junction(GO:0005923) |
0.9 | 2.8 | GO:0045251 | mitochondrial electron transfer flavoprotein complex(GO:0017133) electron transfer flavoprotein complex(GO:0045251) |
0.9 | 2.8 | GO:0048179 | activin receptor complex(GO:0048179) |
0.9 | 2.7 | GO:0005971 | ribonucleoside-diphosphate reductase complex(GO:0005971) |
0.9 | 6.4 | GO:0030677 | nucleolar ribonuclease P complex(GO:0005655) ribonuclease P complex(GO:0030677) multimeric ribonuclease P complex(GO:0030681) |
0.9 | 31.9 | GO:0032420 | stereocilium(GO:0032420) |
0.9 | 0.9 | GO:0034709 | methylosome(GO:0034709) |
0.9 | 14.3 | GO:0005868 | cytoplasmic dynein complex(GO:0005868) |
0.9 | 1.8 | GO:0030134 | ER to Golgi transport vesicle(GO:0030134) |
0.9 | 4.5 | GO:0005663 | DNA replication factor C complex(GO:0005663) |
0.9 | 2.7 | GO:1990124 | messenger ribonucleoprotein complex(GO:1990124) |
0.9 | 0.9 | GO:0016460 | myosin II complex(GO:0016460) |
0.9 | 8.7 | GO:0014704 | intercalated disc(GO:0014704) |
0.9 | 2.6 | GO:0071953 | elastic fiber(GO:0071953) |
0.9 | 8.6 | GO:0071006 | U2-type catalytic step 1 spliceosome(GO:0071006) |
0.9 | 32.6 | GO:0005902 | microvillus(GO:0005902) |
0.9 | 6.0 | GO:0036038 | MKS complex(GO:0036038) |
0.9 | 26.4 | GO:0005913 | cell-cell adherens junction(GO:0005913) |
0.9 | 2.6 | GO:0045180 | basal cortex(GO:0045180) |
0.8 | 11.8 | GO:0005605 | basal lamina(GO:0005605) |
0.8 | 8.4 | GO:0005721 | pericentric heterochromatin(GO:0005721) |
0.8 | 9.3 | GO:0000502 | proteasome complex(GO:0000502) |
0.8 | 4.2 | GO:0012507 | ER to Golgi transport vesicle membrane(GO:0012507) |
0.8 | 40.0 | GO:0019005 | SCF ubiquitin ligase complex(GO:0019005) |
0.8 | 0.8 | GO:0005845 | mRNA cap binding complex(GO:0005845) RNA cap binding complex(GO:0034518) |
0.8 | 10.7 | GO:0030863 | cortical cytoskeleton(GO:0030863) |
0.8 | 2.5 | GO:0005796 | Golgi lumen(GO:0005796) |
0.8 | 1.6 | GO:0030687 | preribosome, large subunit precursor(GO:0030687) |
0.8 | 1.6 | GO:0008274 | gamma-tubulin large complex(GO:0000931) gamma-tubulin ring complex(GO:0008274) |
0.8 | 0.8 | GO:0033503 | HULC complex(GO:0033503) |
0.8 | 6.5 | GO:0070652 | HAUS complex(GO:0070652) |
0.8 | 0.8 | GO:0005952 | cAMP-dependent protein kinase complex(GO:0005952) |
0.8 | 4.0 | GO:0097225 | sperm midpiece(GO:0097225) |
0.8 | 32.2 | GO:0009898 | cytoplasmic side of plasma membrane(GO:0009898) |
0.8 | 2.4 | GO:0005640 | nuclear outer membrane(GO:0005640) |
0.8 | 2.4 | GO:0002193 | MAML1-RBP-Jkappa- ICN1 complex(GO:0002193) |
0.8 | 28.9 | GO:0042383 | sarcolemma(GO:0042383) |
0.8 | 24.7 | GO:0005643 | nuclear pore(GO:0005643) |
0.8 | 69.9 | GO:0030176 | integral component of endoplasmic reticulum membrane(GO:0030176) |
0.8 | 3.0 | GO:0097542 | ciliary tip(GO:0097542) |
0.8 | 3.0 | GO:1990130 | Iml1 complex(GO:1990130) |
0.7 | 2.2 | GO:0005642 | annulate lamellae(GO:0005642) |
0.7 | 2.2 | GO:0030891 | VCB complex(GO:0030891) |
0.7 | 16.0 | GO:0005844 | polysome(GO:0005844) |
0.7 | 4.4 | GO:0090543 | Flemming body(GO:0090543) |
0.7 | 5.8 | GO:0000506 | glycosylphosphatidylinositol-N-acetylglucosaminyltransferase (GPI-GnT) complex(GO:0000506) |
0.7 | 2.2 | GO:0044613 | nuclear pore central transport channel(GO:0044613) |
0.7 | 30.1 | GO:0044853 | plasma membrane raft(GO:0044853) |
0.7 | 0.7 | GO:0044214 | spanning component of plasma membrane(GO:0044214) spanning component of membrane(GO:0089717) |
0.7 | 0.7 | GO:0031306 | intrinsic component of mitochondrial outer membrane(GO:0031306) |
0.7 | 12.8 | GO:0005903 | brush border(GO:0005903) |
0.7 | 75.2 | GO:0005770 | late endosome(GO:0005770) |
0.7 | 1.4 | GO:0046691 | intracellular canaliculus(GO:0046691) |
0.7 | 1.4 | GO:0000813 | ESCRT I complex(GO:0000813) |
0.7 | 4.9 | GO:0010369 | chromocenter(GO:0010369) |
0.7 | 13.9 | GO:0000786 | nucleosome(GO:0000786) |
0.7 | 0.7 | GO:1990423 | RZZ complex(GO:1990423) |
0.7 | 23.7 | GO:0030173 | integral component of Golgi membrane(GO:0030173) |
0.7 | 6.9 | GO:0001527 | microfibril(GO:0001527) |
0.7 | 8.3 | GO:0005795 | Golgi stack(GO:0005795) |
0.7 | 2.7 | GO:0016600 | flotillin complex(GO:0016600) |
0.7 | 0.7 | GO:0030175 | filopodium(GO:0030175) |
0.7 | 12.9 | GO:0005719 | nuclear euchromatin(GO:0005719) |
0.7 | 2.0 | GO:0008024 | cyclin/CDK positive transcription elongation factor complex(GO:0008024) |
0.7 | 30.9 | GO:0016605 | PML body(GO:0016605) |
0.7 | 0.7 | GO:0000322 | storage vacuole(GO:0000322) |
0.7 | 26.8 | GO:0042645 | nucleoid(GO:0009295) mitochondrial nucleoid(GO:0042645) |
0.7 | 167.4 | GO:0000323 | lytic vacuole(GO:0000323) lysosome(GO:0005764) |
0.7 | 22.4 | GO:0016529 | sarcoplasmic reticulum(GO:0016529) |
0.7 | 4.6 | GO:0002116 | semaphorin receptor complex(GO:0002116) |
0.7 | 10.5 | GO:0080008 | Cul4-RING E3 ubiquitin ligase complex(GO:0080008) |
0.7 | 3.3 | GO:0099738 | cell cortex region(GO:0099738) |
0.7 | 28.0 | GO:0005604 | basement membrane(GO:0005604) |
0.6 | 3.2 | GO:0032391 | photoreceptor connecting cilium(GO:0032391) |
0.6 | 0.6 | GO:0098862 | cluster of actin-based cell projections(GO:0098862) |
0.6 | 4.5 | GO:0000791 | euchromatin(GO:0000791) |
0.6 | 0.6 | GO:0070531 | BRCA1-A complex(GO:0070531) |
0.6 | 8.9 | GO:0035145 | exon-exon junction complex(GO:0035145) |
0.6 | 2.5 | GO:0030914 | STAGA complex(GO:0030914) |
0.6 | 110.3 | GO:0005925 | focal adhesion(GO:0005925) |
0.6 | 0.6 | GO:0005697 | telomerase holoenzyme complex(GO:0005697) |
0.6 | 3.1 | GO:0000815 | ESCRT III complex(GO:0000815) |
0.6 | 23.7 | GO:0016363 | nuclear matrix(GO:0016363) |
0.6 | 0.6 | GO:0033180 | proton-transporting V-type ATPase, V1 domain(GO:0033180) |
0.6 | 0.6 | GO:0043293 | apoptosome(GO:0043293) |
0.6 | 42.7 | GO:0005581 | collagen trimer(GO:0005581) |
0.6 | 3.7 | GO:0070847 | core mediator complex(GO:0070847) |
0.6 | 4.3 | GO:0031209 | SCAR complex(GO:0031209) |
0.6 | 3.7 | GO:0000127 | transcription factor TFIIIC complex(GO:0000127) |
0.6 | 1.8 | GO:0001891 | phagocytic cup(GO:0001891) |
0.6 | 4.8 | GO:0030991 | intraciliary transport particle A(GO:0030991) |
0.6 | 6.6 | GO:0042588 | zymogen granule(GO:0042588) |
0.6 | 4.8 | GO:0031010 | ISWI-type complex(GO:0031010) |
0.6 | 49.2 | GO:0000775 | chromosome, centromeric region(GO:0000775) |
0.6 | 0.6 | GO:0045178 | basal part of cell(GO:0045178) |
0.6 | 0.6 | GO:0071942 | XPC complex(GO:0071942) |
0.6 | 1.8 | GO:0036449 | microtubule minus-end(GO:0036449) |
0.6 | 40.7 | GO:0090575 | RNA polymerase II transcription factor complex(GO:0090575) |
0.6 | 5.2 | GO:0002080 | acrosomal membrane(GO:0002080) |
0.6 | 9.3 | GO:0000781 | chromosome, telomeric region(GO:0000781) |
0.6 | 2.8 | GO:0031501 | mannosyltransferase complex(GO:0031501) |
0.6 | 1.7 | GO:0000276 | mitochondrial proton-transporting ATP synthase complex, coupling factor F(o)(GO:0000276) |
0.6 | 1.1 | GO:0034274 | Atg12-Atg5-Atg16 complex(GO:0034274) |
0.6 | 1.1 | GO:0045098 | type III intermediate filament(GO:0045098) |
0.6 | 6.1 | GO:0015629 | actin cytoskeleton(GO:0015629) |
0.6 | 2.8 | GO:1902555 | endoribonuclease complex(GO:1902555) |
0.6 | 1.7 | GO:0005827 | polar microtubule(GO:0005827) |
0.6 | 1.7 | GO:0042581 | specific granule(GO:0042581) |
0.5 | 2.2 | GO:0005968 | Rab-protein geranylgeranyltransferase complex(GO:0005968) |
0.5 | 1.1 | GO:0033186 | CAF-1 complex(GO:0033186) |
0.5 | 4.9 | GO:0043196 | varicosity(GO:0043196) |
0.5 | 10.7 | GO:0030992 | intraciliary transport particle B(GO:0030992) |
0.5 | 30.5 | GO:0016607 | nuclear speck(GO:0016607) |
0.5 | 3.5 | GO:0051233 | spindle midzone(GO:0051233) |
0.5 | 1.0 | GO:0016222 | procollagen-proline 4-dioxygenase complex(GO:0016222) |
0.5 | 4.4 | GO:0005657 | replication fork(GO:0005657) |
0.5 | 13.9 | GO:0005788 | endoplasmic reticulum lumen(GO:0005788) |
0.5 | 4.3 | GO:0030667 | secretory granule membrane(GO:0030667) |
0.5 | 4.3 | GO:0034364 | high-density lipoprotein particle(GO:0034364) |
0.5 | 2.4 | GO:0036513 | Derlin-1 retrotranslocation complex(GO:0036513) |
0.5 | 1.9 | GO:0034098 | VCP-NPL4-UFD1 AAA ATPase complex(GO:0034098) |
0.5 | 19.6 | GO:0000793 | condensed chromosome(GO:0000793) |
0.5 | 1.9 | GO:1990246 | uniplex complex(GO:1990246) |
0.5 | 4.1 | GO:0000242 | pericentriolar material(GO:0000242) |
0.5 | 8.3 | GO:0005876 | spindle microtubule(GO:0005876) |
0.5 | 1.8 | GO:0071204 | histone pre-mRNA 3'end processing complex(GO:0071204) |
0.5 | 53.8 | GO:0005777 | peroxisome(GO:0005777) microbody(GO:0042579) |
0.5 | 0.9 | GO:0033061 | DNA recombinase mediator complex(GO:0033061) |
0.4 | 0.9 | GO:0002177 | manchette(GO:0002177) |
0.4 | 1.8 | GO:0005786 | signal recognition particle, endoplasmic reticulum targeting(GO:0005786) signal recognition particle(GO:0048500) |
0.4 | 7.4 | GO:0022627 | cytosolic small ribosomal subunit(GO:0022627) |
0.4 | 0.4 | GO:0097512 | cardiac myofibril(GO:0097512) |
0.4 | 1.3 | GO:0072687 | meiotic spindle(GO:0072687) |
0.4 | 0.4 | GO:0034679 | integrin alpha9-beta1 complex(GO:0034679) |
0.4 | 0.9 | GO:0005958 | DNA-dependent protein kinase-DNA ligase 4 complex(GO:0005958) |
0.4 | 3.0 | GO:0000346 | transcription export complex(GO:0000346) |
0.4 | 1.3 | GO:0098536 | deuterosome(GO:0098536) |
0.4 | 3.0 | GO:0031616 | spindle pole centrosome(GO:0031616) |
0.4 | 0.9 | GO:1990923 | PET complex(GO:1990923) |
0.4 | 10.1 | GO:0030660 | Golgi-associated vesicle membrane(GO:0030660) |
0.4 | 12.2 | GO:0001750 | photoreceptor outer segment(GO:0001750) |
0.4 | 5.4 | GO:0016328 | lateral plasma membrane(GO:0016328) |
0.4 | 16.7 | GO:0005819 | spindle(GO:0005819) |
0.4 | 1.2 | GO:0005712 | chiasma(GO:0005712) |
0.4 | 0.4 | GO:0098799 | outer mitochondrial membrane protein complex(GO:0098799) |
0.4 | 2.4 | GO:0042599 | lamellar body(GO:0042599) |
0.4 | 2.0 | GO:0032982 | myosin filament(GO:0032982) |
0.4 | 590.0 | GO:0070062 | extracellular exosome(GO:0070062) |
0.4 | 25.5 | GO:0005814 | centriole(GO:0005814) |
0.4 | 17.6 | GO:0012505 | endomembrane system(GO:0012505) |
0.4 | 31.5 | GO:0045111 | intermediate filament cytoskeleton(GO:0045111) |
0.4 | 1.9 | GO:0071547 | piP-body(GO:0071547) |
0.4 | 0.8 | GO:0071012 | catalytic step 1 spliceosome(GO:0071012) |
0.4 | 0.4 | GO:0030062 | mitochondrial tricarboxylic acid cycle enzyme complex(GO:0030062) |
0.4 | 1.1 | GO:0071797 | LUBAC complex(GO:0071797) |
0.4 | 2.6 | GO:0071004 | U2-type prespliceosome(GO:0071004) |
0.4 | 1.1 | GO:0071339 | MLL1/2 complex(GO:0044665) MLL1 complex(GO:0071339) |
0.4 | 0.7 | GO:1904949 | ATPase complex(GO:1904949) |
0.4 | 3.6 | GO:0032039 | integrator complex(GO:0032039) |
0.4 | 1.4 | GO:0071011 | precatalytic spliceosome(GO:0071011) |
0.4 | 27.0 | GO:0045177 | apical part of cell(GO:0045177) |
0.3 | 1.4 | GO:0008622 | epsilon DNA polymerase complex(GO:0008622) |
0.3 | 1.4 | GO:0033588 | Elongator holoenzyme complex(GO:0033588) |
0.3 | 88.3 | GO:0019866 | organelle inner membrane(GO:0019866) |
0.3 | 1.7 | GO:0070776 | H3 histone acetyltransferase complex(GO:0070775) MOZ/MORF histone acetyltransferase complex(GO:0070776) |
0.3 | 0.7 | GO:0034399 | nuclear periphery(GO:0034399) |
0.3 | 1.9 | GO:0035686 | sperm fibrous sheath(GO:0035686) |
0.3 | 1.0 | GO:0000120 | RNA polymerase I transcription factor complex(GO:0000120) |
0.3 | 11.1 | GO:0000932 | cytoplasmic mRNA processing body(GO:0000932) |
0.3 | 1.3 | GO:0071010 | prespliceosome(GO:0071010) |
0.3 | 0.3 | GO:0097255 | R2TP complex(GO:0097255) |
0.3 | 1.9 | GO:0000808 | origin recognition complex(GO:0000808) nuclear origin of replication recognition complex(GO:0005664) |
0.3 | 31.4 | GO:0005759 | mitochondrial matrix(GO:0005759) |
0.3 | 0.6 | GO:0090576 | RNA polymerase III transcription factor complex(GO:0090576) |
0.3 | 0.9 | GO:0030897 | HOPS complex(GO:0030897) |
0.3 | 2.4 | GO:0042555 | MCM complex(GO:0042555) |
0.3 | 0.3 | GO:0032389 | MutLalpha complex(GO:0032389) |
0.3 | 2.4 | GO:0009925 | basal plasma membrane(GO:0009925) |
0.3 | 10.7 | GO:0016323 | basolateral plasma membrane(GO:0016323) |
0.3 | 2.7 | GO:0030014 | CCR4-NOT complex(GO:0030014) |
0.3 | 0.6 | GO:0070939 | Dsl1p complex(GO:0070939) |
0.3 | 2.7 | GO:0046540 | U4/U6 x U5 tri-snRNP complex(GO:0046540) |
0.3 | 1.2 | GO:0042382 | paraspeckles(GO:0042382) |
0.3 | 0.6 | GO:0031428 | box C/D snoRNP complex(GO:0031428) |
0.3 | 187.0 | GO:0005829 | cytosol(GO:0005829) |
0.3 | 6.6 | GO:0016592 | mediator complex(GO:0016592) |
0.3 | 3.1 | GO:0005686 | U2 snRNP(GO:0005686) |
0.3 | 4.8 | GO:0005666 | DNA-directed RNA polymerase III complex(GO:0005666) |
0.3 | 39.7 | GO:0005813 | centrosome(GO:0005813) |
0.3 | 0.6 | GO:0000176 | nuclear exosome (RNase complex)(GO:0000176) |
0.3 | 0.5 | GO:0035838 | growing cell tip(GO:0035838) cell tip(GO:0051286) |
0.3 | 4.2 | GO:0005922 | connexon complex(GO:0005922) |
0.3 | 1.6 | GO:0005671 | Ada2/Gcn5/Ada3 transcription activator complex(GO:0005671) |
0.3 | 0.3 | GO:0033647 | host intracellular organelle(GO:0033647) host intracellular membrane-bounded organelle(GO:0033648) |
0.3 | 0.3 | GO:0032280 | symmetric synapse(GO:0032280) |
0.3 | 1.0 | GO:0071546 | pi-body(GO:0071546) |
0.3 | 3.8 | GO:0032809 | neuronal cell body membrane(GO:0032809) |
0.3 | 0.5 | GO:0038201 | TORC2 complex(GO:0031932) TOR complex(GO:0038201) |
0.2 | 0.5 | GO:0031512 | motile primary cilium(GO:0031512) |
0.2 | 1.2 | GO:0072669 | tRNA-splicing ligase complex(GO:0072669) |
0.2 | 0.5 | GO:0032299 | ribonuclease H2 complex(GO:0032299) |
0.2 | 0.5 | GO:0030140 | trans-Golgi network transport vesicle(GO:0030140) |
0.2 | 4.5 | GO:0008287 | protein serine/threonine phosphatase complex(GO:0008287) phosphatase complex(GO:1903293) |
0.2 | 0.7 | GO:0000812 | Swr1 complex(GO:0000812) |
0.2 | 11.8 | GO:0001669 | acrosomal vesicle(GO:0001669) |
0.2 | 0.5 | GO:0016281 | eukaryotic translation initiation factor 4F complex(GO:0016281) |
0.2 | 0.2 | GO:0001917 | photoreceptor inner segment(GO:0001917) |
0.2 | 0.4 | GO:0070469 | respiratory chain(GO:0070469) |
0.2 | 2.4 | GO:0005849 | mRNA cleavage factor complex(GO:0005849) |
0.2 | 6.1 | GO:0005815 | microtubule organizing center(GO:0005815) |
0.2 | 853.9 | GO:0005737 | cytoplasm(GO:0005737) |
0.2 | 0.6 | GO:0005736 | DNA-directed RNA polymerase I complex(GO:0005736) |
0.2 | 0.5 | GO:0034457 | Mpp10 complex(GO:0034457) |
0.2 | 0.3 | GO:0089701 | U2AF(GO:0089701) |
0.2 | 2.3 | GO:0071013 | catalytic step 2 spliceosome(GO:0071013) |
0.1 | 13.8 | GO:0035068 | micro-ribonucleoprotein complex(GO:0035068) |
0.1 | 0.3 | GO:0030057 | desmosome(GO:0030057) |
0.1 | 0.3 | GO:0005858 | axonemal dynein complex(GO:0005858) |
0.1 | 0.3 | GO:0033202 | DNA helicase complex(GO:0033202) |
0.1 | 1.0 | GO:1902493 | protein acetyltransferase complex(GO:0031248) acetyltransferase complex(GO:1902493) |
0.1 | 1.2 | GO:0032040 | small-subunit processome(GO:0032040) |
0.1 | 3.4 | GO:0005578 | proteinaceous extracellular matrix(GO:0005578) |
0.1 | 0.3 | GO:0044666 | MLL3/4 complex(GO:0044666) |
0.1 | 0.2 | GO:0031462 | Cul2-RING ubiquitin ligase complex(GO:0031462) |
0.1 | 27.5 | GO:0005615 | extracellular space(GO:0005615) |
0.1 | 0.1 | GO:0033176 | proton-transporting V-type ATPase complex(GO:0033176) |
0.0 | 0.1 | GO:0016272 | prefoldin complex(GO:0016272) |
0.0 | 0.0 | GO:0017071 | intracellular cyclic nucleotide activated cation channel complex(GO:0017071) |
0.0 | 2.4 | GO:0005730 | nucleolus(GO:0005730) |
0.0 | 0.0 | GO:0001533 | cornified envelope(GO:0001533) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
13.8 | 41.3 | GO:0008310 | single-stranded DNA 3'-5' exodeoxyribonuclease activity(GO:0008310) |
12.7 | 63.4 | GO:0031849 | olfactory receptor binding(GO:0031849) |
11.9 | 35.6 | GO:0001069 | regulatory region RNA binding(GO:0001069) |
10.7 | 42.8 | GO:0070053 | thrombospondin receptor activity(GO:0070053) |
9.6 | 38.4 | GO:0031433 | telethonin binding(GO:0031433) |
9.5 | 28.6 | GO:0038181 | bile acid receptor activity(GO:0038181) |
8.6 | 34.3 | GO:0043723 | N-cyclopropylmelamine deaminase activity(GO:0034547) N-cyclopropylammeline deaminase activity(GO:0034548) N-cyclopropylammelide alkylamino hydrolase activity(GO:0034549) 2,5-diamino-6-ribitylamino-4(3H)-pyrimidinone 5'-phosphate deaminase activity(GO:0043723) tRNA-specific adenosine-37 deaminase activity(GO:0043829) archaeal-specific GTP cyclohydrolase activity(GO:0044682) tRNA-specific adenosine-34 deaminase activity(GO:0052717) |
8.5 | 33.9 | GO:0072542 | protein phosphatase activator activity(GO:0072542) |
8.2 | 32.6 | GO:0034056 | estrogen response element binding(GO:0034056) |
7.1 | 28.3 | GO:0019834 | phospholipase A2 inhibitor activity(GO:0019834) |
7.0 | 28.2 | GO:0000293 | ferric-chelate reductase activity(GO:0000293) |
6.8 | 20.5 | GO:0003829 | beta-1,3-galactosyl-O-glycosyl-glycoprotein beta-1,6-N-acetylglucosaminyltransferase activity(GO:0003829) |
6.7 | 73.8 | GO:0001730 | 2'-5'-oligoadenylate synthetase activity(GO:0001730) |
6.5 | 19.5 | GO:0018479 | benzaldehyde dehydrogenase (NAD+) activity(GO:0018479) |
6.4 | 38.3 | GO:0016936 | galactoside binding(GO:0016936) |
6.2 | 24.7 | GO:0031721 | hemoglobin alpha binding(GO:0031721) |
6.1 | 30.7 | GO:0017034 | Rap guanyl-nucleotide exchange factor activity(GO:0017034) |
5.9 | 17.7 | GO:0043423 | 3-phosphoinositide-dependent protein kinase binding(GO:0043423) |
5.9 | 23.6 | GO:0008532 | N-acetyllactosaminide beta-1,3-N-acetylglucosaminyltransferase activity(GO:0008532) |
5.8 | 40.4 | GO:0035005 | 1-phosphatidylinositol-4-phosphate 3-kinase activity(GO:0035005) |
5.6 | 28.2 | GO:0042609 | CD4 receptor binding(GO:0042609) |
5.6 | 33.4 | GO:0005072 | transforming growth factor beta receptor, cytoplasmic mediator activity(GO:0005072) |
5.5 | 16.5 | GO:0005157 | macrophage colony-stimulating factor receptor binding(GO:0005157) |
5.3 | 10.7 | GO:0070573 | metallodipeptidase activity(GO:0070573) |
5.3 | 21.2 | GO:0004046 | aminoacylase activity(GO:0004046) |
5.3 | 15.9 | GO:0035663 | Toll-like receptor 2 binding(GO:0035663) |
5.2 | 25.8 | GO:0051525 | NFAT protein binding(GO:0051525) |
5.1 | 15.3 | GO:0004771 | sterol esterase activity(GO:0004771) |
5.1 | 20.4 | GO:1990239 | steroid hormone binding(GO:1990239) |
5.0 | 20.1 | GO:0003956 | NAD(P)+-protein-arginine ADP-ribosyltransferase activity(GO:0003956) |
5.0 | 25.1 | GO:0005143 | interleukin-12 receptor binding(GO:0005143) |
5.0 | 10.0 | GO:1990829 | C-rich single-stranded DNA binding(GO:1990829) |
4.9 | 14.6 | GO:0004687 | myosin light chain kinase activity(GO:0004687) |
4.9 | 24.4 | GO:0042015 | interleukin-20 binding(GO:0042015) |
4.7 | 19.0 | GO:0030984 | kininogen binding(GO:0030984) |
4.7 | 18.8 | GO:0004095 | carnitine O-palmitoyltransferase activity(GO:0004095) |
4.6 | 32.5 | GO:0016443 | bidentate ribonuclease III activity(GO:0016443) |
4.6 | 4.6 | GO:0034211 | GTP-dependent protein kinase activity(GO:0034211) |
4.6 | 13.7 | GO:0071535 | RING-like zinc finger domain binding(GO:0071535) |
4.5 | 18.0 | GO:0004566 | beta-glucuronidase activity(GO:0004566) |
4.5 | 13.4 | GO:0004800 | thyroxine 5'-deiodinase activity(GO:0004800) |
4.3 | 81.9 | GO:0003950 | NAD+ ADP-ribosyltransferase activity(GO:0003950) |
4.3 | 17.2 | GO:0016401 | palmitoyl-CoA oxidase activity(GO:0016401) |
4.3 | 12.8 | GO:0005220 | inositol 1,4,5-trisphosphate-sensitive calcium-release channel activity(GO:0005220) |
4.2 | 12.6 | GO:0003876 | AMP deaminase activity(GO:0003876) adenosine-phosphate deaminase activity(GO:0047623) |
4.1 | 12.3 | GO:0004948 | calcitonin receptor activity(GO:0004948) |
4.0 | 19.9 | GO:0043426 | MRF binding(GO:0043426) |
4.0 | 15.8 | GO:0043515 | kinetochore binding(GO:0043515) |
3.9 | 11.7 | GO:0035877 | death effector domain binding(GO:0035877) |
3.9 | 11.6 | GO:0031711 | bradykinin receptor binding(GO:0031711) |
3.8 | 11.5 | GO:0097200 | cysteine-type endopeptidase activity involved in execution phase of apoptosis(GO:0097200) |
3.8 | 11.3 | GO:0015143 | urate transmembrane transporter activity(GO:0015143) salt transmembrane transporter activity(GO:1901702) |
3.7 | 29.6 | GO:0016004 | phospholipase activator activity(GO:0016004) |
3.7 | 14.7 | GO:0015265 | urea channel activity(GO:0015265) |
3.6 | 14.5 | GO:0015038 | glutathione disulfide oxidoreductase activity(GO:0015038) |
3.6 | 53.7 | GO:0005521 | lamin binding(GO:0005521) |
3.6 | 32.0 | GO:0031386 | protein tag(GO:0031386) |
3.5 | 10.5 | GO:0046978 | TAP1 binding(GO:0046978) TAP2 binding(GO:0046979) |
3.5 | 14.0 | GO:0008865 | fructokinase activity(GO:0008865) mannokinase activity(GO:0019158) |
3.4 | 30.5 | GO:0016920 | pyroglutamyl-peptidase activity(GO:0016920) |
3.3 | 23.0 | GO:0005381 | iron ion transmembrane transporter activity(GO:0005381) |
3.3 | 16.4 | GO:0008454 | alpha-1,3-mannosylglycoprotein 4-beta-N-acetylglucosaminyltransferase activity(GO:0008454) |
3.3 | 36.0 | GO:0004861 | cyclin-dependent protein serine/threonine kinase inhibitor activity(GO:0004861) |
3.2 | 6.5 | GO:0003953 | NAD+ nucleosidase activity(GO:0003953) |
3.2 | 6.4 | GO:0008603 | cAMP-dependent protein kinase regulator activity(GO:0008603) |
3.2 | 9.5 | GO:0102007 | lactonohydrolase activity(GO:0046573) acyl-L-homoserine-lactone lactonohydrolase activity(GO:0102007) |
3.1 | 40.7 | GO:0008329 | signaling pattern recognition receptor activity(GO:0008329) pattern recognition receptor activity(GO:0038187) |
3.1 | 12.3 | GO:0035276 | ethanol binding(GO:0035276) |
3.1 | 9.2 | GO:0008732 | threonine aldolase activity(GO:0004793) L-allo-threonine aldolase activity(GO:0008732) |
3.1 | 12.2 | GO:0015183 | L-aspartate transmembrane transporter activity(GO:0015183) |
3.0 | 9.1 | GO:0004064 | arylesterase activity(GO:0004064) |
3.0 | 9.1 | GO:0005114 | type II transforming growth factor beta receptor binding(GO:0005114) |
3.0 | 9.1 | GO:0042030 | ATPase inhibitor activity(GO:0042030) |
3.0 | 6.0 | GO:0019957 | C-C chemokine binding(GO:0019957) |
3.0 | 12.0 | GO:0004551 | nucleotide diphosphatase activity(GO:0004551) |
3.0 | 9.0 | GO:0009041 | uridylate kinase activity(GO:0009041) |
3.0 | 91.9 | GO:0042805 | actinin binding(GO:0042805) |
3.0 | 11.8 | GO:0034714 | type III transforming growth factor beta receptor binding(GO:0034714) |
3.0 | 3.0 | GO:0045340 | mercury ion binding(GO:0045340) |
2.9 | 32.4 | GO:0070412 | R-SMAD binding(GO:0070412) |
2.9 | 14.6 | GO:0005432 | calcium:sodium antiporter activity(GO:0005432) |
2.9 | 95.9 | GO:0001102 | RNA polymerase II activating transcription factor binding(GO:0001102) |
2.9 | 8.7 | GO:0015222 | serotonin transmembrane transporter activity(GO:0015222) |
2.9 | 8.7 | GO:0016508 | long-chain-enoyl-CoA hydratase activity(GO:0016508) |
2.9 | 17.3 | GO:0032554 | purine deoxyribonucleotide binding(GO:0032554) |
2.9 | 17.3 | GO:0034190 | apolipoprotein receptor binding(GO:0034190) |
2.9 | 8.6 | GO:0004514 | nicotinate-nucleotide diphosphorylase (carboxylating) activity(GO:0004514) |
2.9 | 20.0 | GO:0008432 | JUN kinase binding(GO:0008432) |
2.9 | 5.7 | GO:0070883 | pre-miRNA binding(GO:0070883) |
2.8 | 8.4 | GO:0030350 | iron-responsive element binding(GO:0030350) |
2.8 | 2.8 | GO:0015204 | urea transmembrane transporter activity(GO:0015204) |
2.8 | 11.0 | GO:0070052 | collagen V binding(GO:0070052) |
2.7 | 41.0 | GO:0005545 | 1-phosphatidylinositol binding(GO:0005545) |
2.7 | 13.6 | GO:0016174 | NAD(P)H oxidase activity(GO:0016174) |
2.7 | 5.4 | GO:0019211 | phosphatase activator activity(GO:0019211) |
2.7 | 10.8 | GO:0004614 | phosphoglucomutase activity(GO:0004614) |
2.7 | 21.5 | GO:0046977 | TAP binding(GO:0046977) |
2.7 | 8.0 | GO:0008321 | Ral guanyl-nucleotide exchange factor activity(GO:0008321) |
2.7 | 18.7 | GO:1904264 | ubiquitin protein ligase activity involved in ERAD pathway(GO:1904264) |
2.7 | 21.3 | GO:0034046 | poly(G) binding(GO:0034046) |
2.6 | 7.9 | GO:0001025 | RNA polymerase III transcription factor binding(GO:0001025) |
2.6 | 18.4 | GO:0016714 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced pteridine as one donor, and incorporation of one atom of oxygen(GO:0016714) |
2.6 | 18.3 | GO:0102338 | fatty acid elongase activity(GO:0009922) 3-oxo-arachidoyl-CoA synthase activity(GO:0102336) 3-oxo-cerotoyl-CoA synthase activity(GO:0102337) 3-oxo-lignoceronyl-CoA synthase activity(GO:0102338) |
2.6 | 7.8 | GO:0035175 | histone kinase activity (H3-S10 specific)(GO:0035175) |
2.6 | 52.0 | GO:0005035 | tumor necrosis factor-activated receptor activity(GO:0005031) death receptor activity(GO:0005035) |
2.6 | 10.4 | GO:0009374 | biotin binding(GO:0009374) |
2.6 | 12.9 | GO:0030881 | beta-2-microglobulin binding(GO:0030881) |
2.6 | 48.9 | GO:0033613 | activating transcription factor binding(GO:0033613) |
2.6 | 5.1 | GO:0042392 | sphingosine-1-phosphate phosphatase activity(GO:0042392) |
2.6 | 23.1 | GO:0008093 | cytoskeletal adaptor activity(GO:0008093) |
2.5 | 17.8 | GO:0003836 | beta-galactoside (CMP) alpha-2,3-sialyltransferase activity(GO:0003836) |
2.5 | 5.0 | GO:0002094 | polyprenyltransferase activity(GO:0002094) |
2.5 | 7.5 | GO:0043546 | molybdopterin cofactor binding(GO:0043546) |
2.5 | 14.9 | GO:0035325 | Toll-like receptor binding(GO:0035325) |
2.5 | 7.5 | GO:0048248 | CXCR3 chemokine receptor binding(GO:0048248) |
2.5 | 9.9 | GO:0047023 | androsterone dehydrogenase activity(GO:0047023) |
2.5 | 17.3 | GO:0071933 | Arp2/3 complex binding(GO:0071933) |
2.5 | 7.4 | GO:0034513 | box H/ACA snoRNA binding(GO:0034513) |
2.5 | 9.9 | GO:0071253 | connexin binding(GO:0071253) |
2.5 | 12.3 | GO:0004030 | aldehyde dehydrogenase [NAD(P)+] activity(GO:0004030) |
2.4 | 14.7 | GO:0031730 | CCR5 chemokine receptor binding(GO:0031730) |
2.4 | 17.1 | GO:0050700 | CARD domain binding(GO:0050700) |
2.4 | 7.3 | GO:0030172 | troponin C binding(GO:0030172) |
2.4 | 9.7 | GO:0016997 | exo-alpha-sialidase activity(GO:0004308) alpha-sialidase activity(GO:0016997) exo-alpha-(2->3)-sialidase activity(GO:0052794) exo-alpha-(2->6)-sialidase activity(GO:0052795) exo-alpha-(2->8)-sialidase activity(GO:0052796) |
2.4 | 12.0 | GO:0070290 | N-acylphosphatidylethanolamine-specific phospholipase D activity(GO:0070290) |
2.4 | 31.1 | GO:0005161 | platelet-derived growth factor receptor binding(GO:0005161) |
2.4 | 7.2 | GO:0004731 | purine-nucleoside phosphorylase activity(GO:0004731) |
2.4 | 7.1 | GO:0045503 | dynein light chain binding(GO:0045503) |
2.4 | 16.5 | GO:0005229 | intracellular calcium activated chloride channel activity(GO:0005229) |
2.3 | 14.0 | GO:0004311 | farnesyltranstransferase activity(GO:0004311) |
2.3 | 13.8 | GO:0015288 | porin activity(GO:0015288) |
2.3 | 6.8 | GO:0008503 | benzodiazepine receptor activity(GO:0008503) |
2.3 | 9.0 | GO:0004060 | arylamine N-acetyltransferase activity(GO:0004060) |
2.2 | 4.5 | GO:0030899 | calcium-dependent ATPase activity(GO:0030899) |
2.2 | 11.2 | GO:0005007 | fibroblast growth factor-activated receptor activity(GO:0005007) |
2.2 | 8.9 | GO:0031852 | mu-type opioid receptor binding(GO:0031852) |
2.2 | 6.7 | GO:0033300 | dehydroascorbic acid transporter activity(GO:0033300) |
2.2 | 8.9 | GO:0004791 | thioredoxin-disulfide reductase activity(GO:0004791) |
2.2 | 6.6 | GO:0030492 | hemoglobin binding(GO:0030492) |
2.2 | 26.4 | GO:0070006 | metalloaminopeptidase activity(GO:0070006) |
2.2 | 8.7 | GO:0052650 | NADP-retinol dehydrogenase activity(GO:0052650) |
2.2 | 8.7 | GO:0004974 | leukotriene receptor activity(GO:0004974) |
2.2 | 10.8 | GO:0004668 | protein-arginine deiminase activity(GO:0004668) |
2.2 | 43.0 | GO:0043027 | cysteine-type endopeptidase inhibitor activity involved in apoptotic process(GO:0043027) |
2.1 | 17.2 | GO:0005159 | insulin-like growth factor receptor binding(GO:0005159) |
2.1 | 6.4 | GO:0047961 | glycine N-acyltransferase activity(GO:0047961) |
2.1 | 6.4 | GO:0003986 | acetyl-CoA hydrolase activity(GO:0003986) |
2.1 | 2.1 | GO:0008297 | single-stranded DNA exodeoxyribonuclease activity(GO:0008297) |
2.1 | 4.2 | GO:0030911 | TPR domain binding(GO:0030911) |
2.1 | 20.7 | GO:0017166 | vinculin binding(GO:0017166) |
2.1 | 24.7 | GO:0004694 | eukaryotic translation initiation factor 2alpha kinase activity(GO:0004694) |
2.1 | 12.4 | GO:0019870 | potassium channel inhibitor activity(GO:0019870) |
2.1 | 24.7 | GO:0070742 | C2H2 zinc finger domain binding(GO:0070742) |
2.1 | 8.2 | GO:0019960 | C-X3-C chemokine binding(GO:0019960) |
2.0 | 26.5 | GO:0004089 | carbonate dehydratase activity(GO:0004089) |
2.0 | 18.3 | GO:0031432 | titin binding(GO:0031432) |
2.0 | 2.0 | GO:0051425 | PTB domain binding(GO:0051425) |
2.0 | 20.1 | GO:0070700 | BMP receptor binding(GO:0070700) |
2.0 | 6.0 | GO:0016149 | translation release factor activity, codon specific(GO:0016149) |
2.0 | 8.0 | GO:0033142 | progesterone receptor binding(GO:0033142) |
2.0 | 5.9 | GO:0031708 | endothelin B receptor binding(GO:0031708) |
1.9 | 42.9 | GO:0042605 | peptide antigen binding(GO:0042605) |
1.9 | 29.1 | GO:0030552 | cAMP binding(GO:0030552) |
1.9 | 3.9 | GO:0060230 | lipoprotein lipase activator activity(GO:0060230) |
1.9 | 15.5 | GO:0038036 | sphingosine-1-phosphate receptor activity(GO:0038036) |
1.9 | 9.7 | GO:0016634 | oxidoreductase activity, acting on the CH-CH group of donors, oxygen as acceptor(GO:0016634) |
1.9 | 5.7 | GO:0050816 | phosphothreonine binding(GO:0050816) |
1.9 | 9.6 | GO:0070891 | lipoteichoic acid binding(GO:0070891) |
1.9 | 15.3 | GO:0004571 | mannosyl-oligosaccharide 1,2-alpha-mannosidase activity(GO:0004571) |
1.9 | 5.7 | GO:0019976 | interleukin-2 binding(GO:0019976) |
1.9 | 17.1 | GO:0031702 | type 1 angiotensin receptor binding(GO:0031702) |
1.9 | 9.4 | GO:0050897 | cobalt ion binding(GO:0050897) |
1.9 | 7.5 | GO:0004897 | ciliary neurotrophic factor receptor activity(GO:0004897) |
1.9 | 33.8 | GO:0016780 | phosphotransferase activity, for other substituted phosphate groups(GO:0016780) |
1.9 | 45.0 | GO:0004118 | calmodulin-dependent cyclic-nucleotide phosphodiesterase activity(GO:0004117) cGMP-stimulated cyclic-nucleotide phosphodiesterase activity(GO:0004118) cGMP-inhibited cyclic-nucleotide phosphodiesterase activity(GO:0004119) photoreceptor cyclic-nucleotide phosphodiesterase activity(GO:0004120) 7,8-dihydro-D-neopterin 2',3'-cyclic phosphate phosphodiesterase activity(GO:0044688) inositol phosphosphingolipid phospholipase activity(GO:0052712) inositol phosphorylceramide phospholipase activity(GO:0052713) mannosyl-inositol phosphorylceramide phospholipase activity(GO:0052714) mannosyl-diinositol phosphorylceramide phospholipase activity(GO:0052715) |
1.9 | 1.9 | GO:0043398 | HLH domain binding(GO:0043398) |
1.9 | 1.9 | GO:0031701 | angiotensin receptor binding(GO:0031701) |
1.9 | 22.4 | GO:0046703 | natural killer cell lectin-like receptor binding(GO:0046703) |
1.9 | 5.6 | GO:0008184 | glycogen phosphorylase activity(GO:0008184) |
1.8 | 20.3 | GO:0045028 | G-protein coupled nucleotide receptor activity(GO:0001608) G-protein coupled purinergic nucleotide receptor activity(GO:0045028) |
1.8 | 5.5 | GO:0008525 | phosphatidylcholine transporter activity(GO:0008525) |
1.8 | 9.1 | GO:0001205 | transcriptional activator activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001205) |
1.8 | 7.2 | GO:0015173 | aromatic amino acid transmembrane transporter activity(GO:0015173) |
1.8 | 14.4 | GO:0048407 | platelet-derived growth factor binding(GO:0048407) |
1.8 | 5.4 | GO:0050508 | glucuronosyl-N-acetylglucosaminyl-proteoglycan 4-alpha-N-acetylglucosaminyltransferase activity(GO:0050508) |
1.8 | 5.4 | GO:0004711 | ribosomal protein S6 kinase activity(GO:0004711) |
1.8 | 1.8 | GO:0070051 | fibrinogen binding(GO:0070051) |
1.8 | 1.8 | GO:0008142 | oxysterol binding(GO:0008142) |
1.8 | 5.3 | GO:0047276 | N-acetyllactosaminide 3-alpha-galactosyltransferase activity(GO:0047276) |
1.8 | 8.9 | GO:0045125 | bioactive lipid receptor activity(GO:0045125) |
1.8 | 23.1 | GO:0070064 | proline-rich region binding(GO:0070064) |
1.8 | 10.6 | GO:0005225 | volume-sensitive anion channel activity(GO:0005225) |
1.8 | 19.3 | GO:0008195 | phosphatidate phosphatase activity(GO:0008195) |
1.7 | 1.7 | GO:0031749 | D2 dopamine receptor binding(GO:0031749) |
1.7 | 12.1 | GO:0030235 | nitric-oxide synthase regulator activity(GO:0030235) |
1.7 | 5.2 | GO:0008823 | cupric reductase activity(GO:0008823) ferric-chelate reductase (NADPH) activity(GO:0052851) |
1.7 | 6.8 | GO:0004312 | fatty acid synthase activity(GO:0004312) |
1.7 | 5.1 | GO:0043140 | ATP-dependent 3'-5' DNA helicase activity(GO:0043140) |
1.7 | 5.1 | GO:0043184 | vascular endothelial growth factor receptor 2 binding(GO:0043184) |
1.7 | 6.8 | GO:0000405 | bubble DNA binding(GO:0000405) |
1.7 | 27.2 | GO:0030506 | ankyrin binding(GO:0030506) |
1.7 | 20.3 | GO:0016661 | oxidoreductase activity, acting on other nitrogenous compounds as donors(GO:0016661) |
1.7 | 30.4 | GO:0001848 | complement binding(GO:0001848) |
1.7 | 8.4 | GO:0004679 | AMP-activated protein kinase activity(GO:0004679) |
1.7 | 15.1 | GO:0016624 | oxidoreductase activity, acting on the aldehyde or oxo group of donors, disulfide as acceptor(GO:0016624) |
1.7 | 5.0 | GO:0008384 | IkappaB kinase activity(GO:0008384) |
1.7 | 77.0 | GO:0070491 | repressing transcription factor binding(GO:0070491) |
1.7 | 23.2 | GO:0004697 | protein kinase C activity(GO:0004697) |
1.7 | 5.0 | GO:0015319 | sodium:inorganic phosphate symporter activity(GO:0015319) |
1.6 | 1.6 | GO:0051373 | FATZ binding(GO:0051373) |
1.6 | 6.6 | GO:0000403 | Y-form DNA binding(GO:0000403) |
1.6 | 8.2 | GO:0000774 | adenyl-nucleotide exchange factor activity(GO:0000774) |
1.6 | 1.6 | GO:0017098 | sulfonylurea receptor binding(GO:0017098) |
1.6 | 4.9 | GO:0008898 | S-adenosylmethionine-homocysteine S-methyltransferase activity(GO:0008898) |
1.6 | 14.6 | GO:0005041 | low-density lipoprotein receptor activity(GO:0005041) |
1.6 | 25.8 | GO:0005070 | SH3/SH2 adaptor activity(GO:0005070) |
1.6 | 4.8 | GO:0001758 | retinal dehydrogenase activity(GO:0001758) |
1.6 | 12.8 | GO:0005068 | transmembrane receptor protein tyrosine kinase adaptor activity(GO:0005068) |
1.6 | 12.8 | GO:0005123 | death receptor binding(GO:0005123) |
1.6 | 6.4 | GO:0004740 | pyruvate dehydrogenase (acetyl-transferring) kinase activity(GO:0004740) |
1.6 | 4.8 | GO:0016309 | 1-phosphatidylinositol-5-phosphate 4-kinase activity(GO:0016309) |
1.6 | 19.1 | GO:0008191 | metalloendopeptidase inhibitor activity(GO:0008191) |
1.6 | 49.2 | GO:0005132 | type I interferon receptor binding(GO:0005132) |
1.6 | 4.7 | GO:0003726 | double-stranded RNA adenosine deaminase activity(GO:0003726) |
1.6 | 3.1 | GO:0035650 | AP-1 adaptor complex binding(GO:0035650) |
1.5 | 4.6 | GO:0016823 | hydrolase activity, acting on acid carbon-carbon bonds(GO:0016822) hydrolase activity, acting on acid carbon-carbon bonds, in ketonic substances(GO:0016823) |
1.5 | 6.1 | GO:0003873 | 6-phosphofructo-2-kinase activity(GO:0003873) |
1.5 | 4.6 | GO:1990460 | leptin receptor binding(GO:1990460) |
1.5 | 16.8 | GO:0034185 | apolipoprotein binding(GO:0034185) |
1.5 | 1.5 | GO:1990380 | Lys48-specific deubiquitinase activity(GO:1990380) |
1.5 | 4.6 | GO:0008597 | calcium-dependent protein serine/threonine phosphatase regulator activity(GO:0008597) |
1.5 | 43.8 | GO:0017112 | Rab guanyl-nucleotide exchange factor activity(GO:0017112) |
1.5 | 20.9 | GO:0017049 | GTP-Rho binding(GO:0017049) |
1.5 | 7.5 | GO:0004784 | superoxide dismutase activity(GO:0004784) oxidoreductase activity, acting on superoxide radicals as acceptor(GO:0016721) |
1.5 | 2.9 | GO:0001884 | pyrimidine nucleoside binding(GO:0001884) |
1.5 | 2.9 | GO:0098748 | clathrin adaptor activity(GO:0035615) endocytic adaptor activity(GO:0098748) |
1.5 | 1.5 | GO:0016303 | 1-phosphatidylinositol-3-kinase activity(GO:0016303) |
1.5 | 14.5 | GO:0060590 | ATPase regulator activity(GO:0060590) |
1.4 | 5.8 | GO:0030292 | protein tyrosine kinase inhibitor activity(GO:0030292) |
1.4 | 2.9 | GO:0003987 | acetate-CoA ligase activity(GO:0003987) |
1.4 | 11.5 | GO:0016505 | peptidase activator activity involved in apoptotic process(GO:0016505) |
1.4 | 2.9 | GO:0002054 | nucleobase binding(GO:0002054) |
1.4 | 2.9 | GO:0031720 | haptoglobin binding(GO:0031720) |
1.4 | 2.8 | GO:0004075 | biotin carboxylase activity(GO:0004075) |
1.4 | 2.8 | GO:0016262 | protein N-acetylglucosaminyltransferase activity(GO:0016262) |
1.4 | 4.2 | GO:0050833 | pyruvate transmembrane transporter activity(GO:0050833) |
1.4 | 5.6 | GO:0004305 | ethanolamine kinase activity(GO:0004305) |
1.4 | 7.0 | GO:0001665 | alpha-N-acetylgalactosaminide alpha-2,6-sialyltransferase activity(GO:0001665) |
1.4 | 19.6 | GO:0016493 | C-C chemokine receptor activity(GO:0016493) |
1.4 | 11.2 | GO:0010314 | phosphatidylinositol-5-phosphate binding(GO:0010314) |
1.4 | 57.1 | GO:0030674 | protein binding, bridging(GO:0030674) |
1.4 | 4.2 | GO:0004359 | glutaminase activity(GO:0004359) |
1.4 | 81.6 | GO:0003727 | single-stranded RNA binding(GO:0003727) |
1.4 | 6.8 | GO:0048019 | receptor antagonist activity(GO:0048019) |
1.4 | 6.8 | GO:0017040 | ceramidase activity(GO:0017040) |
1.4 | 27.2 | GO:0043531 | ADP binding(GO:0043531) |
1.4 | 43.4 | GO:0004715 | non-membrane spanning protein tyrosine kinase activity(GO:0004715) |
1.3 | 2.7 | GO:0004939 | beta-adrenergic receptor activity(GO:0004939) |
1.3 | 13.5 | GO:0030898 | actin-dependent ATPase activity(GO:0030898) |
1.3 | 8.0 | GO:0016812 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in cyclic amides(GO:0016812) |
1.3 | 5.3 | GO:0043559 | insulin binding(GO:0043559) |
1.3 | 13.1 | GO:0015271 | outward rectifier potassium channel activity(GO:0015271) |
1.3 | 1.3 | GO:0005223 | intracellular cGMP activated cation channel activity(GO:0005223) |
1.3 | 1.3 | GO:1904288 | BAT3 complex binding(GO:1904288) |
1.3 | 2.5 | GO:0071074 | eukaryotic initiation factor eIF2 binding(GO:0071074) |
1.3 | 3.8 | GO:0036033 | mediator complex binding(GO:0036033) |
1.3 | 16.4 | GO:0008253 | 5'-nucleotidase activity(GO:0008253) |
1.3 | 7.6 | GO:0048027 | mRNA 5'-UTR binding(GO:0048027) |
1.3 | 6.3 | GO:0001968 | fibronectin binding(GO:0001968) |
1.2 | 22.5 | GO:0046961 | proton-transporting ATPase activity, rotational mechanism(GO:0046961) |
1.2 | 1.2 | GO:0070644 | vitamin D response element binding(GO:0070644) |
1.2 | 12.4 | GO:0019200 | carbohydrate kinase activity(GO:0019200) |
1.2 | 3.7 | GO:0043199 | sulfate binding(GO:0043199) |
1.2 | 1.2 | GO:0008796 | bis(5'-nucleosyl)-tetraphosphatase activity(GO:0008796) |
1.2 | 1.2 | GO:0032422 | purine-rich negative regulatory element binding(GO:0032422) |
1.2 | 213.4 | GO:0003924 | GTPase activity(GO:0003924) |
1.2 | 4.9 | GO:0090482 | vitamin transmembrane transporter activity(GO:0090482) |
1.2 | 31.4 | GO:0005547 | phosphatidylinositol-3,4,5-trisphosphate binding(GO:0005547) |
1.2 | 4.8 | GO:0098639 | collagen binding involved in cell-matrix adhesion(GO:0098639) |
1.2 | 2.4 | GO:0004706 | JUN kinase kinase kinase activity(GO:0004706) |
1.2 | 7.2 | GO:0005172 | vascular endothelial growth factor receptor binding(GO:0005172) |
1.2 | 1.2 | GO:0034617 | tetrahydrobiopterin binding(GO:0034617) |
1.2 | 28.8 | GO:0005164 | tumor necrosis factor receptor binding(GO:0005164) |
1.2 | 4.8 | GO:1901567 | icosanoid binding(GO:0050542) fatty acid derivative binding(GO:1901567) |
1.2 | 4.7 | GO:0070728 | leucine binding(GO:0070728) |
1.2 | 5.8 | GO:0034416 | bisphosphoglycerate phosphatase activity(GO:0034416) |
1.2 | 12.8 | GO:0044213 | intronic transcription regulatory region sequence-specific DNA binding(GO:0001161) intronic transcription regulatory region DNA binding(GO:0044213) |
1.2 | 5.8 | GO:0035612 | AP-2 adaptor complex binding(GO:0035612) |
1.2 | 10.4 | GO:0004499 | N,N-dimethylaniline monooxygenase activity(GO:0004499) |
1.2 | 18.4 | GO:0003785 | actin monomer binding(GO:0003785) |
1.2 | 20.7 | GO:0050681 | androgen receptor binding(GO:0050681) |
1.1 | 1.1 | GO:0030229 | very-low-density lipoprotein particle receptor activity(GO:0030229) |
1.1 | 6.9 | GO:0045545 | syndecan binding(GO:0045545) |
1.1 | 6.8 | GO:0008131 | primary amine oxidase activity(GO:0008131) |
1.1 | 11.3 | GO:0001223 | transcription coactivator binding(GO:0001223) |
1.1 | 13.6 | GO:0035591 | signaling adaptor activity(GO:0035591) |
1.1 | 3.4 | GO:0034452 | dynactin binding(GO:0034452) |
1.1 | 19.3 | GO:0070530 | K63-linked polyubiquitin binding(GO:0070530) |
1.1 | 21.4 | GO:0030332 | cyclin binding(GO:0030332) |
1.1 | 9.0 | GO:0042975 | peroxisome proliferator activated receptor binding(GO:0042975) |
1.1 | 2.2 | GO:0019770 | IgG receptor activity(GO:0019770) |
1.1 | 3.4 | GO:0016635 | oxidoreductase activity, acting on the CH-CH group of donors, quinone or related compound as acceptor(GO:0016635) |
1.1 | 1.1 | GO:0035651 | AP-3 adaptor complex binding(GO:0035651) |
1.1 | 9.0 | GO:0003810 | protein-glutamine gamma-glutamyltransferase activity(GO:0003810) |
1.1 | 6.7 | GO:0008508 | bile acid:sodium symporter activity(GO:0008508) |
1.1 | 31.0 | GO:0016903 | oxidoreductase activity, acting on the aldehyde or oxo group of donors(GO:0016903) |
1.1 | 2.2 | GO:0048763 | calcium-induced calcium release activity(GO:0048763) |
1.1 | 2.2 | GO:0004677 | DNA-dependent protein kinase activity(GO:0004677) |
1.1 | 3.3 | GO:0017116 | single-stranded DNA-dependent ATP-dependent DNA helicase activity(GO:0017116) |
1.1 | 9.7 | GO:0042171 | lysophosphatidic acid acyltransferase activity(GO:0042171) |
1.1 | 3.2 | GO:0019959 | interleukin-8 binding(GO:0019959) |
1.1 | 22.7 | GO:0004298 | threonine-type endopeptidase activity(GO:0004298) threonine-type peptidase activity(GO:0070003) |
1.1 | 1.1 | GO:0003933 | GTP cyclohydrolase activity(GO:0003933) |
1.1 | 9.7 | GO:0001784 | phosphotyrosine binding(GO:0001784) |
1.1 | 9.6 | GO:0042056 | chemoattractant activity(GO:0042056) |
1.1 | 6.4 | GO:0052850 | enoyl-[acyl-carrier-protein] reductase activity(GO:0016631) 2,3-dihydroxy-2,3-dihydro-phenylpropionate dehydrogenase activity(GO:0018498) cis-2,3-dihydrodiol DDT dehydrogenase activity(GO:0018499) trans-9R,10R-dihydrodiolphenanthrene dehydrogenase activity(GO:0018500) cis-chlorobenzene dihydrodiol dehydrogenase activity(GO:0018501) 2,5-dichloro-2,5-cyclohexadiene-1,4-diol dehydrogenase activity(GO:0018502) trans-1,2-dihydrodiolphenanthrene dehydrogenase activity(GO:0018503) 3,4-dihydroxy-3,4-dihydrofluorene dehydrogenase activity(GO:0034790) benzo(a)pyrene-trans-11,12-dihydrodiol dehydrogenase activity(GO:0034805) benzo(a)pyrene-cis-4,5-dihydrodiol dehydrogenase activity(GO:0034809) citronellyl-CoA dehydrogenase activity(GO:0034824) menthone dehydrogenase activity(GO:0034838) phthalate 3,4-cis-dihydrodiol dehydrogenase activity(GO:0034912) cinnamate reductase activity(GO:0043786) NADPH-dependent curcumin reductase activity(GO:0052849) NADPH-dependent dihydrocurcumin reductase activity(GO:0052850) |
1.1 | 1.1 | GO:0016532 | superoxide dismutase copper chaperone activity(GO:0016532) |
1.1 | 1.1 | GO:0061629 | RNA polymerase II sequence-specific DNA binding transcription factor binding(GO:0061629) |
1.1 | 2.1 | GO:0097322 | 7SK snRNA binding(GO:0097322) |
1.1 | 5.3 | GO:0005021 | vascular endothelial growth factor-activated receptor activity(GO:0005021) |
1.1 | 18.0 | GO:0004602 | glutathione peroxidase activity(GO:0004602) |
1.1 | 4.2 | GO:0019103 | pyrimidine nucleotide binding(GO:0019103) |
1.1 | 8.4 | GO:0004779 | sulfate adenylyltransferase activity(GO:0004779) |
1.0 | 3.1 | GO:0004920 | interleukin-10 receptor activity(GO:0004920) |
1.0 | 3.1 | GO:0016899 | oxidoreductase activity, acting on the CH-OH group of donors, oxygen as acceptor(GO:0016899) |
1.0 | 9.4 | GO:0005523 | tropomyosin binding(GO:0005523) |
1.0 | 2.1 | GO:0031493 | nucleosomal histone binding(GO:0031493) |
1.0 | 2.1 | GO:0017002 | activin-activated receptor activity(GO:0017002) |
1.0 | 3.1 | GO:0045134 | uridine-diphosphatase activity(GO:0045134) |
1.0 | 71.5 | GO:0005178 | integrin binding(GO:0005178) |
1.0 | 4.1 | GO:0016208 | AMP binding(GO:0016208) |
1.0 | 12.2 | GO:0015238 | drug transmembrane transporter activity(GO:0015238) |
1.0 | 8.1 | GO:0016889 | endodeoxyribonuclease activity, producing 3'-phosphomonoesters(GO:0016889) |
1.0 | 1.0 | GO:0043533 | inositol 1,3,4,5 tetrakisphosphate binding(GO:0043533) |
1.0 | 9.1 | GO:0004176 | ATP-dependent peptidase activity(GO:0004176) |
1.0 | 3.0 | GO:0042134 | rRNA primary transcript binding(GO:0042134) |
1.0 | 10.1 | GO:0015129 | lactate transmembrane transporter activity(GO:0015129) |
1.0 | 3.0 | GO:0004468 | lysine N-acetyltransferase activity, acting on acetyl phosphate as donor(GO:0004468) |
1.0 | 6.0 | GO:0035613 | RNA stem-loop binding(GO:0035613) |
1.0 | 4.0 | GO:0008381 | mechanically-gated ion channel activity(GO:0008381) mechanically gated channel activity(GO:0022833) |
1.0 | 1.0 | GO:0004924 | oncostatin-M receptor activity(GO:0004924) |
1.0 | 2.0 | GO:0070326 | very-low-density lipoprotein particle receptor binding(GO:0070326) |
1.0 | 3.0 | GO:0004487 | methenyltetrahydrofolate cyclohydrolase activity(GO:0004477) methylenetetrahydrofolate dehydrogenase (NAD+) activity(GO:0004487) |
1.0 | 6.0 | GO:0004112 | cyclic-nucleotide phosphodiesterase activity(GO:0004112) |
1.0 | 5.0 | GO:0030550 | acetylcholine receptor inhibitor activity(GO:0030550) |
1.0 | 3.0 | GO:0031996 | thioesterase binding(GO:0031996) |
1.0 | 30.5 | GO:0051539 | 4 iron, 4 sulfur cluster binding(GO:0051539) |
1.0 | 2.9 | GO:0031492 | nucleosomal DNA binding(GO:0031492) |
1.0 | 2.9 | GO:0019776 | Atg8 ligase activity(GO:0019776) |
1.0 | 9.7 | GO:0030371 | translation repressor activity(GO:0030371) |
1.0 | 7.7 | GO:0051787 | misfolded protein binding(GO:0051787) |
1.0 | 7.7 | GO:0004017 | adenylate kinase activity(GO:0004017) |
1.0 | 1.9 | GO:0031735 | CCR10 chemokine receptor binding(GO:0031735) |
1.0 | 1.0 | GO:0016743 | carboxyl- or carbamoyltransferase activity(GO:0016743) |
1.0 | 5.8 | GO:0032036 | myosin heavy chain binding(GO:0032036) |
1.0 | 1.9 | GO:0019237 | centromeric DNA binding(GO:0019237) |
1.0 | 5.7 | GO:0030553 | cGMP binding(GO:0030553) |
1.0 | 8.6 | GO:0015174 | basic amino acid transmembrane transporter activity(GO:0015174) |
1.0 | 16.2 | GO:0005452 | inorganic anion exchanger activity(GO:0005452) |
0.9 | 2.8 | GO:0003910 | DNA ligase activity(GO:0003909) DNA ligase (ATP) activity(GO:0003910) |
0.9 | 2.8 | GO:1990050 | phosphatidic acid transporter activity(GO:1990050) |
0.9 | 103.7 | GO:0001047 | core promoter binding(GO:0001047) |
0.9 | 2.8 | GO:0008970 | phosphatidylcholine 1-acylhydrolase activity(GO:0008970) |
0.9 | 4.7 | GO:0004957 | prostaglandin E receptor activity(GO:0004957) |
0.9 | 13.1 | GO:0035035 | histone acetyltransferase binding(GO:0035035) |
0.9 | 5.6 | GO:0035312 | 5'-3' exodeoxyribonuclease activity(GO:0035312) |
0.9 | 6.6 | GO:0034711 | inhibin binding(GO:0034711) |
0.9 | 7.4 | GO:0042288 | MHC class I protein binding(GO:0042288) |
0.9 | 6.5 | GO:0008113 | peptide-methionine (S)-S-oxide reductase activity(GO:0008113) |
0.9 | 62.9 | GO:0004197 | cysteine-type endopeptidase activity(GO:0004197) |
0.9 | 1.8 | GO:0016530 | metallochaperone activity(GO:0016530) |
0.9 | 1.8 | GO:0033192 | calmodulin-dependent protein phosphatase activity(GO:0033192) |
0.9 | 2.7 | GO:0004748 | ribonucleoside-diphosphate reductase activity, thioredoxin disulfide as acceptor(GO:0004748) oxidoreductase activity, acting on CH or CH2 groups, disulfide as acceptor(GO:0016728) ribonucleoside-diphosphate reductase activity(GO:0061731) |
0.9 | 8.2 | GO:0001206 | transcriptional repressor activity, RNA polymerase II distal enhancer sequence-specific binding(GO:0001206) |
0.9 | 2.7 | GO:0034584 | piRNA binding(GO:0034584) |
0.9 | 3.6 | GO:0045296 | cadherin binding(GO:0045296) |
0.9 | 4.5 | GO:0000150 | recombinase activity(GO:0000150) |
0.9 | 7.1 | GO:0008307 | structural constituent of muscle(GO:0008307) |
0.9 | 12.4 | GO:0008157 | protein phosphatase 1 binding(GO:0008157) |
0.9 | 7.1 | GO:0022889 | L-serine transmembrane transporter activity(GO:0015194) serine transmembrane transporter activity(GO:0022889) |
0.9 | 25.6 | GO:0005200 | structural constituent of cytoskeleton(GO:0005200) |
0.9 | 7.9 | GO:0005388 | calcium-transporting ATPase activity(GO:0005388) |
0.9 | 1.8 | GO:0051379 | epinephrine binding(GO:0051379) |
0.9 | 4.4 | GO:0016308 | 1-phosphatidylinositol-4-phosphate 5-kinase activity(GO:0016308) |
0.9 | 6.1 | GO:0008440 | inositol-1,4,5-trisphosphate 3-kinase activity(GO:0008440) |
0.9 | 5.2 | GO:0034902 | alkyl sulfatase activity(GO:0018741) endosulfan hemisulfate sulfatase activity(GO:0034889) endosulfan sulfate hydrolase activity(GO:0034902) |
0.9 | 2.6 | GO:0005375 | copper ion transmembrane transporter activity(GO:0005375) |
0.9 | 3.4 | GO:0071987 | WD40-repeat domain binding(GO:0071987) |
0.9 | 1.7 | GO:0000253 | 3-keto sterol reductase activity(GO:0000253) |
0.9 | 2.6 | GO:0034235 | GPI anchor binding(GO:0034235) |
0.9 | 17.9 | GO:0005385 | zinc ion transmembrane transporter activity(GO:0005385) |
0.8 | 10.1 | GO:0008601 | protein phosphatase type 2A regulator activity(GO:0008601) |
0.8 | 13.4 | GO:0070008 | serine-type exopeptidase activity(GO:0070008) |
0.8 | 4.2 | GO:0000146 | microfilament motor activity(GO:0000146) |
0.8 | 2.5 | GO:0004345 | glucose-6-phosphate dehydrogenase activity(GO:0004345) |
0.8 | 6.6 | GO:0016832 | aldehyde-lyase activity(GO:0016832) |
0.8 | 11.6 | GO:0017128 | phospholipid scramblase activity(GO:0017128) |
0.8 | 3.3 | GO:0000400 | four-way junction DNA binding(GO:0000400) |
0.8 | 0.8 | GO:0032405 | MutLalpha complex binding(GO:0032405) |
0.8 | 0.8 | GO:0070538 | oleic acid binding(GO:0070538) |
0.8 | 2.5 | GO:0000171 | ribonuclease MRP activity(GO:0000171) |
0.8 | 1.6 | GO:0008309 | double-stranded DNA exodeoxyribonuclease activity(GO:0008309) |
0.8 | 3.3 | GO:0005042 | netrin receptor activity(GO:0005042) |
0.8 | 5.7 | GO:0017160 | Ral GTPase binding(GO:0017160) |
0.8 | 10.6 | GO:0017134 | fibroblast growth factor binding(GO:0017134) |
0.8 | 2.4 | GO:2001070 | starch binding(GO:2001070) |
0.8 | 8.1 | GO:0051183 | vitamin transporter activity(GO:0051183) |
0.8 | 2.4 | GO:0004720 | protein-lysine 6-oxidase activity(GO:0004720) |
0.8 | 2.4 | GO:0070403 | NAD+ binding(GO:0070403) |
0.8 | 2.4 | GO:0004366 | glycerol-3-phosphate O-acyltransferase activity(GO:0004366) |
0.8 | 6.4 | GO:0004438 | phosphatidylinositol-3-phosphatase activity(GO:0004438) |
0.8 | 4.8 | GO:0015321 | sodium:phosphate symporter activity(GO:0005436) sodium-dependent phosphate transmembrane transporter activity(GO:0015321) |
0.8 | 26.4 | GO:0016836 | hydro-lyase activity(GO:0016836) |
0.8 | 2.4 | GO:0051575 | 5'-deoxyribose-5-phosphate lyase activity(GO:0051575) |
0.8 | 2.4 | GO:0004605 | phosphatidate cytidylyltransferase activity(GO:0004605) |
0.8 | 7.2 | GO:1900750 | glutathione binding(GO:0043295) oligopeptide binding(GO:1900750) |
0.8 | 3.2 | GO:0043262 | adenosine-diphosphatase activity(GO:0043262) |
0.8 | 6.3 | GO:1990841 | promoter-specific chromatin binding(GO:1990841) |
0.8 | 4.7 | GO:0003884 | D-amino-acid oxidase activity(GO:0003884) |
0.8 | 6.3 | GO:0034821 | pinocarveol dehydrogenase activity(GO:0018446) chloral hydrate dehydrogenase activity(GO:0018447) hydroxymethylmethylsilanediol oxidase activity(GO:0018448) 1-phenylethanol dehydrogenase activity(GO:0018449) myrtenol dehydrogenase activity(GO:0018450) cis-1,2-dihydroxy-1,2-dihydro-8-carboxynaphthalene dehydrogenase activity(GO:0034522) 3-hydroxy-4-methyloctanoyl-CoA dehydrogenase activity(GO:0034582) 2-hydroxy-4-isopropenylcyclohexane-1-carboxyl-CoA dehydrogenase activity(GO:0034778) cis-9,10-dihydroanthracene-9,10-diol dehydrogenase activity(GO:0034817) citronellol dehydrogenase activity(GO:0034821) naphthyl-2-hydroxymethyl-succinyl-CoA dehydrogenase activity(GO:0034847) 2,4,4-trimethyl-1-pentanol dehydrogenase activity(GO:0034863) 2,4,4-trimethyl-3-hydroxypentanoyl-CoA dehydrogenase activity(GO:0034868) 1-hydroxy-4,4-dimethylpentan-3-one dehydrogenase activity(GO:0034871) endosulfan diol dehydrogenase activity(GO:0034891) endosulfan hydroxyether dehydrogenase activity(GO:0034901) 3-hydroxy-2-methylhexanoyl-CoA dehydrogenase activity(GO:0034918) 3-hydroxy-2,6-dimethyl-5-methylene-heptanoyl-CoA dehydrogenase activity(GO:0034944) versicolorin reductase activity(GO:0042469) ketoreductase activity(GO:0045703) |
0.8 | 13.3 | GO:0004181 | metallocarboxypeptidase activity(GO:0004181) |
0.8 | 18.8 | GO:0003725 | double-stranded RNA binding(GO:0003725) |
0.8 | 3.1 | GO:0019864 | IgG binding(GO:0019864) |
0.8 | 3.9 | GO:0019784 | NEDD8-specific protease activity(GO:0019784) |
0.8 | 3.9 | GO:0008429 | phosphatidylethanolamine binding(GO:0008429) |
0.8 | 0.8 | GO:0036122 | BMP binding(GO:0036122) |
0.8 | 2.3 | GO:0004726 | non-membrane spanning protein tyrosine phosphatase activity(GO:0004726) |
0.8 | 3.1 | GO:0004792 | thiosulfate sulfurtransferase activity(GO:0004792) |
0.8 | 3.1 | GO:0051010 | microtubule plus-end binding(GO:0051010) |
0.8 | 2.3 | GO:0097493 | structural molecule activity conferring elasticity(GO:0097493) |
0.8 | 7.6 | GO:0004806 | triglyceride lipase activity(GO:0004806) |
0.8 | 6.9 | GO:0008641 | small protein activating enzyme activity(GO:0008641) |
0.8 | 2.3 | GO:0004461 | lactose synthase activity(GO:0004461) |
0.8 | 3.0 | GO:0000099 | sulfur amino acid transmembrane transporter activity(GO:0000099) |
0.8 | 7.5 | GO:0004016 | adenylate cyclase activity(GO:0004016) |
0.8 | 3.8 | GO:0061505 | DNA topoisomerase type II (ATP-hydrolyzing) activity(GO:0003918) DNA topoisomerase II activity(GO:0061505) |
0.7 | 3.0 | GO:1990247 | N6-methyladenosine-containing RNA binding(GO:1990247) |
0.7 | 16.4 | GO:0004693 | cyclin-dependent protein serine/threonine kinase activity(GO:0004693) cyclin-dependent protein kinase activity(GO:0097472) |
0.7 | 3.0 | GO:0043138 | 3'-5' DNA helicase activity(GO:0043138) |
0.7 | 3.0 | GO:0016671 | oxidoreductase activity, acting on a sulfur group of donors, disulfide as acceptor(GO:0016671) |
0.7 | 0.7 | GO:0032190 | acrosin binding(GO:0032190) |
0.7 | 1.5 | GO:0097642 | calcitonin family receptor activity(GO:0097642) |
0.7 | 1.5 | GO:0098821 | BMP receptor activity(GO:0098821) |
0.7 | 1.5 | GO:0097371 | MDM2/MDM4 family protein binding(GO:0097371) |
0.7 | 14.8 | GO:0051059 | NF-kappaB binding(GO:0051059) |
0.7 | 5.2 | GO:0031545 | peptidyl-proline 4-dioxygenase activity(GO:0031545) |
0.7 | 1.5 | GO:0003906 | DNA-(apurinic or apyrimidinic site) lyase activity(GO:0003906) |
0.7 | 11.7 | GO:0004709 | MAP kinase kinase kinase activity(GO:0004709) |
0.7 | 2.9 | GO:0005324 | long-chain fatty acid transporter activity(GO:0005324) |
0.7 | 2.2 | GO:0016641 | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor(GO:0016641) |
0.7 | 2.2 | GO:0019966 | interleukin-1 binding(GO:0019966) |
0.7 | 10.7 | GO:0004012 | phospholipid-translocating ATPase activity(GO:0004012) |
0.7 | 2.9 | GO:0010997 | anaphase-promoting complex binding(GO:0010997) |
0.7 | 2.8 | GO:0097027 | ubiquitin-protein transferase activator activity(GO:0097027) |
0.7 | 0.7 | GO:0004488 | methylenetetrahydrofolate dehydrogenase (NADP+) activity(GO:0004488) |
0.7 | 2.1 | GO:0042296 | ISG15 transferase activity(GO:0042296) |
0.7 | 10.5 | GO:0015095 | magnesium ion transmembrane transporter activity(GO:0015095) |
0.7 | 1.4 | GO:0016886 | ligase activity, forming phosphoric ester bonds(GO:0016886) |
0.7 | 2.1 | GO:0016941 | natriuretic peptide receptor activity(GO:0016941) |
0.7 | 2.8 | GO:0008190 | eukaryotic initiation factor 4E binding(GO:0008190) |
0.7 | 6.2 | GO:0008242 | omega peptidase activity(GO:0008242) |
0.7 | 4.8 | GO:0004526 | ribonuclease P activity(GO:0004526) |
0.7 | 2.8 | GO:0044548 | S100 protein binding(GO:0044548) |
0.7 | 0.7 | GO:0019862 | IgA binding(GO:0019862) |
0.7 | 2.1 | GO:0015252 | hydrogen ion channel activity(GO:0015252) |
0.7 | 3.4 | GO:0030346 | protein phosphatase 2B binding(GO:0030346) |
0.7 | 4.7 | GO:0008140 | cAMP response element binding protein binding(GO:0008140) |
0.7 | 2.7 | GO:0004439 | phosphatidylinositol-4,5-bisphosphate 5-phosphatase activity(GO:0004439) |
0.7 | 3.3 | GO:0047372 | acylglycerol lipase activity(GO:0047372) |
0.7 | 1.3 | GO:0031014 | troponin T binding(GO:0031014) |
0.7 | 4.0 | GO:0030249 | guanylate cyclase regulator activity(GO:0030249) |
0.7 | 0.7 | GO:0005315 | inorganic phosphate transmembrane transporter activity(GO:0005315) |
0.7 | 7.3 | GO:0015279 | store-operated calcium channel activity(GO:0015279) |
0.7 | 2.6 | GO:0016783 | sulfurtransferase activity(GO:0016783) |
0.7 | 3.3 | GO:0005111 | type 2 fibroblast growth factor receptor binding(GO:0005111) |
0.7 | 0.7 | GO:0016882 | cyclo-ligase activity(GO:0016882) |
0.7 | 2.0 | GO:0019808 | polyamine binding(GO:0019808) |
0.6 | 3.9 | GO:0005372 | water transmembrane transporter activity(GO:0005372) |
0.6 | 5.8 | GO:0016646 | oxidoreductase activity, acting on the CH-NH group of donors, NAD or NADP as acceptor(GO:0016646) |
0.6 | 5.1 | GO:0016861 | intramolecular oxidoreductase activity, interconverting aldoses and ketoses(GO:0016861) |
0.6 | 6.4 | GO:0001618 | virus receptor activity(GO:0001618) |
0.6 | 1.3 | GO:0008192 | RNA guanylyltransferase activity(GO:0008192) |
0.6 | 29.9 | GO:0042826 | histone deacetylase binding(GO:0042826) |
0.6 | 22.9 | GO:0002039 | p53 binding(GO:0002039) |
0.6 | 5.1 | GO:0050321 | tau-protein kinase activity(GO:0050321) |
0.6 | 3.2 | GO:0050786 | RAGE receptor binding(GO:0050786) |
0.6 | 9.5 | GO:0017056 | structural constituent of nuclear pore(GO:0017056) |
0.6 | 1.9 | GO:0070324 | thyroid hormone binding(GO:0070324) |
0.6 | 0.6 | GO:0005134 | interleukin-2 receptor binding(GO:0005134) |
0.6 | 2.5 | GO:0016901 | oxidoreductase activity, acting on the CH-OH group of donors, quinone or similar compound as acceptor(GO:0016901) |
0.6 | 13.1 | GO:0048365 | Rac GTPase binding(GO:0048365) |
0.6 | 1.2 | GO:0047192 | 1-alkylglycerophosphocholine O-acetyltransferase activity(GO:0047192) |
0.6 | 1.9 | GO:0035473 | lipase binding(GO:0035473) |
0.6 | 1.2 | GO:0005138 | interleukin-6 receptor binding(GO:0005138) |
0.6 | 1.2 | GO:0031078 | histone deacetylase activity (H3-K14 specific)(GO:0031078) NAD-dependent histone deacetylase activity (H3-K14 specific)(GO:0032041) |
0.6 | 3.7 | GO:0016813 | hydrolase activity, acting on carbon-nitrogen (but not peptide) bonds, in linear amidines(GO:0016813) |
0.6 | 4.3 | GO:0018633 | 3-(3-hydroxyphenyl)propionate hydroxylase activity(GO:0008688) 4-chlorobenzaldehyde oxidase activity(GO:0018471) 3,5-xylenol methylhydroxylase activity(GO:0018630) phenylacetate hydroxylase activity(GO:0018631) 4-nitrophenol 4-monooxygenase activity(GO:0018632) dimethyl sulfide monooxygenase activity(GO:0018633) alpha-pinene monooxygenase [NADH] activity(GO:0018634) phenanthrene 9,10-monooxygenase activity(GO:0018636) 1-hydroxy-2-naphthoate hydroxylase activity(GO:0018637) toluene 4-monooxygenase activity(GO:0018638) xylene monooxygenase activity(GO:0018639) dibenzothiophene monooxygenase activity(GO:0018640) 6-hydroxy-3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018641) chlorophenol 4-monooxygenase activity(GO:0018642) carbon disulfide oxygenase activity(GO:0018643) toluene 2-monooxygenase activity(GO:0018644) 1-hydroxy-2-oxolimonene 1,2-monooxygenase activity(GO:0018646) phenanthrene 1,2-monooxygenase activity(GO:0018647) tetrahydrofuran hydroxylase activity(GO:0018649) styrene monooxygenase activity(GO:0018650) toluene-4-sulfonate monooxygenase activity(GO:0018651) toluene-sulfonate methyl-monooxygenase activity(GO:0018652) 3-methyl-2-oxo-1,2-dihydroquinoline 6-monooxygenase activity(GO:0018653) 2-hydroxy-phenylacetate hydroxylase activity(GO:0018654) 2-oxo-delta3-4,5,5-trimethylcyclopentenylacetyl-CoA 1,2-monooxygenase activity(GO:0018655) phenanthrene 3,4-monooxygenase activity(GO:0018656) toluene 3-monooxygenase activity(GO:0018657) 4-hydroxyphenylacetate,NADH:oxygen oxidoreductase (3-hydroxylating) activity(GO:0018660) limonene monooxygenase activity(GO:0019113) 2-methylnaphthalene hydroxylase activity(GO:0034526) 1-methylnaphthalene hydroxylase activity(GO:0034534) bisphenol A hydroxylase A activity(GO:0034560) salicylate 5-hydroxylase activity(GO:0034785) isobutylamine N-hydroxylase activity(GO:0034791) branched-chain dodecylbenzene sulfonate monooxygenase activity(GO:0034802) 3-HSA hydroxylase activity(GO:0034819) 4-hydroxypyridine-3-hydroxylase activity(GO:0034894) 2-octaprenyl-3-methyl-6-methoxy-1,4-benzoquinol hydroxylase activity(GO:0043719) 6-hydroxynicotinate 3-monooxygenase activity(GO:0043731) thalianol hydroxylase activity(GO:0080014) |
0.6 | 0.6 | GO:0015111 | iodide transmembrane transporter activity(GO:0015111) |
0.6 | 24.3 | GO:0004722 | protein serine/threonine phosphatase activity(GO:0004722) |
0.6 | 6.7 | GO:0008413 | 8-oxo-7,8-dihydroguanosine triphosphate pyrophosphatase activity(GO:0008413) |
0.6 | 5.4 | GO:0003689 | DNA clamp loader activity(GO:0003689) protein-DNA loading ATPase activity(GO:0033170) |
0.6 | 7.8 | GO:0032266 | phosphatidylinositol-3-phosphate binding(GO:0032266) |
0.6 | 0.6 | GO:0070653 | high-density lipoprotein particle receptor binding(GO:0070653) |
0.6 | 109.2 | GO:0005096 | GTPase activator activity(GO:0005096) |
0.6 | 5.4 | GO:0034987 | immunoglobulin receptor binding(GO:0034987) |
0.6 | 1.8 | GO:0008199 | ferric iron binding(GO:0008199) |
0.6 | 0.6 | GO:0008905 | mannose-phosphate guanylyltransferase activity(GO:0008905) |
0.6 | 5.3 | GO:0004303 | estradiol 17-beta-dehydrogenase activity(GO:0004303) |
0.6 | 0.6 | GO:0016415 | octanoyltransferase activity(GO:0016415) |
0.6 | 0.6 | GO:0019238 | cyclohydrolase activity(GO:0019238) |
0.6 | 1.8 | GO:0038132 | neuregulin binding(GO:0038132) |
0.6 | 0.6 | GO:0050145 | nucleoside phosphate kinase activity(GO:0050145) |
0.6 | 3.5 | GO:0003688 | DNA replication origin binding(GO:0003688) |
0.6 | 64.2 | GO:0004867 | serine-type endopeptidase inhibitor activity(GO:0004867) |
0.6 | 7.5 | GO:0043015 | gamma-tubulin binding(GO:0043015) |
0.6 | 5.2 | GO:0016504 | peptidase activator activity(GO:0016504) |
0.6 | 99.5 | GO:0070735 | UDP-N-acetylmuramoylalanyl-D-glutamyl-2,6-diaminopimelate-D-alanyl-D-alanine ligase activity(GO:0008766) ribosomal S6-glutamic acid ligase activity(GO:0018169) coenzyme F420-0 gamma-glutamyl ligase activity(GO:0043773) coenzyme F420-2 alpha-glutamyl ligase activity(GO:0043774) protein-glycine ligase activity(GO:0070735) protein-glycine ligase activity, initiating(GO:0070736) protein-glycine ligase activity, elongating(GO:0070737) tubulin-glycine ligase activity(GO:0070738) |
0.6 | 1.1 | GO:0045505 | dynein intermediate chain binding(GO:0045505) |
0.6 | 2.3 | GO:0004945 | angiotensin type II receptor activity(GO:0004945) |
0.6 | 25.5 | GO:0004896 | cytokine receptor activity(GO:0004896) |
0.6 | 15.3 | GO:0030374 | ligand-dependent nuclear receptor transcription coactivator activity(GO:0030374) |
0.6 | 15.8 | GO:0005507 | copper ion binding(GO:0005507) |
0.6 | 0.6 | GO:0031705 | bombesin receptor binding(GO:0031705) |
0.6 | 11.3 | GO:0005537 | mannose binding(GO:0005537) |
0.6 | 14.7 | GO:0048487 | beta-tubulin binding(GO:0048487) |
0.6 | 2.3 | GO:0015199 | amino-acid betaine transmembrane transporter activity(GO:0015199) carnitine transmembrane transporter activity(GO:0015226) |
0.6 | 0.6 | GO:0043141 | ATP-dependent 5'-3' DNA helicase activity(GO:0043141) |
0.6 | 2.2 | GO:0004594 | pantothenate kinase activity(GO:0004594) |
0.6 | 1.7 | GO:0005146 | leukemia inhibitory factor receptor binding(GO:0005146) |
0.6 | 68.7 | GO:0005125 | cytokine activity(GO:0005125) |
0.6 | 5.0 | GO:0005149 | interleukin-1 receptor binding(GO:0005149) |
0.6 | 1.7 | GO:0035515 | oxidative RNA demethylase activity(GO:0035515) |
0.6 | 5.6 | GO:0016538 | cyclin-dependent protein serine/threonine kinase regulator activity(GO:0016538) |
0.6 | 1.1 | GO:0051734 | polynucleotide 5'-hydroxyl-kinase activity(GO:0051731) ATP-dependent polynucleotide kinase activity(GO:0051734) |
0.6 | 1.7 | GO:0047756 | chondroitin 4-sulfotransferase activity(GO:0047756) |
0.5 | 7.7 | GO:0016500 | protein-hormone receptor activity(GO:0016500) |
0.5 | 1.6 | GO:0080130 | L-phenylalanine:2-oxoglutarate aminotransferase activity(GO:0080130) |
0.5 | 21.2 | GO:0019208 | phosphatase regulator activity(GO:0019208) |
0.5 | 22.2 | GO:0043130 | ubiquitin binding(GO:0043130) |
0.5 | 13.5 | GO:0051117 | ATPase binding(GO:0051117) |
0.5 | 2.2 | GO:0015245 | fatty acid transporter activity(GO:0015245) |
0.5 | 0.5 | GO:0035673 | oligopeptide transmembrane transporter activity(GO:0035673) |
0.5 | 2.1 | GO:0016018 | cyclosporin A binding(GO:0016018) |
0.5 | 2.1 | GO:0004301 | epoxide hydrolase activity(GO:0004301) |
0.5 | 3.2 | GO:0036312 | phosphatidylinositol 3-kinase regulatory subunit binding(GO:0036312) |
0.5 | 19.1 | GO:0035257 | nuclear hormone receptor binding(GO:0035257) |
0.5 | 2.1 | GO:0005536 | glucose binding(GO:0005536) |
0.5 | 1.1 | GO:0016406 | carnitine O-acyltransferase activity(GO:0016406) |
0.5 | 3.7 | GO:0008020 | G-protein coupled photoreceptor activity(GO:0008020) |
0.5 | 2.1 | GO:0004449 | isocitrate dehydrogenase (NAD+) activity(GO:0004449) |
0.5 | 3.1 | GO:0019955 | cytokine binding(GO:0019955) |
0.5 | 2.1 | GO:0001515 | opioid peptide activity(GO:0001515) |
0.5 | 2.6 | GO:0004534 | 5'-3' exoribonuclease activity(GO:0004534) |
0.5 | 2.0 | GO:0051429 | corticotropin-releasing hormone receptor binding(GO:0051429) |
0.5 | 13.2 | GO:0015485 | cholesterol binding(GO:0015485) |
0.5 | 1.0 | GO:0016520 | growth hormone-releasing hormone receptor activity(GO:0016520) |
0.5 | 5.1 | GO:0004596 | peptide alpha-N-acetyltransferase activity(GO:0004596) |
0.5 | 3.0 | GO:0016502 | purinergic nucleotide receptor activity(GO:0001614) nucleotide receptor activity(GO:0016502) |
0.5 | 15.1 | GO:0005044 | scavenger receptor activity(GO:0005044) |
0.5 | 4.5 | GO:0003796 | lysozyme activity(GO:0003796) |
0.5 | 2.5 | GO:0004769 | steroid delta-isomerase activity(GO:0004769) |
0.5 | 7.5 | GO:0015645 | fatty acid ligase activity(GO:0015645) |
0.5 | 1.5 | GO:0070815 | procollagen-lysine 5-dioxygenase activity(GO:0008475) peptidyl-lysine 5-dioxygenase activity(GO:0070815) |
0.5 | 3.9 | GO:0043539 | protein serine/threonine kinase activator activity(GO:0043539) |
0.5 | 2.9 | GO:0043024 | ribosomal small subunit binding(GO:0043024) |
0.5 | 6.7 | GO:0016799 | hydrolase activity, hydrolyzing N-glycosyl compounds(GO:0016799) |
0.5 | 1.9 | GO:0050431 | transforming growth factor beta binding(GO:0050431) |
0.5 | 1.4 | GO:0003985 | acetyl-CoA C-acetyltransferase activity(GO:0003985) C-acetyltransferase activity(GO:0016453) |
0.5 | 16.0 | GO:0030414 | peptidase inhibitor activity(GO:0030414) |
0.5 | 1.9 | GO:0016778 | diphosphotransferase activity(GO:0016778) |
0.5 | 8.4 | GO:0003887 | DNA-directed DNA polymerase activity(GO:0003887) |
0.5 | 1.9 | GO:0005344 | oxygen transporter activity(GO:0005344) |
0.5 | 0.9 | GO:0061676 | importin-alpha family protein binding(GO:0061676) |
0.5 | 0.5 | GO:0008296 | 3'-5'-exodeoxyribonuclease activity(GO:0008296) |
0.5 | 6.9 | GO:0005154 | epidermal growth factor receptor binding(GO:0005154) |
0.5 | 14.6 | GO:0005484 | SNAP receptor activity(GO:0005484) |
0.5 | 3.2 | GO:0016846 | carbon-sulfur lyase activity(GO:0016846) |
0.4 | 1.3 | GO:0016647 | oxidoreductase activity, acting on the CH-NH group of donors, oxygen as acceptor(GO:0016647) |
0.4 | 3.6 | GO:0045294 | alpha-catenin binding(GO:0045294) |
0.4 | 0.4 | GO:0002161 | aminoacyl-tRNA editing activity(GO:0002161) |
0.4 | 0.9 | GO:0008545 | JUN kinase kinase activity(GO:0008545) |
0.4 | 0.9 | GO:0016802 | adenosylhomocysteinase activity(GO:0004013) trialkylsulfonium hydrolase activity(GO:0016802) |
0.4 | 1.3 | GO:1990226 | histone methyltransferase binding(GO:1990226) |
0.4 | 1.7 | GO:0015220 | choline transmembrane transporter activity(GO:0015220) |
0.4 | 0.9 | GO:0003945 | N-acetyllactosamine synthase activity(GO:0003945) |
0.4 | 1.3 | GO:0004611 | phosphoenolpyruvate carboxykinase activity(GO:0004611) |
0.4 | 3.0 | GO:0017081 | chloride channel regulator activity(GO:0017081) |
0.4 | 0.4 | GO:0004833 | tryptophan 2,3-dioxygenase activity(GO:0004833) |
0.4 | 0.9 | GO:0030228 | lipoprotein particle receptor activity(GO:0030228) |
0.4 | 1.7 | GO:0050664 | oxidoreductase activity, acting on NAD(P)H, oxygen as acceptor(GO:0050664) |
0.4 | 0.4 | GO:0004003 | ATP-dependent DNA helicase activity(GO:0004003) |
0.4 | 2.1 | GO:0030983 | mismatched DNA binding(GO:0030983) |
0.4 | 4.2 | GO:0019531 | oxalate transmembrane transporter activity(GO:0019531) |
0.4 | 1.3 | GO:0016838 | carbon-oxygen lyase activity, acting on phosphates(GO:0016838) |
0.4 | 1.3 | GO:0015232 | heme transporter activity(GO:0015232) |
0.4 | 0.4 | GO:0016716 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, another compound as one donor, and incorporation of one atom of oxygen(GO:0016716) |
0.4 | 0.4 | GO:0048406 | nerve growth factor binding(GO:0048406) |
0.4 | 23.2 | GO:0003777 | microtubule motor activity(GO:0003777) |
0.4 | 2.1 | GO:0019825 | oxygen binding(GO:0019825) |
0.4 | 0.8 | GO:0034713 | type I transforming growth factor beta receptor binding(GO:0034713) |
0.4 | 1.6 | GO:0015057 | thrombin receptor activity(GO:0015057) |
0.4 | 19.5 | GO:0005089 | Rho guanyl-nucleotide exchange factor activity(GO:0005089) |
0.4 | 1.2 | GO:0070097 | delta-catenin binding(GO:0070097) |
0.4 | 1.2 | GO:0000014 | single-stranded DNA endodeoxyribonuclease activity(GO:0000014) |
0.4 | 1.9 | GO:0010181 | FMN binding(GO:0010181) |
0.4 | 47.6 | GO:0016791 | phosphatase activity(GO:0016791) |
0.4 | 13.1 | GO:0035064 | methylated histone binding(GO:0035064) |
0.4 | 1.9 | GO:0051861 | glycolipid binding(GO:0051861) |
0.4 | 1.9 | GO:0015248 | sterol transporter activity(GO:0015248) |
0.4 | 4.6 | GO:0070566 | adenylyltransferase activity(GO:0070566) |
0.4 | 1.1 | GO:0019136 | deoxynucleoside kinase activity(GO:0019136) |
0.4 | 0.4 | GO:0005131 | growth hormone receptor binding(GO:0005131) |
0.4 | 3.4 | GO:0008308 | voltage-gated anion channel activity(GO:0008308) |
0.4 | 4.6 | GO:0017025 | TBP-class protein binding(GO:0017025) |
0.4 | 1.1 | GO:0004802 | transketolase activity(GO:0004802) |
0.4 | 44.6 | GO:0019001 | guanyl nucleotide binding(GO:0019001) |
0.4 | 1.1 | GO:0003964 | telomerase activity(GO:0003720) RNA-directed DNA polymerase activity(GO:0003964) |
0.4 | 1.1 | GO:0004719 | protein-L-isoaspartate (D-aspartate) O-methyltransferase activity(GO:0004719) |
0.4 | 0.4 | GO:0004549 | tRNA-specific ribonuclease activity(GO:0004549) |
0.4 | 2.9 | GO:0031418 | L-ascorbic acid binding(GO:0031418) |
0.4 | 0.4 | GO:0015440 | peptide-transporting ATPase activity(GO:0015440) |
0.4 | 3.3 | GO:0017154 | semaphorin receptor activity(GO:0017154) |
0.4 | 0.4 | GO:0005105 | type 1 fibroblast growth factor receptor binding(GO:0005105) |
0.4 | 6.9 | GO:0004521 | endoribonuclease activity(GO:0004521) |
0.4 | 30.2 | GO:0004222 | metalloendopeptidase activity(GO:0004222) |
0.4 | 7.2 | GO:0070001 | aspartic-type endopeptidase activity(GO:0004190) aspartic-type peptidase activity(GO:0070001) |
0.4 | 24.3 | GO:0061630 | ubiquitin protein ligase activity(GO:0061630) |
0.4 | 2.1 | GO:0001530 | lipopolysaccharide binding(GO:0001530) |
0.4 | 0.7 | GO:0004703 | G-protein coupled receptor kinase activity(GO:0004703) |
0.4 | 0.7 | GO:0030274 | LIM domain binding(GO:0030274) |
0.4 | 2.1 | GO:0103116 | alpha-D-galactofuranose transporter activity(GO:0103116) |
0.4 | 0.4 | GO:0034511 | U3 snoRNA binding(GO:0034511) |
0.3 | 0.3 | GO:0052872 | tocotrienol omega-hydroxylase activity(GO:0052872) |
0.3 | 3.8 | GO:0005520 | insulin-like growth factor binding(GO:0005520) |
0.3 | 2.8 | GO:0008568 | microtubule-severing ATPase activity(GO:0008568) |
0.3 | 2.1 | GO:0008200 | ion channel inhibitor activity(GO:0008200) |
0.3 | 1.0 | GO:0000340 | RNA 7-methylguanosine cap binding(GO:0000340) |
0.3 | 0.3 | GO:0055056 | D-glucose transmembrane transporter activity(GO:0055056) |
0.3 | 1.0 | GO:0005329 | dopamine transmembrane transporter activity(GO:0005329) |
0.3 | 0.7 | GO:0004065 | arylsulfatase activity(GO:0004065) |
0.3 | 6.9 | GO:0033764 | steroid dehydrogenase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor(GO:0033764) |
0.3 | 1.4 | GO:0008494 | translation activator activity(GO:0008494) |
0.3 | 1.0 | GO:0035925 | mRNA 3'-UTR AU-rich region binding(GO:0035925) |
0.3 | 4.1 | GO:0019843 | rRNA binding(GO:0019843) |
0.3 | 1.0 | GO:0001595 | angiotensin receptor activity(GO:0001595) |
0.3 | 1.3 | GO:0047238 | glucuronosyl-N-acetylgalactosaminyl-proteoglycan 4-beta-N-acetylgalactosaminyltransferase activity(GO:0047238) |
0.3 | 0.7 | GO:0016638 | oxidoreductase activity, acting on the CH-NH2 group of donors(GO:0016638) |
0.3 | 7.0 | GO:0005212 | structural constituent of eye lens(GO:0005212) |
0.3 | 0.7 | GO:0004630 | phospholipase D activity(GO:0004630) |
0.3 | 1.0 | GO:0008484 | sulfuric ester hydrolase activity(GO:0008484) |
0.3 | 2.0 | GO:0043274 | phospholipase binding(GO:0043274) |
0.3 | 1.3 | GO:0070567 | cytidylyltransferase activity(GO:0070567) |
0.3 | 1.3 | GO:0070513 | death domain binding(GO:0070513) |
0.3 | 1.3 | GO:0017176 | phosphatidylinositol N-acetylglucosaminyltransferase activity(GO:0017176) |
0.3 | 3.9 | GO:0052890 | oxidoreductase activity, acting on the CH-CH group of donors, with a flavin as acceptor(GO:0052890) |
0.3 | 0.6 | GO:0019763 | immunoglobulin receptor activity(GO:0019763) |
0.3 | 1.0 | GO:0043208 | glycosphingolipid binding(GO:0043208) |
0.3 | 0.6 | GO:0005347 | ATP transmembrane transporter activity(GO:0005347) |
0.3 | 0.6 | GO:0017151 | DEAD/H-box RNA helicase binding(GO:0017151) |
0.3 | 1.3 | GO:0005166 | neurotrophin p75 receptor binding(GO:0005166) |
0.3 | 0.9 | GO:0030144 | alpha-1,6-mannosylglycoprotein 6-beta-N-acetylglucosaminyltransferase activity(GO:0030144) |
0.3 | 0.3 | GO:0009881 | photoreceptor activity(GO:0009881) |
0.3 | 9.2 | GO:0005518 | collagen binding(GO:0005518) |
0.3 | 0.6 | GO:0048030 | disaccharide binding(GO:0048030) |
0.3 | 1.5 | GO:0008353 | RNA polymerase II carboxy-terminal domain kinase activity(GO:0008353) |
0.3 | 0.9 | GO:0004829 | threonine-tRNA ligase activity(GO:0004829) |
0.3 | 0.6 | GO:0008607 | phosphorylase kinase regulator activity(GO:0008607) |
0.3 | 0.9 | GO:0004936 | alpha-adrenergic receptor activity(GO:0004936) |
0.3 | 0.3 | GO:0004645 | phosphorylase activity(GO:0004645) |
0.3 | 5.9 | GO:0016676 | cytochrome-c oxidase activity(GO:0004129) heme-copper terminal oxidase activity(GO:0015002) oxidoreductase activity, acting on a heme group of donors, oxygen as acceptor(GO:0016676) |
0.3 | 0.6 | GO:0016888 | endodeoxyribonuclease activity, producing 5'-phosphomonoesters(GO:0016888) |
0.3 | 4.7 | GO:0016763 | transferase activity, transferring pentosyl groups(GO:0016763) |
0.3 | 1.2 | GO:0038024 | cargo receptor activity(GO:0038024) |
0.3 | 6.4 | GO:0008536 | Ran GTPase binding(GO:0008536) |
0.3 | 0.9 | GO:0043014 | alpha-tubulin binding(GO:0043014) |
0.3 | 2.8 | GO:0004568 | chitinase activity(GO:0004568) |
0.3 | 9.4 | GO:0003697 | single-stranded DNA binding(GO:0003697) |
0.3 | 7.4 | GO:0051087 | chaperone binding(GO:0051087) |
0.3 | 1.4 | GO:0004994 | somatostatin receptor activity(GO:0004994) |
0.3 | 1.7 | GO:0004622 | lysophospholipase activity(GO:0004622) |
0.3 | 0.6 | GO:0016842 | amidine-lyase activity(GO:0016842) |
0.3 | 1.4 | GO:0051400 | BH domain binding(GO:0051400) |
0.3 | 0.3 | GO:0004942 | anaphylatoxin receptor activity(GO:0004942) |
0.3 | 9.2 | GO:0031072 | heat shock protein binding(GO:0031072) |
0.3 | 25.4 | GO:0004842 | ubiquitin-protein transferase activity(GO:0004842) |
0.3 | 4.6 | GO:0001056 | RNA polymerase III activity(GO:0001056) |
0.3 | 1.1 | GO:0070628 | proteasome binding(GO:0070628) |
0.3 | 0.3 | GO:0004367 | glycerol-3-phosphate dehydrogenase [NAD+] activity(GO:0004367) |
0.3 | 0.5 | GO:0033691 | sialic acid binding(GO:0033691) |
0.3 | 0.3 | GO:0004069 | L-aspartate:2-oxoglutarate aminotransferase activity(GO:0004069) |
0.3 | 2.1 | GO:0005542 | folic acid binding(GO:0005542) |
0.3 | 0.5 | GO:0070548 | L-glutamine aminotransferase activity(GO:0070548) |
0.3 | 0.8 | GO:0050501 | hyaluronan synthase activity(GO:0050501) |
0.3 | 0.5 | GO:0017153 | sodium:dicarboxylate symporter activity(GO:0017153) |
0.3 | 0.5 | GO:0042379 | chemokine receptor binding(GO:0042379) |
0.3 | 0.5 | GO:0003708 | retinoic acid receptor activity(GO:0003708) |
0.3 | 0.8 | GO:0001727 | lipid kinase activity(GO:0001727) |
0.3 | 7.9 | GO:0004540 | ribonuclease activity(GO:0004540) |
0.3 | 8.7 | GO:0008391 | arachidonic acid monooxygenase activity(GO:0008391) |
0.3 | 1.3 | GO:0005412 | glucose:sodium symporter activity(GO:0005412) |
0.3 | 1.8 | GO:0016679 | oxidoreductase activity, acting on diphenols and related substances as donors(GO:0016679) |
0.3 | 0.5 | GO:0008271 | secondary active sulfate transmembrane transporter activity(GO:0008271) |
0.3 | 2.0 | GO:0016713 | oxidoreductase activity, acting on paired donors, with incorporation or reduction of molecular oxygen, reduced iron-sulfur protein as one donor, and incorporation of one atom of oxygen(GO:0016713) |
0.3 | 1.0 | GO:0015450 | P-P-bond-hydrolysis-driven protein transmembrane transporter activity(GO:0015450) |
0.2 | 0.2 | GO:0004887 | thyroid hormone receptor activity(GO:0004887) |
0.2 | 0.7 | GO:0005415 | nucleoside:sodium symporter activity(GO:0005415) |
0.2 | 4.7 | GO:0008395 | steroid hydroxylase activity(GO:0008395) |
0.2 | 0.7 | GO:0030345 | extracellular matrix structural constituent conferring compression resistance(GO:0030021) structural constituent of tooth enamel(GO:0030345) |
0.2 | 0.5 | GO:0048038 | quinone binding(GO:0048038) |
0.2 | 0.5 | GO:0008240 | tripeptidyl-peptidase activity(GO:0008240) |
0.2 | 0.5 | GO:0046915 | transition metal ion transmembrane transporter activity(GO:0046915) |
0.2 | 1.6 | GO:0000049 | tRNA binding(GO:0000049) |
0.2 | 0.9 | GO:0004045 | aminoacyl-tRNA hydrolase activity(GO:0004045) |
0.2 | 33.1 | GO:0004252 | serine-type endopeptidase activity(GO:0004252) |
0.2 | 16.0 | GO:0008234 | cysteine-type peptidase activity(GO:0008234) |
0.2 | 1.4 | GO:0008094 | DNA-dependent ATPase activity(GO:0008094) |
0.2 | 0.7 | GO:0004663 | Rab geranylgeranyltransferase activity(GO:0004663) |
0.2 | 2.0 | GO:0015385 | sodium:proton antiporter activity(GO:0015385) potassium:proton antiporter activity(GO:0015386) |
0.2 | 1.1 | GO:0008553 | hydrogen-exporting ATPase activity, phosphorylative mechanism(GO:0008553) |
0.2 | 3.3 | GO:0015078 | hydrogen ion transmembrane transporter activity(GO:0015078) |
0.2 | 8.2 | GO:0008527 | taste receptor activity(GO:0008527) |
0.2 | 0.4 | GO:0004448 | isocitrate dehydrogenase activity(GO:0004448) |
0.2 | 0.2 | GO:0031013 | troponin I binding(GO:0031013) |
0.2 | 0.6 | GO:1901611 | phosphatidylglycerol binding(GO:1901611) |
0.2 | 4.7 | GO:0043022 | ribosome binding(GO:0043022) |
0.2 | 0.6 | GO:0001055 | RNA polymerase II activity(GO:0001055) |
0.2 | 0.4 | GO:1990188 | euchromatin binding(GO:1990188) |
0.2 | 1.7 | GO:0004745 | retinol dehydrogenase activity(GO:0004745) |
0.2 | 0.4 | GO:0047631 | ADP-ribose diphosphatase activity(GO:0047631) |
0.2 | 0.8 | GO:0032453 | histone demethylase activity (H3-K4 specific)(GO:0032453) |
0.2 | 0.2 | GO:0070410 | co-SMAD binding(GO:0070410) |
0.2 | 0.4 | GO:0051011 | microtubule minus-end binding(GO:0051011) |
0.2 | 0.4 | GO:0035586 | purinergic receptor activity(GO:0035586) |
0.2 | 0.6 | GO:0047184 | 1-acylglycerophosphocholine O-acyltransferase activity(GO:0047184) |
0.2 | 0.4 | GO:0003916 | DNA topoisomerase activity(GO:0003916) |
0.2 | 6.4 | GO:0016790 | thiolester hydrolase activity(GO:0016790) |
0.2 | 0.4 | GO:0016668 | oxidoreductase activity, acting on a sulfur group of donors, NAD(P) as acceptor(GO:0016668) |
0.2 | 2.6 | GO:0045502 | dynein binding(GO:0045502) |
0.2 | 0.6 | GO:0004430 | 1-phosphatidylinositol 4-kinase activity(GO:0004430) |
0.2 | 0.4 | GO:0000104 | succinate dehydrogenase activity(GO:0000104) |
0.2 | 0.2 | GO:0051990 | (R)-2-hydroxyglutarate dehydrogenase activity(GO:0051990) |
0.2 | 0.4 | GO:0042608 | T cell receptor binding(GO:0042608) |
0.2 | 5.1 | GO:0050253 | retinyl-palmitate esterase activity(GO:0050253) |
0.2 | 0.4 | GO:0016803 | ether hydrolase activity(GO:0016803) |
0.2 | 0.2 | GO:0047429 | dITP diphosphatase activity(GO:0035870) XTP diphosphatase activity(GO:0036222) nucleoside-triphosphate diphosphatase activity(GO:0047429) |
0.2 | 0.4 | GO:0003988 | acetyl-CoA C-acyltransferase activity(GO:0003988) |
0.2 | 1.1 | GO:0042162 | telomeric DNA binding(GO:0042162) |
0.2 | 0.2 | GO:0031628 | opioid receptor binding(GO:0031628) |
0.2 | 0.2 | GO:0000064 | L-ornithine transmembrane transporter activity(GO:0000064) |
0.2 | 7.6 | GO:0008565 | protein transporter activity(GO:0008565) |
0.2 | 0.8 | GO:0001134 | transcription factor activity, transcription factor recruiting(GO:0001134) |
0.2 | 2.5 | GO:0004653 | polypeptide N-acetylgalactosaminyltransferase activity(GO:0004653) |
0.2 | 0.3 | GO:1990254 | keratin filament binding(GO:1990254) |
0.2 | 1.2 | GO:0016907 | G-protein coupled acetylcholine receptor activity(GO:0016907) |
0.2 | 0.3 | GO:0005087 | Ran guanyl-nucleotide exchange factor activity(GO:0005087) |
0.2 | 0.2 | GO:0051766 | inositol trisphosphate kinase activity(GO:0051766) |
0.2 | 0.6 | GO:0004144 | diacylglycerol O-acyltransferase activity(GO:0004144) |
0.1 | 1.9 | GO:0005158 | insulin receptor binding(GO:0005158) |
0.1 | 0.4 | GO:0030280 | structural constituent of epidermis(GO:0030280) |
0.1 | 2.3 | GO:0001540 | beta-amyloid binding(GO:0001540) |
0.1 | 0.3 | GO:0019107 | myristoyltransferase activity(GO:0019107) |
0.1 | 26.2 | GO:0003735 | structural constituent of ribosome(GO:0003735) |
0.1 | 0.8 | GO:0033695 | oxidoreductase activity, acting on CH or CH2 groups, quinone or similar compound as acceptor(GO:0033695) caffeine oxidase activity(GO:0034875) |
0.1 | 1.5 | GO:0005243 | gap junction channel activity(GO:0005243) |
0.1 | 0.1 | GO:0005534 | galactose binding(GO:0005534) |
0.1 | 0.5 | GO:0004415 | hyalurononglucosaminidase activity(GO:0004415) |
0.1 | 0.9 | GO:0016884 | carbon-nitrogen ligase activity, with glutamine as amido-N-donor(GO:0016884) |
0.1 | 0.1 | GO:0016744 | transferase activity, transferring aldehyde or ketonic groups(GO:0016744) |
0.1 | 3.9 | GO:0005496 | steroid binding(GO:0005496) |
0.1 | 10.9 | GO:0005550 | pheromone binding(GO:0005550) |
0.1 | 3.4 | GO:0016765 | transferase activity, transferring alkyl or aryl (other than methyl) groups(GO:0016765) |
0.1 | 2.0 | GO:0008237 | metallopeptidase activity(GO:0008237) |
0.1 | 0.3 | GO:0008198 | ferrous iron binding(GO:0008198) |
0.1 | 0.7 | GO:0010485 | H4 histone acetyltransferase activity(GO:0010485) |
0.1 | 0.3 | GO:0015157 | sucrose:proton symporter activity(GO:0008506) sucrose transmembrane transporter activity(GO:0008515) disaccharide transmembrane transporter activity(GO:0015154) oligosaccharide transmembrane transporter activity(GO:0015157) |
0.1 | 0.8 | GO:0019841 | retinol binding(GO:0019841) |
0.1 | 1.4 | GO:0003756 | protein disulfide isomerase activity(GO:0003756) intramolecular oxidoreductase activity, transposing S-S bonds(GO:0016864) |
0.1 | 3.2 | GO:0016651 | oxidoreductase activity, acting on NAD(P)H(GO:0016651) |
0.1 | 1.9 | GO:0016749 | N-succinyltransferase activity(GO:0016749) |
0.1 | 3.6 | GO:0004519 | endonuclease activity(GO:0004519) |
0.1 | 0.6 | GO:0070273 | phosphatidylinositol-4-phosphate binding(GO:0070273) |
0.1 | 0.4 | GO:0030247 | pattern binding(GO:0001871) polysaccharide binding(GO:0030247) |
0.1 | 0.3 | GO:1901682 | sulfur compound transmembrane transporter activity(GO:1901682) |
0.1 | 2.0 | GO:0050699 | WW domain binding(GO:0050699) |
0.1 | 0.3 | GO:0019206 | nucleoside kinase activity(GO:0019206) |
0.1 | 0.1 | GO:0016880 | acid-ammonia (or amide) ligase activity(GO:0016880) |
0.1 | 0.2 | GO:0015166 | polyol transmembrane transporter activity(GO:0015166) |
0.1 | 0.8 | GO:0005351 | sugar:proton symporter activity(GO:0005351) |
0.1 | 94.9 | GO:0004984 | olfactory receptor activity(GO:0004984) |
0.1 | 0.3 | GO:0001591 | dopamine neurotransmitter receptor activity, coupled via Gi/Go(GO:0001591) |
0.1 | 0.2 | GO:0008408 | 3'-5' exonuclease activity(GO:0008408) |
0.1 | 0.1 | GO:0035184 | histone threonine kinase activity(GO:0035184) |
0.1 | 0.2 | GO:0004582 | dolichyl-phosphate beta-D-mannosyltransferase activity(GO:0004582) |
0.1 | 13.2 | GO:0003779 | actin binding(GO:0003779) |
0.1 | 0.1 | GO:0001846 | opsonin binding(GO:0001846) |
0.1 | 0.4 | GO:0001221 | transcription cofactor binding(GO:0001221) |
0.1 | 6.4 | GO:0016887 | ATPase activity(GO:0016887) |
0.1 | 0.1 | GO:0070095 | fructose-6-phosphate binding(GO:0070095) |
0.1 | 2.2 | GO:0016627 | oxidoreductase activity, acting on the CH-CH group of donors(GO:0016627) |
0.1 | 0.2 | GO:0005549 | odorant binding(GO:0005549) |
0.1 | 2.0 | GO:0008135 | translation factor activity, RNA binding(GO:0008135) |
0.1 | 0.3 | GO:0004457 | lactate dehydrogenase activity(GO:0004457) |
0.1 | 0.1 | GO:0036137 | kynurenine-oxoglutarate transaminase activity(GO:0016212) kynurenine aminotransferase activity(GO:0036137) |
0.1 | 0.1 | GO:0005275 | amine transmembrane transporter activity(GO:0005275) |
0.1 | 0.1 | GO:0004052 | arachidonate 12-lipoxygenase activity(GO:0004052) |
0.1 | 0.1 | GO:0030976 | thiamine pyrophosphate binding(GO:0030976) |
0.1 | 0.2 | GO:0042284 | sphingolipid delta-4 desaturase activity(GO:0042284) |
0.1 | 7.2 | GO:0016741 | transferase activity, transferring one-carbon groups(GO:0016741) |
0.1 | 0.5 | GO:0016881 | acid-amino acid ligase activity(GO:0016881) |
0.0 | 0.1 | GO:0033829 | O-fucosylpeptide 3-beta-N-acetylglucosaminyltransferase activity(GO:0033829) |
0.0 | 0.1 | GO:0034481 | chondroitin sulfotransferase activity(GO:0034481) |
0.0 | 0.2 | GO:0008410 | CoA-transferase activity(GO:0008410) |
0.0 | 0.7 | GO:0005186 | pheromone activity(GO:0005186) |
0.0 | 0.2 | GO:0001054 | RNA polymerase I activity(GO:0001054) |
0.0 | 0.0 | GO:0050252 | retinol O-fatty-acyltransferase activity(GO:0050252) |
0.0 | 0.1 | GO:0002046 | opsin binding(GO:0002046) |
0.0 | 0.3 | GO:0030515 | snoRNA binding(GO:0030515) |
0.0 | 0.0 | GO:0030551 | cyclic nucleotide binding(GO:0030551) |
0.0 | 0.1 | GO:0032050 | clathrin heavy chain binding(GO:0032050) |
0.0 | 0.0 | GO:0030548 | acetylcholine receptor regulator activity(GO:0030548) neurotransmitter receptor regulator activity(GO:0099602) |
0.0 | 0.1 | GO:0017110 | nucleoside-diphosphatase activity(GO:0017110) |
0.0 | 0.0 | GO:0016774 | phosphotransferase activity, carboxyl group as acceptor(GO:0016774) |
0.0 | 0.0 | GO:0016176 | superoxide-generating NADPH oxidase activator activity(GO:0016176) |
0.0 | 0.5 | GO:0000980 | RNA polymerase II distal enhancer sequence-specific DNA binding(GO:0000980) |
0.0 | 0.0 | GO:0030620 | U2 snRNA binding(GO:0030620) |
0.0 | 0.0 | GO:0016885 | CoA carboxylase activity(GO:0016421) ligase activity, forming carbon-carbon bonds(GO:0016885) |
0.0 | 0.1 | GO:0004165 | dodecenoyl-CoA delta-isomerase activity(GO:0004165) |
0.0 | 0.0 | GO:0023029 | MHC class Ib protein binding(GO:0023029) |
0.0 | 0.3 | GO:0016209 | antioxidant activity(GO:0016209) |
0.0 | 0.7 | GO:0004812 | aminoacyl-tRNA ligase activity(GO:0004812) |
0.0 | 0.0 | GO:0030628 | pre-mRNA 3'-splice site binding(GO:0030628) |
0.0 | 0.1 | GO:0004062 | aryl sulfotransferase activity(GO:0004062) |
0.0 | 0.1 | GO:0017162 | aryl hydrocarbon receptor binding(GO:0017162) |
0.0 | 0.2 | GO:0016503 | pheromone receptor activity(GO:0016503) |
0.0 | 0.1 | GO:0051287 | NAD binding(GO:0051287) |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
3.9 | 30.9 | ST TYPE I INTERFERON PATHWAY | Type I Interferon (alpha/beta IFN) Pathway |
3.8 | 60.1 | PID IL2 PI3K PATHWAY | IL2 signaling events mediated by PI3K |
3.7 | 161.3 | PID HNF3B PATHWAY | FOXA2 and FOXA3 transcription factor networks |
3.5 | 17.6 | SA PTEN PATHWAY | PTEN is a tumor suppressor that dephosphorylates the lipid messenger phosphatidylinositol triphosphate. |
3.5 | 24.7 | ST STAT3 PATHWAY | STAT3 Pathway |
3.3 | 23.3 | SA FAS SIGNALING | The TNF-type receptor Fas induces apoptosis on ligand binding. |
3.3 | 86.5 | PID IL2 STAT5 PATHWAY | IL2 signaling events mediated by STAT5 |
3.2 | 15.9 | PID IL5 PATHWAY | IL5-mediated signaling events |
2.9 | 202.7 | PID SMAD2 3NUCLEAR PATHWAY | Regulation of nuclear SMAD2/3 signaling |
2.9 | 22.8 | PID LYMPH ANGIOGENESIS PATHWAY | VEGFR3 signaling in lymphatic endothelium |
2.5 | 62.8 | PID TOLL ENDOGENOUS PATHWAY | Endogenous TLR signaling |
2.5 | 20.1 | PID ANTHRAX PATHWAY | Cellular roles of Anthrax toxin |
2.5 | 32.3 | SA MMP CYTOKINE CONNECTION | Cytokines can induce activation of matrix metalloproteinases, which degrade extracellular matrix. |
2.4 | 38.9 | PID NFKAPPAB CANONICAL PATHWAY | Canonical NF-kappaB pathway |
2.4 | 72.2 | SIG PIP3 SIGNALING IN B LYMPHOCYTES | Genes related to PIP3 signaling in B lymphocytes |
2.4 | 92.5 | PID IL12 2PATHWAY | IL12-mediated signaling events |
2.4 | 37.8 | PID TRAIL PATHWAY | TRAIL signaling pathway |
2.4 | 65.9 | PID ANGIOPOIETIN RECEPTOR PATHWAY | Angiopoietin receptor Tie2-mediated signaling |
2.3 | 77.3 | PID HES HEY PATHWAY | Notch-mediated HES/HEY network |
2.3 | 9.0 | PID TCR RAS PATHWAY | Ras signaling in the CD4+ TCR pathway |
2.3 | 69.8 | PID NFAT TFPATHWAY | Calcineurin-regulated NFAT-dependent transcription in lymphocytes |
2.2 | 58.4 | PID KIT PATHWAY | Signaling events mediated by Stem cell factor receptor (c-Kit) |
2.2 | 74.1 | PID ILK PATHWAY | Integrin-linked kinase signaling |
2.2 | 88.9 | PID RHOA REG PATHWAY | Regulation of RhoA activity |
2.1 | 6.4 | PID CD40 PATHWAY | CD40/CD40L signaling |
2.1 | 27.0 | PID FCER1 PATHWAY | Fc-epsilon receptor I signaling in mast cells |
2.0 | 10.2 | PID S1P META PATHWAY | Sphingosine 1-phosphate (S1P) pathway |
2.0 | 70.2 | PID INTEGRIN3 PATHWAY | Beta3 integrin cell surface interactions |
2.0 | 80.1 | PID HIF1 TFPATHWAY | HIF-1-alpha transcription factor network |
1.9 | 29.1 | PID TCPTP PATHWAY | Signaling events mediated by TCPTP |
1.9 | 3.8 | PID FAS PATHWAY | FAS (CD95) signaling pathway |
1.9 | 1.9 | SA B CELL RECEPTOR COMPLEXES | Antigen binding to B cell receptors activates protein tyrosine kinases, such as the Src family, which ultimate activate MAP kinases. |
1.9 | 28.0 | PID S1P S1P3 PATHWAY | S1P3 pathway |
1.8 | 12.9 | PID GMCSF PATHWAY | GMCSF-mediated signaling events |
1.8 | 29.3 | PID MYC PATHWAY | C-MYC pathway |
1.8 | 41.2 | PID PI3KCI PATHWAY | Class I PI3K signaling events |
1.8 | 37.2 | PID TCR PATHWAY | TCR signaling in naïve CD4+ T cells |
1.8 | 17.5 | SA CASPASE CASCADE | Apoptosis is mediated by caspases, cysteine proteases arranged in a proteolytic cascade. |
1.7 | 15.6 | PID ARF6 DOWNSTREAM PATHWAY | Arf6 downstream pathway |
1.7 | 8.5 | SA REG CASCADE OF CYCLIN EXPR | Expression of cyclins regulates progression through the cell cycle by activating cyclin-dependent kinases. |
1.7 | 3.3 | SA PROGRAMMED CELL DEATH | Programmed cell death, or apoptosis, eliminates damaged or unneeded cells. |
1.6 | 24.6 | PID INTEGRIN2 PATHWAY | Beta2 integrin cell surface interactions |
1.6 | 11.2 | SA G2 AND M PHASES | Cdc25 activates the cdc2/cyclin B complex to induce the G2/M transition. |
1.5 | 32.6 | PID CASPASE PATHWAY | Caspase cascade in apoptosis |
1.4 | 47.5 | PID PLK1 PATHWAY | PLK1 signaling events |
1.3 | 5.3 | PID TCR CALCIUM PATHWAY | Calcium signaling in the CD4+ TCR pathway |
1.3 | 1.3 | PID EPHA2 FWD PATHWAY | EPHA2 forward signaling |
1.2 | 12.5 | PID INTEGRIN A9B1 PATHWAY | Alpha9 beta1 integrin signaling events |
1.2 | 22.3 | PID FAK PATHWAY | Signaling events mediated by focal adhesion kinase |
1.2 | 3.6 | PID IL8 CXCR1 PATHWAY | IL8- and CXCR1-mediated signaling events |
1.2 | 4.8 | SIG INSULIN RECEPTOR PATHWAY IN CARDIAC MYOCYTES | Genes related to the insulin receptor pathway |
1.2 | 25.4 | PID TNF PATHWAY | TNF receptor signaling pathway |
1.2 | 47.1 | PID P73PATHWAY | p73 transcription factor network |
1.2 | 3.6 | ST INTERLEUKIN 4 PATHWAY | Interleukin 4 (IL-4) Pathway |
1.2 | 7.1 | ST PAC1 RECEPTOR PATHWAY | PAC1 Receptor Pathway |
1.2 | 4.7 | PID P38 MK2 PATHWAY | p38 signaling mediated by MAPKAP kinases |
1.2 | 5.8 | PID IGF1 PATHWAY | IGF1 pathway |
1.1 | 14.3 | PID CXCR3 PATHWAY | CXCR3-mediated signaling events |
1.1 | 15.2 | PID FRA PATHWAY | Validated transcriptional targets of AP1 family members Fra1 and Fra2 |
1.1 | 12.8 | PID IL6 7 PATHWAY | IL6-mediated signaling events |
1.1 | 21.3 | PID ATF2 PATHWAY | ATF-2 transcription factor network |
1.1 | 7.4 | PID ECADHERIN KERATINOCYTE PATHWAY | E-cadherin signaling in keratinocytes |
1.0 | 3.1 | PID THROMBIN PAR1 PATHWAY | PAR1-mediated thrombin signaling events |
1.0 | 4.2 | PID RETINOIC ACID PATHWAY | Retinoic acid receptors-mediated signaling |
1.0 | 12.1 | PID CD8 TCR DOWNSTREAM PATHWAY | Downstream signaling in naïve CD8+ T cells |
1.0 | 17.0 | PID VEGFR1 2 PATHWAY | Signaling events mediated by VEGFR1 and VEGFR2 |
1.0 | 1.0 | ST JAK STAT PATHWAY | Jak-STAT Pathway |
1.0 | 6.7 | PID INTEGRIN A4B1 PATHWAY | Alpha4 beta1 integrin signaling events |
0.9 | 125.9 | NABA ECM AFFILIATED | Genes encoding proteins affiliated structurally or functionally to extracellular matrix proteins |
0.9 | 6.5 | PID INTEGRIN4 PATHWAY | Alpha6 beta4 integrin-ligand interactions |
0.9 | 8.4 | PID SYNDECAN 4 PATHWAY | Syndecan-4-mediated signaling events |
0.9 | 3.7 | PID FOXO PATHWAY | FoxO family signaling |
0.9 | 11.9 | PID INSULIN PATHWAY | Insulin Pathway |
0.9 | 2.7 | PID ER NONGENOMIC PATHWAY | Plasma membrane estrogen receptor signaling |
0.9 | 21.4 | NABA BASEMENT MEMBRANES | Genes encoding structural components of basement membranes |
0.9 | 11.6 | PID RAS PATHWAY | Regulation of Ras family activation |
0.9 | 16.0 | PID RHOA PATHWAY | RhoA signaling pathway |
0.9 | 7.8 | PID ALK2 PATHWAY | ALK2 signaling events |
0.9 | 162.7 | NABA ECM REGULATORS | Genes encoding enzymes and their regulators involved in the remodeling of the extracellular matrix |
0.8 | 7.6 | PID AMB2 NEUTROPHILS PATHWAY | amb2 Integrin signaling |
0.8 | 5.0 | PID ALK1 PATHWAY | ALK1 signaling events |
0.8 | 15.6 | PID ATM PATHWAY | ATM pathway |
0.8 | 7.3 | ST WNT CA2 CYCLIC GMP PATHWAY | Wnt/Ca2+/cyclic GMP signaling. |
0.8 | 5.7 | PID PRL SIGNALING EVENTS PATHWAY | Signaling events mediated by PRL |
0.8 | 51.1 | PID P53 DOWNSTREAM PATHWAY | Direct p53 effectors |
0.8 | 7.9 | PID HIF2PATHWAY | HIF-2-alpha transcription factor network |
0.8 | 6.2 | PID INSULIN GLUCOSE PATHWAY | Insulin-mediated glucose transport |
0.7 | 2.2 | ST JNK MAPK PATHWAY | JNK MAPK Pathway |
0.7 | 1.5 | ST IL 13 PATHWAY | Interleukin 13 (IL-13) Pathway |
0.7 | 16.1 | PID ENDOTHELIN PATHWAY | Endothelins |
0.7 | 2.8 | PID IL27 PATHWAY | IL27-mediated signaling events |
0.7 | 1.4 | PID AR NONGENOMIC PATHWAY | Nongenotropic Androgen signaling |
0.7 | 5.3 | PID ERB GENOMIC PATHWAY | Validated nuclear estrogen receptor beta network |
0.7 | 14.5 | PID TGFBR PATHWAY | TGF-beta receptor signaling |
0.7 | 23.0 | PID CMYB PATHWAY | C-MYB transcription factor network |
0.7 | 10.5 | PID HDAC CLASSII PATHWAY | Signaling events mediated by HDAC Class II |
0.7 | 3.9 | PID BETA CATENIN DEG PATHWAY | Degradation of beta catenin |
0.7 | 16.9 | PID P53 REGULATION PATHWAY | p53 pathway |
0.6 | 1.3 | ST DIFFERENTIATION PATHWAY IN PC12 CELLS | Differentiation Pathway in PC12 Cells; this is a specific case of PAC1 Receptor Pathway. |
0.6 | 0.6 | ST T CELL SIGNAL TRANSDUCTION | T Cell Signal Transduction |
0.6 | 2.5 | SIG CHEMOTAXIS | Genes related to chemotaxis |
0.6 | 5.5 | PID HDAC CLASSIII PATHWAY | Signaling events mediated by HDAC Class III |
0.6 | 6.0 | PID UPA UPAR PATHWAY | Urokinase-type plasminogen activator (uPA) and uPAR-mediated signaling |
0.6 | 7.2 | PID MET PATHWAY | Signaling events mediated by Hepatocyte Growth Factor Receptor (c-Met) |
0.6 | 1.2 | PID LPA4 PATHWAY | LPA4-mediated signaling events |
0.5 | 6.0 | PID CIRCADIAN PATHWAY | Circadian rhythm pathway |
0.5 | 13.1 | PID RAC1 PATHWAY | RAC1 signaling pathway |
0.5 | 4.3 | PID LYSOPHOSPHOLIPID PATHWAY | LPA receptor mediated events |
0.5 | 5.3 | PID ECADHERIN STABILIZATION PATHWAY | Stabilization and expansion of the E-cadherin adherens junction |
0.5 | 6.8 | ST ERK1 ERK2 MAPK PATHWAY | ERK1/ERK2 MAPK Pathway |
0.5 | 8.1 | PID AR TF PATHWAY | Regulation of Androgen receptor activity |
0.5 | 3.5 | PID P38 MKK3 6PATHWAY | p38 MAPK signaling pathway |
0.5 | 14.1 | PID ERA GENOMIC PATHWAY | Validated nuclear estrogen receptor alpha network |
0.5 | 2.0 | PID HIF1A PATHWAY | Hypoxic and oxygen homeostasis regulation of HIF-1-alpha |
0.5 | 5.4 | ST MYOCYTE AD PATHWAY | Myocyte Adrenergic Pathway is a specific case of the generalized Adrenergic Pathway. |
0.5 | 2.9 | PID TXA2PATHWAY | Thromboxane A2 receptor signaling |
0.5 | 1.4 | ST PHOSPHOINOSITIDE 3 KINASE PATHWAY | PI3K Pathway |
0.5 | 6.0 | PID FOXM1 PATHWAY | FOXM1 transcription factor network |
0.5 | 7.8 | PID RXR VDR PATHWAY | RXR and RAR heterodimerization with other nuclear receptor |
0.5 | 8.2 | PID FGF PATHWAY | FGF signaling pathway |
0.4 | 1.3 | PID WNT CANONICAL PATHWAY | Canonical Wnt signaling pathway |
0.4 | 7.2 | PID HDAC CLASSI PATHWAY | Signaling events mediated by HDAC Class I |
0.4 | 2.5 | PID ERBB2 ERBB3 PATHWAY | ErbB2/ErbB3 signaling events |
0.4 | 4.5 | PID BCR 5PATHWAY | BCR signaling pathway |
0.4 | 6.9 | PID RHODOPSIN PATHWAY | Visual signal transduction: Rods |
0.4 | 3.6 | PID A6B1 A6B4 INTEGRIN PATHWAY | a6b1 and a6b4 Integrin signaling |
0.4 | 2.4 | PID CONE PATHWAY | Visual signal transduction: Cones |
0.4 | 8.7 | ST WNT BETA CATENIN PATHWAY | Wnt/beta-catenin Pathway |
0.4 | 1.1 | PID NECTIN PATHWAY | Nectin adhesion pathway |
0.3 | 2.1 | PID SMAD2 3PATHWAY | Regulation of cytoplasmic and nuclear SMAD2/3 signaling |
0.3 | 0.7 | PID PI3KCI AKT PATHWAY | Class I PI3K signaling events mediated by Akt |
0.3 | 8.9 | PID FANCONI PATHWAY | Fanconi anemia pathway |
0.3 | 1.6 | ST GA13 PATHWAY | G alpha 13 Pathway |
0.3 | 1.0 | PID IFNG PATHWAY | IFN-gamma pathway |
0.3 | 0.6 | PID WNT NONCANONICAL PATHWAY | Noncanonical Wnt signaling pathway |
0.3 | 5.6 | PID MYC REPRESS PATHWAY | Validated targets of C-MYC transcriptional repression |
0.3 | 2.1 | PID HNF3A PATHWAY | FOXA1 transcription factor network |
0.3 | 0.3 | PID P38 GAMMA DELTA PATHWAY | Signaling mediated by p38-gamma and p38-delta |
0.3 | 0.3 | PID ERBB NETWORK PATHWAY | ErbB receptor signaling network |
0.3 | 0.3 | ST GRANULE CELL SURVIVAL PATHWAY | Granule Cell Survival Pathway is a specific case of more general PAC1 Receptor Pathway. |
0.3 | 3.1 | PID ALPHA SYNUCLEIN PATHWAY | Alpha-synuclein signaling |
0.2 | 2.9 | PID IL4 2PATHWAY | IL4-mediated signaling events |
0.2 | 0.5 | ST TUMOR NECROSIS FACTOR PATHWAY | Tumor Necrosis Factor Pathway. |
0.2 | 4.3 | PID MTOR 4PATHWAY | mTOR signaling pathway |
0.2 | 0.9 | PID IL2 1PATHWAY | IL2-mediated signaling events |
0.2 | 1.3 | PID PTP1B PATHWAY | Signaling events mediated by PTP1B |
0.2 | 0.6 | PID AVB3 INTEGRIN PATHWAY | Integrins in angiogenesis |
0.2 | 5.8 | NABA PROTEOGLYCANS | Genes encoding proteoglycans |
0.2 | 1.0 | PID IL1 PATHWAY | IL1-mediated signaling events |
0.1 | 3.9 | PID MYC ACTIV PATHWAY | Validated targets of C-MYC transcriptional activation |
0.1 | 0.4 | PID IL8 CXCR2 PATHWAY | IL8- and CXCR2-mediated signaling events |
0.1 | 0.5 | ST G ALPHA S PATHWAY | G alpha s Pathway |
0.1 | 0.8 | PID AURORA A PATHWAY | Aurora A signaling |
0.1 | 0.6 | PID WNT SIGNALING PATHWAY | Wnt signaling network |
0.1 | 1.1 | PID CXCR4 PATHWAY | CXCR4-mediated signaling events |
0.1 | 1.3 | PID BMP PATHWAY | BMP receptor signaling |
0.1 | 7.3 | NABA ECM GLYCOPROTEINS | Genes encoding structural ECM glycoproteins |
0.0 | 0.3 | PID DNA PK PATHWAY | DNA-PK pathway in nonhomologous end joining |
0.0 | 0.7 | PID E2F PATHWAY | E2F transcription factor network |
0.0 | 0.1 | ST P38 MAPK PATHWAY | p38 MAPK Pathway |
0.0 | 0.2 | PID IL23 PATHWAY | IL23-mediated signaling events |
Log-likelihood per target | Total log-likelihood | Term | Description |
---|---|---|---|
10.0 | 501.6 | REACTOME INTERFERON ALPHA BETA SIGNALING | Genes involved in Interferon alpha/beta signaling |
7.5 | 7.5 | REACTOME CYCLIN E ASSOCIATED EVENTS DURING G1 S TRANSITION | Genes involved in Cyclin E associated events during G1/S transition |
6.5 | 58.9 | REACTOME SIGNAL REGULATORY PROTEIN SIRP FAMILY INTERACTIONS | Genes involved in Signal regulatory protein (SIRP) family interactions |
6.3 | 69.4 | REACTOME EXTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Extrinsic Pathway for Apoptosis |
6.3 | 50.1 | REACTOME NFKB ACTIVATION THROUGH FADD RIP1 PATHWAY MEDIATED BY CASPASE 8 AND10 | Genes involved in NF-kB activation through FADD/RIP-1 pathway mediated by caspase-8 and -10 |
5.8 | 11.6 | REACTOME PHOSPHORYLATION OF CD3 AND TCR ZETA CHAINS | Genes involved in Phosphorylation of CD3 and TCR zeta chains |
5.2 | 10.3 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION IN TLR7 8 OR 9 SIGNALING | Genes involved in TRAF6 mediated IRF7 activation in TLR7/8 or 9 signaling |
4.7 | 4.7 | REACTOME PROSTACYCLIN SIGNALLING THROUGH PROSTACYCLIN RECEPTOR | Genes involved in Prostacyclin signalling through prostacyclin receptor |
4.4 | 26.6 | REACTOME IKK COMPLEX RECRUITMENT MEDIATED BY RIP1 | Genes involved in IKK complex recruitment mediated by RIP1 |
4.2 | 42.0 | REACTOME IL 7 SIGNALING | Genes involved in Interleukin-7 signaling |
3.9 | 39.4 | REACTOME SYNTHESIS OF PE | Genes involved in Synthesis of PE |
3.9 | 3.9 | REACTOME CONVERSION FROM APC C CDC20 TO APC C CDH1 IN LATE ANAPHASE | Genes involved in Conversion from APC/C:Cdc20 to APC/C:Cdh1 in late anaphase |
3.6 | 10.9 | REACTOME ENDOSOMAL VACUOLAR PATHWAY | Genes involved in Endosomal/Vacuolar pathway |
3.5 | 20.8 | REACTOME ETHANOL OXIDATION | Genes involved in Ethanol oxidation |
3.3 | 9.8 | REACTOME ACTIVATED TAK1 MEDIATES P38 MAPK ACTIVATION | Genes involved in activated TAK1 mediates p38 MAPK activation |
3.1 | 15.3 | REACTOME IL 6 SIGNALING | Genes involved in Interleukin-6 signaling |
3.0 | 41.8 | REACTOME METABOLISM OF PORPHYRINS | Genes involved in Metabolism of porphyrins |
3.0 | 35.4 | REACTOME GRB2 SOS PROVIDES LINKAGE TO MAPK SIGNALING FOR INTERGRINS | Genes involved in GRB2:SOS provides linkage to MAPK signaling for Intergrins |
2.8 | 19.5 | REACTOME PECAM1 INTERACTIONS | Genes involved in PECAM1 interactions |
2.8 | 25.0 | REACTOME TRAFFICKING AND PROCESSING OF ENDOSOMAL TLR | Genes involved in Trafficking and processing of endosomal TLR |
2.8 | 60.6 | REACTOME INTERFERON GAMMA SIGNALING | Genes involved in Interferon gamma signaling |
2.7 | 2.7 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS | Genes involved in Synthesis of bile acids and bile salts |
2.7 | 31.9 | REACTOME PURINE SALVAGE | Genes involved in Purine salvage |
2.6 | 47.4 | REACTOME ACTIVATED AMPK STIMULATES FATTY ACID OXIDATION IN MUSCLE | Genes involved in Activated AMPK stimulates fatty-acid oxidation in muscle |
2.6 | 64.8 | REACTOME NOD1 2 SIGNALING PATHWAY | Genes involved in NOD1/2 Signaling Pathway |
2.4 | 21.4 | REACTOME TRYPTOPHAN CATABOLISM | Genes involved in Tryptophan catabolism |
2.4 | 4.7 | REACTOME RNA POL I PROMOTER OPENING | Genes involved in RNA Polymerase I Promoter Opening |
2.4 | 21.2 | REACTOME PYRIMIDINE CATABOLISM | Genes involved in Pyrimidine catabolism |
2.3 | 16.3 | REACTOME TIE2 SIGNALING | Genes involved in Tie2 Signaling |
2.3 | 62.6 | REACTOME SYNTHESIS OF PIPS AT THE PLASMA MEMBRANE | Genes involved in Synthesis of PIPs at the plasma membrane |
2.3 | 6.9 | REACTOME THE ROLE OF NEF IN HIV1 REPLICATION AND DISEASE PATHOGENESIS | Genes involved in The role of Nef in HIV-1 replication and disease pathogenesis |
2.3 | 9.2 | REACTOME ER PHAGOSOME PATHWAY | Genes involved in ER-Phagosome pathway |
2.3 | 16.0 | REACTOME YAP1 AND WWTR1 TAZ STIMULATED GENE EXPRESSION | Genes involved in YAP1- and WWTR1 (TAZ)-stimulated gene expression |
2.3 | 22.8 | REACTOME SIGNALING BY FGFR1 FUSION MUTANTS | Genes involved in Signaling by FGFR1 fusion mutants |
2.2 | 20.2 | REACTOME PD1 SIGNALING | Genes involved in PD-1 signaling |
2.2 | 28.7 | REACTOME MITOCHONDRIAL FATTY ACID BETA OXIDATION | Genes involved in Mitochondrial Fatty Acid Beta-Oxidation |
2.2 | 21.9 | REACTOME INTEGRIN ALPHAIIB BETA3 SIGNALING | Genes involved in Integrin alphaIIb beta3 signaling |
2.2 | 26.0 | REACTOME CELL EXTRACELLULAR MATRIX INTERACTIONS | Genes involved in Cell-extracellular matrix interactions |
2.2 | 67.0 | REACTOME IMMUNOREGULATORY INTERACTIONS BETWEEN A LYMPHOID AND A NON LYMPHOID CELL | Genes involved in Immunoregulatory interactions between a Lymphoid and a non-Lymphoid cell |
2.2 | 19.4 | REACTOME PLATELET SENSITIZATION BY LDL | Genes involved in Platelet sensitization by LDL |
2.1 | 18.7 | REACTOME PURINE CATABOLISM | Genes involved in Purine catabolism |
2.1 | 10.3 | REACTOME NFKB IS ACTIVATED AND SIGNALS SURVIVAL | Genes involved in NF-kB is activated and signals survival |
2.1 | 53.8 | REACTOME G1 PHASE | Genes involved in G1 Phase |
2.1 | 6.2 | REACTOME SYNTHESIS SECRETION AND INACTIVATION OF GLP1 | Genes involved in Synthesis, Secretion, and Inactivation of Glucagon-like Peptide-1 (GLP-1) |
2.0 | 38.4 | REACTOME CGMP EFFECTS | Genes involved in cGMP effects |
2.0 | 25.8 | REACTOME SYNTHESIS OF VERY LONG CHAIN FATTY ACYL COAS | Genes involved in Synthesis of very long-chain fatty acyl-CoAs |
2.0 | 43.2 | REACTOME SMOOTH MUSCLE CONTRACTION | Genes involved in Smooth Muscle Contraction |
1.9 | 15.3 | REACTOME PLATELET ADHESION TO EXPOSED COLLAGEN | Genes involved in Platelet Adhesion to exposed collagen |
1.9 | 47.6 | REACTOME SMAD2 SMAD3 SMAD4 HETEROTRIMER REGULATES TRANSCRIPTION | Genes involved in SMAD2/SMAD3:SMAD4 heterotrimer regulates transcription |
1.9 | 20.8 | REACTOME NOTCH HLH TRANSCRIPTION PATHWAY | Genes involved in Notch-HLH transcription pathway |
1.9 | 16.9 | REACTOME REGULATION OF COMPLEMENT CASCADE | Genes involved in Regulation of Complement cascade |
1.9 | 22.3 | REACTOME INTRINSIC PATHWAY | Genes involved in Intrinsic Pathway |
1.8 | 16.6 | REACTOME MTORC1 MEDIATED SIGNALLING | Genes involved in mTORC1-mediated signalling |
1.8 | 14.7 | REACTOME SIGNALING BY CONSTITUTIVELY ACTIVE EGFR | Genes involved in Signaling by constitutively active EGFR |
1.8 | 41.9 | REACTOME COSTIMULATION BY THE CD28 FAMILY | Genes involved in Costimulation by the CD28 family |
1.8 | 152.7 | REACTOME FACTORS INVOLVED IN MEGAKARYOCYTE DEVELOPMENT AND PLATELET PRODUCTION | Genes involved in Factors involved in megakaryocyte development and platelet production |
1.8 | 48.7 | REACTOME SPHINGOLIPID DE NOVO BIOSYNTHESIS | Genes involved in Sphingolipid de novo biosynthesis |
1.8 | 1.8 | REACTOME REGULATION OF RHEB GTPASE ACTIVITY BY AMPK | Genes involved in Regulation of Rheb GTPase activity by AMPK |
1.8 | 10.8 | REACTOME RAP1 SIGNALLING | Genes involved in Rap1 signalling |
1.8 | 7.1 | REACTOME TRAF6 MEDIATED IRF7 ACTIVATION | Genes involved in TRAF6 mediated IRF7 activation |
1.8 | 40.5 | REACTOME MUSCLE CONTRACTION | Genes involved in Muscle contraction |
1.7 | 13.8 | REACTOME N GLYCAN ANTENNAE ELONGATION | Genes involved in N-Glycan antennae elongation |
1.7 | 20.2 | REACTOME TGF BETA RECEPTOR SIGNALING IN EMT EPITHELIAL TO MESENCHYMAL TRANSITION | Genes involved in TGF-beta receptor signaling in EMT (epithelial to mesenchymal transition) |
1.7 | 164.2 | REACTOME SIGNALING BY RHO GTPASES | Genes involved in Signaling by Rho GTPases |
1.6 | 24.4 | REACTOME AMINE DERIVED HORMONES | Genes involved in Amine-derived hormones |
1.6 | 22.4 | REACTOME ANTIGEN ACTIVATES B CELL RECEPTOR LEADING TO GENERATION OF SECOND MESSENGERS | Genes involved in Antigen Activates B Cell Receptor Leading to Generation of Second Messengers |
1.6 | 17.6 | REACTOME P2Y RECEPTORS | Genes involved in P2Y receptors |
1.5 | 17.0 | REACTOME CALNEXIN CALRETICULIN CYCLE | Genes involved in Calnexin/calreticulin cycle |
1.5 | 15.5 | REACTOME CASPASE MEDIATED CLEAVAGE OF CYTOSKELETAL PROTEINS | Genes involved in Caspase-mediated cleavage of cytoskeletal proteins |
1.5 | 43.2 | REACTOME NUCLEAR SIGNALING BY ERBB4 | Genes involved in Nuclear signaling by ERBB4 |
1.5 | 1.5 | REACTOME RORA ACTIVATES CIRCADIAN EXPRESSION | Genes involved in RORA Activates Circadian Expression |
1.5 | 31.9 | REACTOME RIG I MDA5 MEDIATED INDUCTION OF IFN ALPHA BETA PATHWAYS | Genes involved in RIG-I/MDA5 mediated induction of IFN-alpha/beta pathways |
1.5 | 35.9 | REACTOME KERATAN SULFATE BIOSYNTHESIS | Genes involved in Keratan sulfate biosynthesis |
1.5 | 20.9 | REACTOME ERK MAPK TARGETS | Genes involved in ERK/MAPK targets |
1.5 | 16.3 | REACTOME FACILITATIVE NA INDEPENDENT GLUCOSE TRANSPORTERS | Genes involved in Facilitative Na+-independent glucose transporters |
1.5 | 7.3 | REACTOME PRE NOTCH TRANSCRIPTION AND TRANSLATION | Genes involved in Pre-NOTCH Transcription and Translation |
1.4 | 18.7 | REACTOME ENOS ACTIVATION AND REGULATION | Genes involved in eNOS activation and regulation |
1.4 | 12.9 | REACTOME FORMATION OF FIBRIN CLOT CLOTTING CASCADE | Genes involved in Formation of Fibrin Clot (Clotting Cascade) |
1.4 | 40.6 | REACTOME BMAL1 CLOCK NPAS2 ACTIVATES CIRCADIAN EXPRESSION | Genes involved in BMAL1:CLOCK/NPAS2 Activates Circadian Expression |
1.4 | 20.6 | REACTOME AMYLOIDS | Genes involved in Amyloids |
1.4 | 5.5 | REACTOME INHIBITION OF REPLICATION INITIATION OF DAMAGED DNA BY RB1 E2F1 | Genes involved in Inhibition of replication initiation of damaged DNA by RB1/E2F1 |
1.3 | 4.0 | REACTOME LYSOSOME VESICLE BIOGENESIS | Genes involved in Lysosome Vesicle Biogenesis |
1.3 | 13.1 | REACTOME PASSIVE TRANSPORT BY AQUAPORINS | Genes involved in Passive Transport by Aquaporins |
1.3 | 82.4 | REACTOME PPARA ACTIVATES GENE EXPRESSION | Genes involved in PPARA Activates Gene Expression |
1.3 | 30.1 | REACTOME TRANSFERRIN ENDOCYTOSIS AND RECYCLING | Genes involved in Transferrin endocytosis and recycling |
1.3 | 10.3 | REACTOME DARPP 32 EVENTS | Genes involved in DARPP-32 events |
1.3 | 2.6 | REACTOME SHC1 EVENTS IN EGFR SIGNALING | Genes involved in SHC1 events in EGFR signaling |
1.3 | 15.1 | REACTOME PLATELET CALCIUM HOMEOSTASIS | Genes involved in Platelet calcium homeostasis |
1.3 | 13.8 | REACTOME CYCLIN A B1 ASSOCIATED EVENTS DURING G2 M TRANSITION | Genes involved in Cyclin A/B1 associated events during G2/M transition |
1.2 | 6.1 | REACTOME GLYCOPROTEIN HORMONES | Genes involved in Glycoprotein hormones |
1.2 | 34.3 | REACTOME MEIOTIC SYNAPSIS | Genes involved in Meiotic Synapsis |
1.2 | 6.1 | REACTOME SIGNAL ATTENUATION | Genes involved in Signal attenuation |
1.2 | 3.7 | REACTOME REGULATION OF KIT SIGNALING | Genes involved in Regulation of KIT signaling |
1.2 | 15.8 | REACTOME REGULATION OF INSULIN LIKE GROWTH FACTOR IGF ACTIVITY BY INSULIN LIKE GROWTH FACTOR BINDING PROTEINS IGFBPS | Genes involved in Regulation of Insulin-like Growth Factor (IGF) Activity by Insulin-like Growth Factor Binding Proteins (IGFBPs) |
1.2 | 5.9 | REACTOME G ALPHA1213 SIGNALLING EVENTS | Genes involved in G alpha (12/13) signalling events |
1.2 | 9.5 | REACTOME GAP JUNCTION DEGRADATION | Genes involved in Gap junction degradation |
1.2 | 35.0 | REACTOME AMINO ACID TRANSPORT ACROSS THE PLASMA MEMBRANE | Genes involved in Amino acid transport across the plasma membrane |
1.2 | 13.9 | REACTOME NUCLEOTIDE BINDING DOMAIN LEUCINE RICH REPEAT CONTAINING RECEPTOR NLR SIGNALING PATHWAYS | Genes involved in Nucleotide-binding domain, leucine rich repeat containing receptor (NLR) signaling pathways |
1.1 | 5.7 | REACTOME BETA DEFENSINS | Genes involved in Beta defensins |
1.1 | 15.7 | REACTOME SEMA4D IN SEMAPHORIN SIGNALING | Genes involved in Sema4D in semaphorin signaling |
1.1 | 4.5 | REACTOME GROWTH HORMONE RECEPTOR SIGNALING | Genes involved in Growth hormone receptor signaling |
1.1 | 4.5 | REACTOME PLATELET AGGREGATION PLUG FORMATION | Genes involved in Platelet Aggregation (Plug Formation) |
1.1 | 25.6 | REACTOME SULFUR AMINO ACID METABOLISM | Genes involved in Sulfur amino acid metabolism |
1.1 | 11.0 | REACTOME G1 S SPECIFIC TRANSCRIPTION | Genes involved in G1/S-Specific Transcription |
1.1 | 5.4 | REACTOME PROLONGED ERK ACTIVATION EVENTS | Genes involved in Prolonged ERK activation events |
1.1 | 23.8 | REACTOME THROMBOXANE SIGNALLING THROUGH TP RECEPTOR | Genes involved in Thromboxane signalling through TP receptor |
1.1 | 7.5 | REACTOME SIGNALING BY SCF KIT | Genes involved in Signaling by SCF-KIT |
1.1 | 34.1 | REACTOME GOLGI ASSOCIATED VESICLE BIOGENESIS | Genes involved in Golgi Associated Vesicle Biogenesis |
1.1 | 11.7 | REACTOME EICOSANOID LIGAND BINDING RECEPTORS | Genes involved in Eicosanoid ligand-binding receptors |
1.1 | 1.1 | REACTOME NRIF SIGNALS CELL DEATH FROM THE NUCLEUS | Genes involved in NRIF signals cell death from the nucleus |
1.0 | 22.0 | REACTOME MEIOSIS | Genes involved in Meiosis |
1.0 | 11.4 | REACTOME REGULATION OF INSULIN SECRETION BY GLUCAGON LIKE PEPTIDE1 | Genes involved in Regulation of Insulin Secretion by Glucagon-like Peptide-1 |
1.0 | 8.1 | REACTOME OXYGEN DEPENDENT PROLINE HYDROXYLATION OF HYPOXIA INDUCIBLE FACTOR ALPHA | Genes involved in Oxygen-dependent Proline Hydroxylation of Hypoxia-inducible Factor Alpha |
1.0 | 10.1 | REACTOME SYNTHESIS SECRETION AND DEACYLATION OF GHRELIN | Genes involved in Synthesis, Secretion, and Deacylation of Ghrelin |
1.0 | 11.9 | REACTOME OTHER SEMAPHORIN INTERACTIONS | Genes involved in Other semaphorin interactions |
1.0 | 10.8 | REACTOME ANTIGEN PRESENTATION FOLDING ASSEMBLY AND PEPTIDE LOADING OF CLASS I MHC | Genes involved in Antigen Presentation: Folding, assembly and peptide loading of class I MHC |
1.0 | 12.5 | REACTOME TERMINATION OF O GLYCAN BIOSYNTHESIS | Genes involved in Termination of O-glycan biosynthesis |
0.9 | 14.2 | REACTOME ZINC TRANSPORTERS | Genes involved in Zinc transporters |
0.9 | 8.4 | REACTOME ACTIVATION OF BH3 ONLY PROTEINS | Genes involved in Activation of BH3-only proteins |
0.9 | 53.9 | REACTOME MITOTIC PROMETAPHASE | Genes involved in Mitotic Prometaphase |
0.9 | 1.8 | REACTOME DESTABILIZATION OF MRNA BY TRISTETRAPROLIN TTP | Genes involved in Destabilization of mRNA by Tristetraprolin (TTP) |
0.9 | 32.9 | REACTOME MHC CLASS II ANTIGEN PRESENTATION | Genes involved in MHC class II antigen presentation |
0.9 | 7.2 | REACTOME APOPTOTIC CLEAVAGE OF CELL ADHESION PROTEINS | Genes involved in Apoptotic cleavage of cell adhesion proteins |
0.9 | 15.8 | REACTOME PEROXISOMAL LIPID METABOLISM | Genes involved in Peroxisomal lipid metabolism |
0.9 | 7.0 | REACTOME THE ACTIVATION OF ARYLSULFATASES | Genes involved in The activation of arylsulfatases |
0.9 | 14.9 | REACTOME LIPOPROTEIN METABOLISM | Genes involved in Lipoprotein metabolism |
0.9 | 16.5 | REACTOME GLUTATHIONE CONJUGATION | Genes involved in Glutathione conjugation |
0.9 | 6.9 | REACTOME LATENT INFECTION OF HOMO SAPIENS WITH MYCOBACTERIUM TUBERCULOSIS | Genes involved in Latent infection of Homo sapiens with Mycobacterium tuberculosis |
0.9 | 6.0 | REACTOME HORMONE LIGAND BINDING RECEPTORS | Genes involved in Hormone ligand-binding receptors |
0.9 | 9.4 | REACTOME ANTIVIRAL MECHANISM BY IFN STIMULATED GENES | Genes involved in Antiviral mechanism by IFN-stimulated genes |
0.9 | 6.9 | REACTOME ROLE OF DCC IN REGULATING APOPTOSIS | Genes involved in Role of DCC in regulating apoptosis |
0.8 | 1.7 | REACTOME INFLUENZA VIRAL RNA TRANSCRIPTION AND REPLICATION | Genes involved in Influenza Viral RNA Transcription and Replication |
0.8 | 7.6 | REACTOME PYRIMIDINE METABOLISM | Genes involved in Pyrimidine metabolism |
0.8 | 11.7 | REACTOME IL1 SIGNALING | Genes involved in Interleukin-1 signaling |
0.8 | 5.7 | REACTOME GLUCAGON SIGNALING IN METABOLIC REGULATION | Genes involved in Glucagon signaling in metabolic regulation |
0.8 | 11.4 | REACTOME ABCA TRANSPORTERS IN LIPID HOMEOSTASIS | Genes involved in ABCA transporters in lipid homeostasis |
0.8 | 19.4 | REACTOME O LINKED GLYCOSYLATION OF MUCINS | Genes involved in O-linked glycosylation of mucins |
0.8 | 0.8 | REACTOME MRNA DECAY BY 3 TO 5 EXORIBONUCLEASE | Genes involved in mRNA Decay by 3' to 5' Exoribonuclease |
0.8 | 33.4 | REACTOME METABOLISM OF VITAMINS AND COFACTORS | Genes involved in Metabolism of vitamins and cofactors |
0.8 | 18.2 | REACTOME SYNTHESIS OF PA | Genes involved in Synthesis of PA |
0.8 | 9.1 | REACTOME ORGANIC CATION ANION ZWITTERION TRANSPORT | Genes involved in Organic cation/anion/zwitterion transport |
0.8 | 1.5 | REACTOME MRNA CAPPING | Genes involved in mRNA Capping |
0.8 | 16.5 | REACTOME DOWNSTREAM SIGNAL TRANSDUCTION | Genes involved in Downstream signal transduction |
0.7 | 2.2 | REACTOME ACTIVATION OF GENES BY ATF4 | Genes involved in Activation of Genes by ATF4 |
0.7 | 17.0 | REACTOME STEROID HORMONES | Genes involved in Steroid hormones |
0.7 | 8.1 | REACTOME BILE SALT AND ORGANIC ANION SLC TRANSPORTERS | Genes involved in Bile salt and organic anion SLC transporters |
0.7 | 5.8 | REACTOME G0 AND EARLY G1 | Genes involved in G0 and Early G1 |
0.7 | 2.2 | REACTOME DCC MEDIATED ATTRACTIVE SIGNALING | Genes involved in DCC mediated attractive signaling |
0.7 | 4.3 | REACTOME METAL ION SLC TRANSPORTERS | Genes involved in Metal ion SLC transporters |
0.7 | 10.7 | REACTOME DIABETES PATHWAYS | Genes involved in Diabetes pathways |
0.7 | 17.0 | REACTOME GLUCONEOGENESIS | Genes involved in Gluconeogenesis |
0.7 | 13.2 | REACTOME NEP NS2 INTERACTS WITH THE CELLULAR EXPORT MACHINERY | Genes involved in NEP/NS2 Interacts with the Cellular Export Machinery |
0.7 | 6.2 | REACTOME VEGF LIGAND RECEPTOR INTERACTIONS | Genes involved in VEGF ligand-receptor interactions |
0.7 | 9.5 | REACTOME COMPLEMENT CASCADE | Genes involved in Complement cascade |
0.7 | 12.8 | REACTOME AMINE COMPOUND SLC TRANSPORTERS | Genes involved in Amine compound SLC transporters |
0.7 | 4.7 | REACTOME SYNTHESIS OF PIPS AT THE EARLY ENDOSOME MEMBRANE | Genes involved in Synthesis of PIPs at the early endosome membrane |
0.7 | 7.3 | REACTOME GLYCOGEN BREAKDOWN GLYCOGENOLYSIS | Genes involved in Glycogen breakdown (glycogenolysis) |
0.7 | 4.6 | REACTOME RECYCLING PATHWAY OF L1 | Genes involved in Recycling pathway of L1 |
0.7 | 8.5 | REACTOME AMINO ACID SYNTHESIS AND INTERCONVERSION TRANSAMINATION | Genes involved in Amino acid synthesis and interconversion (transamination) |
0.7 | 26.1 | REACTOME CHEMOKINE RECEPTORS BIND CHEMOKINES | Genes involved in Chemokine receptors bind chemokines |
0.6 | 5.8 | REACTOME GLUCOSE TRANSPORT | Genes involved in Glucose transport |
0.6 | 9.6 | REACTOME SYNTHESIS AND INTERCONVERSION OF NUCLEOTIDE DI AND TRIPHOSPHATES | Genes involved in Synthesis and interconversion of nucleotide di- and triphosphates |
0.6 | 2.5 | REACTOME THROMBIN SIGNALLING THROUGH PROTEINASE ACTIVATED RECEPTORS PARS | Genes involved in Thrombin signalling through proteinase activated receptors (PARs) |
0.6 | 1.8 | REACTOME P38MAPK EVENTS | Genes involved in p38MAPK events |
0.6 | 1.8 | REACTOME UNWINDING OF DNA | Genes involved in Unwinding of DNA |
0.6 | 7.1 | REACTOME PROTEOLYTIC CLEAVAGE OF SNARE COMPLEX PROTEINS | Genes involved in Proteolytic cleavage of SNARE complex proteins |
0.6 | 3.5 | REACTOME TRANSPORT TO THE GOLGI AND SUBSEQUENT MODIFICATION | Genes involved in Transport to the Golgi and subsequent modification |
0.6 | 12.3 | REACTOME METABOLISM OF NON CODING RNA | Genes involved in Metabolism of non-coding RNA |
0.6 | 16.4 | REACTOME ION TRANSPORT BY P TYPE ATPASES | Genes involved in Ion transport by P-type ATPases |
0.6 | 3.5 | REACTOME APOPTOSIS INDUCED DNA FRAGMENTATION | Genes involved in Apoptosis induced DNA fragmentation |
0.6 | 4.6 | REACTOME INTRINSIC PATHWAY FOR APOPTOSIS | Genes involved in Intrinsic Pathway for Apoptosis |
0.6 | 7.9 | REACTOME DEADENYLATION OF MRNA | Genes involved in Deadenylation of mRNA |
0.6 | 9.6 | REACTOME SIGNALING BY BMP | Genes involved in Signaling by BMP |
0.6 | 13.8 | REACTOME TIGHT JUNCTION INTERACTIONS | Genes involved in Tight junction interactions |
0.5 | 1.6 | REACTOME ACYL CHAIN REMODELLING OF PS | Genes involved in Acyl chain remodelling of PS |
0.5 | 4.3 | REACTOME METABOLISM OF POLYAMINES | Genes involved in Metabolism of polyamines |
0.5 | 11.5 | REACTOME GLYCOSPHINGOLIPID METABOLISM | Genes involved in Glycosphingolipid metabolism |
0.5 | 8.3 | REACTOME SYNTHESIS OF GLYCOSYLPHOSPHATIDYLINOSITOL GPI | Genes involved in Synthesis of glycosylphosphatidylinositol (GPI) |
0.5 | 2.1 | REACTOME ACTIVATION OF CHAPERONE GENES BY ATF6 ALPHA | Genes involved in Activation of Chaperone Genes by ATF6-alpha |
0.5 | 1.0 | REACTOME PEPTIDE CHAIN ELONGATION | Genes involved in Peptide chain elongation |
0.5 | 4.0 | REACTOME OPSINS | Genes involved in Opsins |
0.5 | 6.3 | REACTOME ABC FAMILY PROTEINS MEDIATED TRANSPORT | Genes involved in ABC-family proteins mediated transport |
0.5 | 6.7 | REACTOME DESTABILIZATION OF MRNA BY BRF1 | Genes involved in Destabilization of mRNA by Butyrate Response Factor 1 (BRF1) |
0.5 | 5.2 | REACTOME REGULATION OF PYRUVATE DEHYDROGENASE PDH COMPLEX | Genes involved in Regulation of pyruvate dehydrogenase (PDH) complex |
0.5 | 0.5 | REACTOME APC CDC20 MEDIATED DEGRADATION OF NEK2A | Genes involved in APC-Cdc20 mediated degradation of Nek2A |
0.5 | 8.4 | REACTOME INTERACTION BETWEEN L1 AND ANKYRINS | Genes involved in Interaction between L1 and Ankyrins |
0.5 | 3.3 | REACTOME SYNTHESIS OF BILE ACIDS AND BILE SALTS VIA 7ALPHA HYDROXYCHOLESTEROL | Genes involved in Synthesis of bile acids and bile salts via 7alpha-hydroxycholesterol |
0.5 | 11.4 | REACTOME ASSOCIATION OF TRIC CCT WITH TARGET PROTEINS DURING BIOSYNTHESIS | Genes involved in Association of TriC/CCT with target proteins during biosynthesis |
0.5 | 8.6 | REACTOME CELL SURFACE INTERACTIONS AT THE VASCULAR WALL | Genes involved in Cell surface interactions at the vascular wall |
0.5 | 13.1 | REACTOME RESPONSE TO ELEVATED PLATELET CYTOSOLIC CA2 | Genes involved in Response to elevated platelet cytosolic Ca2+ |
0.4 | 21.7 | REACTOME DOWNSTREAM SIGNALING EVENTS OF B CELL RECEPTOR BCR | Genes involved in Downstream Signaling Events Of B Cell Receptor (BCR) |
0.4 | 2.6 | REACTOME GLUCURONIDATION | Genes involved in Glucuronidation |
0.4 | 3.1 | REACTOME GLYCOLYSIS | Genes involved in Glycolysis |
0.4 | 6.1 | REACTOME SIGNALING BY HIPPO | Genes involved in Signaling by Hippo |
0.4 | 1.7 | REACTOME N GLYCAN ANTENNAE ELONGATION IN THE MEDIAL TRANS GOLGI | Genes involved in N-glycan antennae elongation in the medial/trans-Golgi |
0.4 | 1.3 | REACTOME ACYL CHAIN REMODELLING OF PI | Genes involved in Acyl chain remodelling of PI |
0.4 | 14.4 | REACTOME UNFOLDED PROTEIN RESPONSE | Genes involved in Unfolded Protein Response |
0.4 | 0.4 | REACTOME ABORTIVE ELONGATION OF HIV1 TRANSCRIPT IN THE ABSENCE OF TAT | Genes involved in Abortive elongation of HIV-1 transcript in the absence of Tat |
0.4 | 5.0 | REACTOME PROCESSING OF INTRONLESS PRE MRNAS | Genes involved in Processing of Intronless Pre-mRNAs |
0.4 | 0.4 | REACTOME PI3K EVENTS IN ERBB2 SIGNALING | Genes involved in PI3K events in ERBB2 signaling |
0.4 | 6.3 | REACTOME PHASE II CONJUGATION | Genes involved in Phase II conjugation |
0.4 | 48.9 | REACTOME ANTIGEN PROCESSING UBIQUITINATION PROTEASOME DEGRADATION | Genes involved in Antigen processing: Ubiquitination & Proteasome degradation |
0.4 | 4.3 | REACTOME SIGNALING BY ACTIVATED POINT MUTANTS OF FGFR1 | Genes involved in Signaling by activated point mutants of FGFR1 |
0.4 | 2.3 | REACTOME E2F ENABLED INHIBITION OF PRE REPLICATION COMPLEX FORMATION | Genes involved in E2F-enabled inhibition of pre-replication complex formation |
0.4 | 6.6 | REACTOME BRANCHED CHAIN AMINO ACID CATABOLISM | Genes involved in Branched-chain amino acid catabolism |
0.4 | 1.2 | REACTOME ADP SIGNALLING THROUGH P2RY12 | Genes involved in ADP signalling through P2Y purinoceptor 12 |
0.4 | 1.6 | REACTOME DIGESTION OF DIETARY CARBOHYDRATE | Genes involved in Digestion of dietary carbohydrate |
0.4 | 3.5 | REACTOME SRP DEPENDENT COTRANSLATIONAL PROTEIN TARGETING TO MEMBRANE | Genes involved in SRP-dependent cotranslational protein targeting to membrane |
0.4 | 2.6 | REACTOME HYALURONAN UPTAKE AND DEGRADATION | Genes involved in Hyaluronan uptake and degradation |
0.4 | 3.9 | REACTOME DEADENYLATION DEPENDENT MRNA DECAY | Genes involved in Deadenylation-dependent mRNA decay |
0.4 | 5.3 | REACTOME GAP JUNCTION TRAFFICKING | Genes involved in Gap junction trafficking |
0.3 | 7.3 | REACTOME PYRUVATE METABOLISM AND CITRIC ACID TCA CYCLE | Genes involved in Pyruvate metabolism and Citric Acid (TCA) cycle |
0.3 | 3.1 | REACTOME PRE NOTCH EXPRESSION AND PROCESSING | Genes involved in Pre-NOTCH Expression and Processing |
0.3 | 24.2 | REACTOME RESPIRATORY ELECTRON TRANSPORT ATP SYNTHESIS BY CHEMIOSMOTIC COUPLING AND HEAT PRODUCTION BY UNCOUPLING PROTEINS | Genes involved in Respiratory electron transport, ATP synthesis by chemiosmotic coupling, and heat production by uncoupling proteins. |
0.3 | 1.7 | REACTOME CTNNB1 PHOSPHORYLATION CASCADE | Genes involved in Beta-catenin phosphorylation cascade |
0.3 | 0.3 | REACTOME P53 INDEPENDENT G1 S DNA DAMAGE CHECKPOINT | Genes involved in p53-Independent G1/S DNA damage checkpoint |
0.3 | 32.3 | REACTOME G ALPHA Q SIGNALLING EVENTS | Genes involved in G alpha (q) signalling events |
0.3 | 3.1 | REACTOME PI 3K CASCADE | Genes involved in PI-3K cascade |
0.3 | 5.3 | REACTOME CELL CYCLE CHECKPOINTS | Genes involved in Cell Cycle Checkpoints |
0.3 | 0.8 | REACTOME HYALURONAN METABOLISM | Genes involved in Hyaluronan metabolism |
0.3 | 8.1 | REACTOME LOSS OF NLP FROM MITOTIC CENTROSOMES | Genes involved in Loss of Nlp from mitotic centrosomes |
0.2 | 0.5 | REACTOME PLATELET ACTIVATION SIGNALING AND AGGREGATION | Genes involved in Platelet activation, signaling and aggregation |
0.2 | 11.0 | REACTOME METABOLISM OF AMINO ACIDS AND DERIVATIVES | Genes involved in Metabolism of amino acids and derivatives |
0.2 | 0.9 | REACTOME INTEGRATION OF PROVIRUS | Genes involved in Integration of provirus |
0.2 | 0.9 | REACTOME AQUAPORIN MEDIATED TRANSPORT | Genes involved in Aquaporin-mediated transport |
0.2 | 7.3 | REACTOME ASPARAGINE N LINKED GLYCOSYLATION | Genes involved in Asparagine N-linked glycosylation |
0.2 | 0.9 | REACTOME NUCLEOTIDE LIKE PURINERGIC RECEPTORS | Genes involved in Nucleotide-like (purinergic) receptors |
0.2 | 0.2 | REACTOME CDT1 ASSOCIATION WITH THE CDC6 ORC ORIGIN COMPLEX | Genes involved in CDT1 association with the CDC6:ORC:origin complex |
0.2 | 0.2 | REACTOME GASTRIN CREB SIGNALLING PATHWAY VIA PKC AND MAPK | Genes involved in Gastrin-CREB signalling pathway via PKC and MAPK |
0.2 | 1.0 | REACTOME HORMONE SENSITIVE LIPASE HSL MEDIATED TRIACYLGLYCEROL HYDROLYSIS | Genes involved in Hormone-sensitive lipase (HSL)-mediated triacylglycerol hydrolysis |
0.2 | 5.2 | REACTOME GLYCEROPHOSPHOLIPID BIOSYNTHESIS | Genes involved in Glycerophospholipid biosynthesis |
0.2 | 6.9 | REACTOME MITOCHONDRIAL PROTEIN IMPORT | Genes involved in Mitochondrial Protein Import |
0.2 | 0.2 | REACTOME REGULATION OF INSULIN SECRETION BY ACETYLCHOLINE | Genes involved in Regulation of Insulin Secretion by Acetylcholine |
0.2 | 1.6 | REACTOME DEPOSITION OF NEW CENPA CONTAINING NUCLEOSOMES AT THE CENTROMERE | Genes involved in Deposition of New CENPA-containing Nucleosomes at the Centromere |
0.2 | 3.3 | REACTOME MITOCHONDRIAL TRNA AMINOACYLATION | Genes involved in Mitochondrial tRNA aminoacylation |
0.2 | 1.1 | REACTOME PTM GAMMA CARBOXYLATION HYPUSINE FORMATION AND ARYLSULFATASE ACTIVATION | Genes involved in PTM: gamma carboxylation, hypusine formation and arylsulfatase activation |
0.2 | 3.2 | REACTOME PHASE1 FUNCTIONALIZATION OF COMPOUNDS | Genes involved in Phase 1 - Functionalization of compounds |
0.1 | 0.1 | REACTOME MEMBRANE BINDING AND TARGETTING OF GAG PROTEINS | Genes involved in Membrane binding and targetting of GAG proteins |
0.1 | 6.6 | REACTOME COLLAGEN FORMATION | Genes involved in Collagen formation |
0.1 | 0.5 | REACTOME INTERACTIONS OF VPR WITH HOST CELLULAR PROTEINS | Genes involved in Interactions of Vpr with host cellular proteins |
0.1 | 0.1 | REACTOME NUCLEAR EVENTS KINASE AND TRANSCRIPTION FACTOR ACTIVATION | Genes involved in Nuclear Events (kinase and transcription factor activation) |
0.1 | 0.1 | REACTOME FRS2 MEDIATED CASCADE | Genes involved in FRS2-mediated cascade |
0.1 | 2.8 | REACTOME RNA POL III TRANSCRIPTION INITIATION FROM TYPE 2 PROMOTER | Genes involved in RNA Polymerase III Transcription Initiation From Type 2 Promoter |
0.1 | 1.8 | REACTOME MRNA SPLICING MINOR PATHWAY | Genes involved in mRNA Splicing - Minor Pathway |
0.1 | 1.2 | REACTOME RNA POL I TRANSCRIPTION TERMINATION | Genes involved in RNA Polymerase I Transcription Termination |
0.1 | 0.3 | REACTOME PROCESSING OF CAPPED INTRONLESS PRE MRNA | Genes involved in Processing of Capped Intronless Pre-mRNA |
0.1 | 0.2 | REACTOME NEGATIVE REGULATION OF FGFR SIGNALING | Genes involved in Negative regulation of FGFR signaling |
0.1 | 0.1 | REACTOME INFLUENZA LIFE CYCLE | Genes involved in Influenza Life Cycle |
0.1 | 6.8 | REACTOME NONSENSE MEDIATED DECAY ENHANCED BY THE EXON JUNCTION COMPLEX | Genes involved in Nonsense Mediated Decay Enhanced by the Exon Junction Complex |
0.1 | 1.7 | REACTOME RNA POL II TRANSCRIPTION PRE INITIATION AND PROMOTER OPENING | Genes involved in RNA Polymerase II Transcription Pre-Initiation And Promoter Opening |
0.1 | 0.6 | REACTOME FORMATION OF INCISION COMPLEX IN GG NER | Genes involved in Formation of incision complex in GG-NER |
0.1 | 0.8 | REACTOME METABOLISM OF NUCLEOTIDES | Genes involved in Metabolism of nucleotides |
0.1 | 1.0 | REACTOME HS GAG DEGRADATION | Genes involved in HS-GAG degradation |
0.1 | 0.1 | REACTOME ADVANCED GLYCOSYLATION ENDPRODUCT RECEPTOR SIGNALING | Genes involved in Advanced glycosylation endproduct receptor signaling |
0.1 | 0.6 | REACTOME EXTENSION OF TELOMERES | Genes involved in Extension of Telomeres |
0.1 | 0.2 | REACTOME LIPID DIGESTION MOBILIZATION AND TRANSPORT | Genes involved in Lipid digestion, mobilization, and transport |
0.1 | 0.8 | REACTOME INWARDLY RECTIFYING K CHANNELS | Genes involved in Inwardly rectifying K+ channels |
0.1 | 0.3 | REACTOME TRANSPORT OF GLUCOSE AND OTHER SUGARS BILE SALTS AND ORGANIC ACIDS METAL IONS AND AMINE COMPOUNDS | Genes involved in Transport of glucose and other sugars, bile salts and organic acids, metal ions and amine compounds |
0.0 | 0.6 | REACTOME 3 UTR MEDIATED TRANSLATIONAL REGULATION | Genes involved in 3' -UTR-mediated translational regulation |
0.0 | 0.1 | REACTOME CLASS I MHC MEDIATED ANTIGEN PROCESSING PRESENTATION | Genes involved in Class I MHC mediated antigen processing & presentation |
0.0 | 0.3 | REACTOME DOUBLE STRAND BREAK REPAIR | Genes involved in Double-Strand Break Repair |
0.0 | 0.2 | REACTOME SIGNAL TRANSDUCTION BY L1 | Genes involved in Signal transduction by L1 |
0.0 | 0.6 | REACTOME EXTRACELLULAR MATRIX ORGANIZATION | Genes involved in Extracellular matrix organization |
0.0 | 0.0 | REACTOME DOWNSTREAM TCR SIGNALING | Genes involved in Downstream TCR signaling |
0.0 | 0.0 | REACTOME MITOTIC M M G1 PHASES | Genes involved in Mitotic M-M/G1 phases |